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ABSTRACT 
Pyrimethamine is a commonly used drug in prophylactic and therapeutic 
treatment of human malaria caused by the parasite Plasmodium falciparum. 
It has been postulated that the mode of action of pyrimethamine is by 
inhibition of the enzyme dihydrofolate reductase (DHFR). This was tested 
genetically in the first part of the study using a cross between a 
pyrimethamine sensitive and a pyrimethamine resistant cloned line 3137 and 
H133. The results of restriction-fragment-length-polymorphism (RFLP) 
analysis on the pattern of pyrimethamine resistance inheritance in the 
progeny confirm that the mutation causing resistance to pyrimethamine in 
HB3 is closely linked to the dihydrofolate reductase-thymidylate synthetase 
(DHFR-TS) gene and may be located within it, as previously inferred from 
sequencing and biochemical results. 
Structural alteration to DHFR resulting from point mutation in the 
DHFR gene has been suggested as one way in which resistance to 
pyrimethamine might occur. However, it is possible that other mechanisms 
e.g. over-production of the enzyme DHFR may also be important. The 
second part of the study investigated this possibility. Quantification of the 
enzyme level revealed no differences between the parents of the cross, 3137 
and HB3. However, pyrimethamine resistant mutant T9/94 (Ml-1) selected 
in vitro was found to produce twice as much protein as the sensitive parent 
clone T9/94, suggesting that over-production of the enzyme can increase 
resistance to pyrimethamine. Over-production of the protein was also 
observed in a naturally occurring pyrimethamine resistant clone PR70/CB3. 
Since a mutant over-producing the enzyme was identified, it was 
decided to initiate studies that would ultimately be able to assess the role of 
vi 
transcriptional control in pyrimethamine resistance. As a first step, the 5' 
flanking regions of the DHFR genes from 3D7 and HB3 were sequenced and 
their transcriptional start sites mapped. Minor variations in the two 
sequences were found. The relationship of the sequence variations to the 
RFLP used in the genetic analysis is discussed. 
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1.1 BIOLOGY AND GENETICS OF PLASMODIUM FALCIPARUM 
1.1.1 Life Cycle of Plasmodium falciparum 
Malaria is a cosmopolitan disease causing a high degree of mortality 
and morbidity in large parts of the world every year. The disease is caused 
by a parasitic protozoan, Plasmodium of which four species are responsible 
for human malaria: Plasmodium falciparum, Plasmodium vivax, Plasmodium 
malariae and Plasmodium ovale. P. falciparum is the most virulent form of 
these species. 
The parasite undergoes a complex life cycle with asexual reproduction 
occurring in mammalian hosts and sexual reproduction in the anopheline 
mosquito vectors (Fig. 1.1). The infection in man begins when the 
sporozoites are inoculated into the bloodstream from the salivary glands of 
a mosquito. The sporozoites then invade the liver cells where they undergo 
the exo-erythrocytic phase of development. During this phase the sporozoites 
mature to become trophozoites which then undergo schizogony to form 
thousands of merozoites. These are released from the liver and enter red 
blood cells in which they start a second phase of erythrocytic development. 
During this phase the parasite again develops into ring and trophozoite and 
then undergoes schizogony to form merozoites which will invade un-infected 
red blood cells and cause the cycle to be repeated. Some of the merozoites 
upon invasion develop into gametocytes which are infective to mosquitoes. 
In the stomach of the mosquitoes, the gametocytes mature into microgametes 
and macrogametes. Fertilization results in the formation of zygotes which 
become motile (ookinetes) and move through the stomach or midgut wall to 
form a cyst (oocyst) in which hundreds of sporozoites develop. The 
sporozoites then migrate to the salivary glands of the mosquitoes where they 
become mature and infective to man. 
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Fig. 1.1 Life cycle of Plasmodium falciparum (adapted 
from Sandosham & Thomas, 1983). 
1.1.2 Speciation 








Historically, Plasmodium species were grouped according to the host 
range based on the belief that the parasites have evolved with their hosts and 
that there is greater relatedness among parasites in related hosts than those 
in hosts greatly separated in evolution. Thus, the species are classified into 
primate, rodent, avian and lizard malarias (Wernsdorfer, 1980). Further 
subdivision is based on morphological (e.g. shapes of gametocytes) and 
biological characters (e.g. cycle periodicity). 
However, with the growing discipline of molecular parasitology, the 
Plasmodium species have been re-grouped according to the base composition 
and organization of their DNA. By this approach, species differing widely in 
host range, morphology and biological characters are grouped together 
(McCutchan et al., 1984a). 
The diversity of different characters in field isolates or clones of 
human or rodent malaria (Walliker, 1983) makes it necessary to subdivide the 
species into subspecies or strains. The heterogeneity in isozyme types, 
protein variants, drug sensitivity and antigenic types has been used to study 
the genetic diversity in parasite populations of rodent or falciparum malaria 
(Carter & Walliker, 1977; Walliker, 1983; Fenton et al., 1985). The use of 
monoclonal antibodies in serological typing of different strains of malaria 
parasite extends the range of methods for identification of different strains 
of this malaria parasite (McBride et al., 1982; 1985). 
1.1.3 Genetic Crosses & Genetic Recombinations 
Genetic crosses provide powerful tools in studying conventional 
genetics in the malaria parasite. However, few genetic studies have been 
performed on malaria parasites due to the technical difficulty in manipulating 
organisms with a complex life cycle in the laboratory. Precise genetic analysis 
relies on the use of genetically pure clones which can be isolated by limiting 
dilution (Rosario, 1981) or micro-manipulation (Trager et al., 1981). It also 
requires the technique of making crosses between parent clones displaying 
well-defined characteristics. 
To date, a number of crosses have been successfully made in rodents 
due to the comparative ease of passaging the parasites through rodents 
(Walliker et al., 1971; 1975; Rosario, 1976; Knowles et al., 1981). The first 
genetic cross of a human malaria parasite was not made until recently 
(Walliker et al., 1987). The method for making crosses is depicted in Fig. 1.2. 
Basically, a cross begins by mixing gametocytes from two cloned lines of 
parasites in vitro which are then fed to mosquitoes to allow cross-fertilization 
of gametes to take place. Because of the presence of male and female 
gametocytes of each parent line in the initial blood mixture, it is possible to 
form three types of zygotes: those of each parent line from self-fertilization 
and the hybrid form from cross-fertilization. Assuming that fertilization 
occurs randomly, equal numbers of parent-type and hybrid zygotes will be 
obtained. The resultant zygotes develop into sporozoites inside the mosquito 
vectors which can then infect mammalian hosts (i.e. chimpanzee, rodent) in 
devQIo?Q4 
which 	the asexual blood stages Parasitized red blood cells 
obtained from the hosts are cloned to obtain an array of progeny for analysis 
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Fig. 1.2 Genetic cross of Plasmodium 
of recombination of various markers, thereby providing an insight into the 
genetics of malaria parasites. 
Studies on the inheritance pattern of variant forms of enzymes and 
drug resistance characters in crosses suggest a eukaryotic life cycle with 
haploid blood forms (Walliker et al., 1971; 1975; Walliker, 1983; 1989). The 
haploid nature of the blood form chromosomes was established by the 
observation of one kind of enzyme in each cloned progeny. Genetically 
determined characters are inherited in a simple Mendelian pattern with 
segregation of various enzyme markers and drug resistance characters. The 
presence of a normal eukaryotic pattern of chromosomal segregation is also 
evident by electron microscopic studies on meiotic division in Plasmodium 
berghei (Sinden & Hartley, 1985). 
The detection of novel-sized chromosomes in 2/3 of the progeny from 
the human malaria cross suggests that some kind of chromosomal 
rearrangement had taken place during the cross (Walliker et al., 1987). This 
may be due to crossing over, reciprocal translocation or gene conversion 
during pairing at meiosis. Indeed, a novel-sized chromosome 4 in one such 
clone was produced by crossing-over between the parental chromosomes 
during meiosis (Sinnis & Wellems, 1988). 
1.1.4 Restriction-fragment-length-polymorphism (RFLP) in P. falciparum 
The advance in genetic studies of P. falc:parum has been accompanied 
by the availability of an increasing number of cloned genes and the feasibility 
of using the restriction-fragment-length-polymorphisms (RFLP) as physical 
markers to tag corresponding genes. RFLP describes the size variations in 
specific restriction enzyme fragments often found closely linked to alleles of 
genes. The mutations responsible for the sickle cell anaemia and 0-
thalassaemia create new restriction enzyme sites and hence new RFLP's (Kan 
et al., 1980; Orkin et al., 1982). The RFLP markers were therefore originally 
used in prenatal diagnosis of a number of human genetic diseases. It is 
usually very accurate, providing an exact diagnosis of sickle cell status to 
greater than 80% (Kan & Dozy, 1978a; b; Philips Ill et al., 1980) and carriers 
of haemophilia A to >96% (Harper et al., 1984; Oberle et al., 1985). 
RFLP's have been used in several attempts to study various aspects of 
Plasmodium genetics such as the inheritance pattern of certain phenotypes, 
the establishment of linkage groups and the correlation of drug resistance 
with a particular target gene (Wellems et al., 1987; 1990; 1991; Peterson et 
al., 1988; Foote et al., 1990b). 
The mutations giving rise to RFLP's in the Plasmodium genes have not 
been investigated. In the case of human genetic diseases, the RFLP is often 
associated with point mutation(s) leading to the creation or destruction of a 
restriction enzyme site (Fig. 1.3a) as in the case of the 3-globin genes (Kan 
et al., 1980; Orkin et al., 1982). It is also possible that a large 
insertion/deletion of sequence is involved (Fig. 1.3b) as is the case of the 
human a-globin gene (Higgs et al. 1981). The nature of the RFLP associated 
with the dihydrofolate reductase-thymidylate synthetase (DHFR-TS) alleles 
of P. falciparum will be studied and discussed in detail in CHAFFER 5. 
1.2 THE WORLD MALARIA SITUATION 
1.2.1 Global Distribution: Past and Present 
Human malaria is endemic in the tropics and sub-tropics and is 
probably as old as mankind itself. There are records suggesting its origin 
from Egypt dating from 1,600 BC and cases were known in ancient China and 
Arabian countries. The first accurate clinical description of malarial fevers 
was given by Hippocrates in 400 BC, who mentioned the symptoms of the 
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Fig. 1.3 Examples of mutations causing restriction-fragment-
length-polymorphism (RFLP). 
Changes of endonuclease recognition sites caused by point 
mutations. Endonuclease recognition sites are designated by 
arrows. Arabic numbers give distances in kilobases (kb). The A 
gene, which is 2kb long, has an additional endonuclease restriction 
site 1kb from the right end of the gene. The mutant a gene is 
closely linked to a DNA sequence change 1kb downstream from 
the right end of the gene resulting in an altered sequence which no 
longer functions as a recognition site. Endonuclease digestion of 
DNA containing the A gene followed by Southern transfer will 
result in detection of a 5kb fragment. However, digestion of DNA 
containing the a gene will result in a longer 7kb fragment. 
Deletion/insertion of DNA sequences. In A gene, an 
endonuclease restriction site is located 5kb from the right end of 
the gene. The mutant a gene is linked to a deletion of 2kb 
downstream from the right end of the gene. Endonuclease 
digestion of DNA containing the A gene followed by Southern 
transfer will result in detection of a 9kb fragment. However, 




















disease as periodic chills, fevers and sweating. Malaria was probably 
introduced into the Americas in the 16th century with the Spanish and 
Portuguese invasions and later with the advent of the African slave trade. 
The global distribution of the disease was then maintained largely unchanged 
until after the end of World War II when an intensive anti-malaria 
programme was put into operation. A concerted effort of vector control, use 
of insecticides and drug prophylaxis brought the population living in 
malarious areas under protection between 1957-1972. However, a resurgence 
of malaria has occurred throughout the tropics since the mid 1970s. By 
contrast, Europe, Australia and the United States have remained malaria-free 
despite cases imported from other countries (for review see Wernsdorfer, 
1980). 
According to the World Health Organization Tropical Disease 
Research 7th Programme Report, Jan 1983-31 Dec 1984 (World Health 
Organization, 1985), nearly 365 million people, representing 1/12th of the 
world's population, are living in highly endemic areas where no specific anti-
malaria measures are being applied e.g. tropical Africa. A further 2,217 
million, 46% of the world's population, are living in endemic areas where 
control measures have been undertaken. It is estimated that the disease is 
responsible for the deaths of one million infants and young children each year 
in Africa. In areas other than tropical Africa the incidence of the disease is 
estimated to be around 20 million cases a year. In Africa south of the 
Sahara some 200 million people are believed to be chronically infected and 
of these about 1/3 suffer acute manifestations of the disease in the course of 
a year. 
Among the four human malaria parasites, P. falcipa,um and P. vivax 
account for most of the human suffering and economic loss due to malaria 
in the world today whereas P. ovale and P. malariae are of regional 
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importance only (World Health Organization, 1985). P. falciparum is the 
prevailing species in tropical Africa. P. vivax occurs most commonly in the 
Americas and Asia. However, with the recent success of malaria control in 
Southern Asia, the incidence of P. vivax infection has fallen although that of 
P. falciparum has remained virtually unchanged, apparently due to drug 
resistance. 
1.2.2 Control Measures and Drug Prophylaxis 
A concerted effort of drug chemotherapy and intensive vector control 
programmes has been carried out to eradicate the disease. Insecticides have 
been widely used to kill the mosquito vectors. The most extensively used 
insecticide, dichioro-diphenyl-trichioroethane (DDT), exerts its residual action 
for up to six months. However, the widespread use of this insecticide has 
selected populations of vector resistant to it. This has prompted a shift from 
chlorinated hydrocarbon insecticides to organophosphorous compounds or the 
more expensive carbamides (Wernsdorfer, 1980). 
Apart from controlling the vectors, chemotherapeutic and 
chemoprophylactic measures have been undertaken as means of treatment 
and protection. A number of antimalarial drugs are available with different 
modes of action on specific stages of the malaria life cycle. Currently used 
drugs include quinine, chloroquine, primaquine, antifolates and sulfonamides 
(Dietrich & Kern, 1981). Their chemical formulae are displayed in Fig. 1.4. 
Quinine: Quinine is primarily schizontocidal for vivax as well as for 
falciparum infections with some gametocidal activity against P. vivax, P. ovale 
and P. malariae. It is effective as a suppressive drug. When used in 
combination with sulfonamides, antifolates, tetracyclines or other compounds, 
it is able to control or avoid clinical attacks especially of chloroquine-resistant 
falciparum malaria. Resistance to quinine was described very early this 
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Chioroquine: Chioroquine is a 4-aminoquinoline used in acute malaria 
attack against P. vivax P. ovale, P. malaiiae and chioroquine-sensitive P. 
falciparum. Being a blood schizontocide, it causes rapid control over 
parasitaemia and clinical symptoms. In the case of chioroquine resistant 
falciparum malaria, a combination of sulfadoxine and pyrimethamine is 
usually used to treat the patients. 
Primaquine: Primaquine is an 8-aminoquinoline currently available 
for the radical treatment of vivax and ovale infections. It is the only tissue 
schizontocide. Its gametocytocidal effect makes it a suitable candidate to be 
used in combination with blood schizontocides in combating spread of drug 
resistant parasites. 
Antifolates: A class of drugs called antifolates provide important 
antimalarial drugs. They derive their name from their target of action, the 
enzyme dihydrofolate reductase (DHFR). Proguaml and pyrimethamine are 
two well known examples of antifolates. They are normally used in 
combination with other drugs in prophylaxis. In addition, proguanil is a 
causal prophylactic antimalarial agent by rendering gametocytes non-infectious 
to mosquitoes. 
S.I ponamides: SuIonamides are long-acting blood schizontocides. 
They exert their antimalarial effect by inhibiting the enzyme dihydropteroate 
synthetase, which is one of the key enzymes in folate metabolism. They exert 
prophylactic activities especially when used in combination with other drugs, 
most commonly antifolates. 
Sul pkones:S(4F ones are schizontocides acting against?. falclpalun2 only. 
They are suppressive when combined with other drugs. 
Drug combinations: Drugs are used together to give either an additive 
effect or a potentiating effect. In the first case, a suppressive drug is usually 
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used with a causal prophylactic or anti-relapse drug e.g chioroquine and the 
DHFR inhibitor, pyrimethamine. In the second case, inhibitors of DHFR 
and sulfonamides or sulfones are usually used as these drugs affect the same 
pathway and act synergistically. 
1.2.3 The Spread of Drug-resistant Parasites 
Drug resistance in malaria has been defined as the "ability of a 
parasite strain to multiply or to survive in the presence of concentrations of 
a drug that normally destroy parasites of the same species or prevent their 
multiplication. Such resistance may be relative (yielding to increased doses 
of the drug tolerated by the host) or complete (withstanding maximum doses 
tolerated by the host)". Three levels of resistance denoted RI (low), Ru 
(medium) and Ru! (high) are generally recognized, according to the response 
of parasites in patients undergoing a standard course of drug treatment. 
Resistance to almost all major antimalarial compounds has been 
reported. Among these, resistance to chioroquine has the greatest impact on 
malaria chemotherapy since chloroquine is the mainstay of malaria treatment. 
Simultaneous emergence of P. falciparum resistant to chloroquine was 
reported from Thailand and Colombia in the late 1950s whereas chloroquine 
resistant P. falciparum did not make its first appearance in East Africa until 
1978. By the end of 1984, chloroquine resistance was widespread in 
Thailand, Venezuela, Colombia, eastern Asia, South America and East Africa 
and continued to spread outwards from these countries (Spencer, 1985). To 
date, chioroquine resistance remains the most serious problem in malaria 
chemotherapy. The distribution of chloroquine-resistant P. falciparum is 
shown in Fig. 1.5. 
A combination of pyrimethamine/sulphadoxine is extensively used for 








[J Areas in which malaria has disappeared. been eradicated or never existed 
Areas with limited risk 
• Areas where significant malaria transmission occurs 
• Areas of chioroquinc-resisrant P. falciparum reported by 1984 
Fig. 1.5 Epidemiological assessment of status of malaria and 
chioroquine-resistant P. falciparum (adapted from World 
Health Organization, 1985). 
Fl 
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resistance to this combination is already widespread in the 'hard-core' areas 
of Southeast Asia and South America and cases of resistance have also been 
reported in East Africa (Hurwitz et al., 1981; Markwalder & Meyer, 1982; 
Stahel et al., 1982; Farraroni et al., 1983). Resistance to 
pyrimethamine/suiphadoxine seems to be directly related to pyrimethamine 
resistance (Spencer et al., 1984). 
The situation is complicated by the failure of some malaria patients 
to respond to multiple drugs. Multi-drug-resistance in plasmodia has become 
a common clinical problem. Isolates obtained from these patients showed 
resistance to multiple drugs (Thaithong et al., 1983). Moreover, a number of 
cloned lines have been tested to be resistant to multiple drugs. 
1.2.4 Strategies for Combatting Drug-resistant Parasites 
Considerable attention has been paid to the design of new drugs. 
Among those tested, mefloquine and qinghaosu are the most promising. 
Mefloquine, a quinolinemethanol (Fig. 1.4), is a potent blood schizontocide 
active against multi-drug-resistant falciparum malaria. This new compound 
is registered for prophylaxis and treatment (Trenholme et al., 1975). 
However, there is fear of cross-resistance between mefloquine and other 
structurally similar drugs i.e. quinine or chioroquine though no clear instance 
of such cross resistance seem to have been reported. Isolated cases of 
mefloquine-resistant falciparum infection have been documented (Boudreau 
et al., 1982; Bygberg et al., 1983) and parasites resistant to mefloquine have 
been cloned from these patients (Webster et al., 1985). Stable resistance has 
also been successfully induced in the laboratory (Oduola et al., 1988). To 
delay the widespread appearance of mefloquine resistance, this new 
compound is now used in combination with sulfadoxine and pyrimethamine. 
Qinghaosu (artemisinine) (Fig. 1.4), the active principle of the Chinese 
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medicinal herb Artemisia annua, and its derivatives have been widely studied 
in China (China Cooperative research group on qinghaosu and its derivatives 
as antimalarials, 1982a) and shown to have a rapid action in treating 
chioroquine resistant falciparum malaria (China Cooperative research group 
on qinghaosu and its derivatives as antimalarials, 1982b; c). Presumably they 
are effective against the erythrocytic stages of malaria parasites by affecting 
protein synthesis and/or membrane function (Jiang et al., 1982; Xiao & Fu, 
1986). Their novel structures and different modes of action make them 
potential new drugs in reducing the risk of emergence of cross-resistant 
parasites. The drugs have already been put into clinical trials (Jiang et al., 
1982; Xiao & Fu, 1986). There has been no marked evidence of cross-
resistance between artemisinine and chioroquine or 
sulfadoxine/pyrimethamine (World Health Organization, 1986) although 
artemisinine-resistant mutants has been induced in the laboratory (Inselburg, 
1985). 
The effect of artemisinine is markedly potentiated when used in 
combinations with mefloquine, primaquine or chioroquine whereas an 
antagonistic effect is obtained when combined with the antifolate compounds. 
Increasing failure rates of drug chemotherapy has prompted research 
into the new area of vaccine development (for reviews see Anders, 1985; 
Nussenzweig & Nussenzweig, 1985; Ravetch et al., 1985; Spriggs, 1985; 
Targett & Sinden, 1985; Wernsdorfer, 1985; Heidrich, 1986; Miller et al., 
1986). However, the design of the first antimalarial vaccine will be a 
complicated process which requires improvement of an expression system for 
large scale production of the vaccine (Smith et al., 1984; Sharma & Godson, 
1985; Young et al., 1985) and a series of pre-clinical and clinical trials (Hall 
et al., 1984; Collins et al., 1986; Herrington et al., 1987; Patarroyo et al., 
1988). It is hoped that some day a vaccine will become available, but until 
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then we will rely on improved chemotherapy. 
1.2.5 The Potential for Developing a New Drug in Treating Chioroquine-
resistant Malaria 
Association of chioroquine resistance with increased efflux of the drug 
from the cell (Krogstad et al., 1987) and the reversal of this efflux 
phenomenon and the chloroquine resistance phenotype by the calcium 
channel blocker, verapamil (Martin et al., 1987) may point to the possible use 
of calcium-channel blockers as a new generation of drugs in treating 
chioroquine-resistant malaria. 
An initial step to a better design of this new class of drugs will require 
an understanding of the modes of action of chioroquine and the mechanisms 
of chioroquine resistance. The mode of action of chioroquine is still 
controversial. It may act by forming a complex with ferriporphyrin IX (FP) 
which prevents the sequestration of FP into malaria pigment, thereby allowing 
FP and the FP-chloroquine complex to exert their intrinsic cellular toxicity 
and causing lysis of malaria parasites (Chou et al., 1980; Orjin et al., 1981; 
Fitch et al., 1983; Fitch, 1986). Alternatively, the elevation of the vacuolar 
pH (Krogstad et al., 1985; Warhurst, 1986; Krogstad & Schlesinger, 1987; 
Choi & Mego, 1988) resulting from accumulation of chloroquine inside the 
malarial food vacuoles (Aikawa, 1972) may interfere with the digestion of 
haemoglobin and hence starve the parasite of amino acids for protein 
synthesis (Homewood et at., 1972; Yayon et al., 1984; 1985). Another 
possibility is that intercalation of chloroquine into DNA (Gutteridge & 
Trigg, 1972) may result in impairment of DNA function such as DNA-
dependent polymerase reaction in DNA synthesis (O'Brien et al., 1966; Ciak 
& Hahn, 1966) and gene function (Kwakye-Berke & Meshnick, 1990). 
Despite the yet unclear mode of action of chloroquine, there are 
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considerable studies on the mechanisms of chioroquine resistance. In analogy 
to the multi-drug-resistance (MDR) phenomenon in cancer cells which can 
also be reversed by verapamil (Slater et al., 1982; Rogan et al., 1984), it was 
speculated that a mechanism similar to that in cancer cells was operating in 
P. falcipamm (for review see Cowman, 1991). MDR in cancer cells involves 
increased expression and amplification of a so-called mdrl gene (Shen et al., 
1986) encoding a membrane P-glycoprotein (Juliano & Ling, 1976; Akiyama 
et al., 1985; Cornwell et al., 1986) which functions as an efflux pump (Fojo et 
al., 1985; Chen et al., 1986; Marx, 1986). This idea became more evident by 
the isolation of genes from P. falcipaium (pfmdrl, pfmdr2) homologous to the 
mammalian mdrl gene (Foote ci' al., 1989; Wilson et al., 1989). 
Circumstantial evidence also relates amplification and sequence variation of 
one of the genes with chloroquine resistance in some field isolates (Foote et 
al., 1990b). However, there are exceptions in which the expected sequence 
variations do not occur. Moreover, genetic analysis showed that there is no 
linkage between the rapid efflux phenomenon, chloroquine resistance 
phenotype and either of the pfmdr genes or their amplification in P. 
falciparum (Wellems et al., 1990). The same study also suggests that 
chloroquine resistance is governed by a single genetic locus, in contrast to 
chloroquine resistance in Plasmodium chabaudi which is multigenic (Rosario, 
1976; Padua, 1981). This leads to the suggestion of the involvement of genes 
other than pfindr in chloroquine resistance (Newbold, 1990). More thorough 
studies will be needed to fully understand the mechanism of chloroquine 
resistance. Recently, the gene governing chioroquine resistance in a 
chioroquine resistant strain has been mapped to a 400kb locus on 
chromosome 7 (Wellems, 1991). 
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13 RESISTANCE TO PYRIMETHAMINE AND RELATED COMPOUNDS 
IN P. FALCIPARUM 
This section will be devoted to a review of the mechanism of resistance to 
pyrimethamine, which is one of the most commonly used antimalarial drugs. 
In addition, resistance to proguanil and sulphonamides will be described since 
these compounds are normally used in combination with pyrimethamine in 
malaria chemotherapy and chemoprophyla.xis. 
Antifolates exert their effects by inhibiting the key enzymes in the 
pathway of folate metabolism. A folate derivative is an essential co-factor in 
the biosynthesis of deoxythymidylate (dTMP) (Fig. 1.6) which is one of the 
building blocks in DNA synthesis. Since malaria parasites do not incorporate 
exogenous thymine or thymidine (Ferone, 1977), thymidylate must be 
synthesized de novo from deoxyuridylate (dUMP), in a reaction catalysed by 
thymidylate synthetase (TS) and mediated by the folate co-factor 5,10-
methylenetetrahydrofolate which serves as both a one-carbon donor and 
reducing agent (Blakley, 1984). The 5,10-methylenetetrahydrofolate is itself 
converted into dihydrofolate. The dihydrofolate produced must be reduced 
immediately to avoid depletion of the intracellular pool of tetrahydrofolate 
which is the precursor for the co-factor. The reduction reaction is catalysed 
by dihydrofolate reductase (DHFR) (Blakley, 1984). The tetrahydrofolate is 
subsequently methylated to 5, 10-methylenetetrahydrofolate by serine 
hydroxymethyltransferase (Blakley, 1984). 
Thus, inhibition of folate metabolism will subsequently inhibit DNA 
synthesis. Pyrimethamine and proguanil exert their inhibitory effects by 
inhibiting dihydrofolate reductase.Sphonamides, on the other hand, prevent 
the production of dihydrofolate by inhibiting dihydropteroate synthetase 
which catalyses the conversion of pteridines to dihydrofolate 
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thymidylate 
dUMP 	Synthatess 	dTMP 
glycine 
transfereel 
Fig. 1.6 	Biochemical pathway for the synthesis 
of deoxythymidylate. 
further back in the metabolic pathway (see Section .1.3.1). 
To date, all the key enzymes for thymidylate synthesis have been 
identified and characterized, including dihydrofolate reductase, thymidylate 
synthetase and serine hydroxymethyltransferase in all the Plasmodium species 
so far examined (Ferone et al., 1969; Reid & Friedkin, 1973; Ferone, 1977; 
Ruenwongsa et al., 1989). 
1.3.1 Folate Metabolism- De novo Pathway 
There are two methods of generating the folate precursors for this 
reaction: de novo and salvage. The relationship of different folate related 
pathways is illustrated in Fig. 1.7. The part concerning de novo synthesis of 
folate from pteridine precursor is blown up and depicted in Fig. 1.8 which 
also shows the chemical formulae of various substrates. 
The de novo pathway has long been thought to be the sole pathway 
occurring in malaria parasites. In this pathway, the 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine is converted into 2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine pyrophosphate which then condenses with p-
aminobenzoate (PABA) into dihydropteroate (Fig. 1.7 & Fig. 1.8). A 
glutamate residue is then incorporated into dihydropteroate to form 
dihydrofolate which is subsequently reduced to tetrahydrofolate. The 
existence of this de novo pathway is presumed by the identification of the 
corresponding enzymes 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase, dihydropteroate synthetase and dihydrofolate reductase 
(McCullough & Maren, 1974; Ferone, 1977; Sherman, 1979; Walter & 
Konigk, 1980). However, dihydrofolate synthetase, the enzyme catalysing the 
conversion of dihydropteroate to dihydrofolate has yet to be discovered. 
This pathway can be inhibited by uphonamides and 
pyrimethamine/proguanil which inhibit dihydropteroate synthetase and 
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Fig. 1.7 Folate related metabolic pathways in P. falciparum. The 
de novo and salvage synthesis of tetrahydrofolate is illustrated in 
the upper part of the diagram. This pathway is inhibited at one 
stage by sulphonamides and at the other stage by pyrimethamine 
and proguanil. The conversion of tetrahydrofolate to the 
methylated co-factors and their roles in the biosynthesis of 
deoxythymidylate and methionine is illustrated in the lower part of 
the diagram. 
Key and Abbreviations: 
* may be salvaged from host plasma 























'dTMP — 	) serine )-1 	 I—methionine' 
thymidylate 	serine hydroxym ethyl- 	methioni 
synthetase transterase 	 synthase 
Fig. 1.8 De novo synthesis of tetrahydrofolate from pteridine, p-
aminobenzoate and L-glutamate. The pterin precursor is 
condensed with p-aminoben.zoate (PABA) into dihydropteroate in 
a reaction catalysed by dihydropteroate synthetase. A glutamate 
residue is then incorporated into dihydropteroate to form 
dihydrofolate, catalysed by dihydrofolate synthetase. The 
dihydrofolate is then reduced to tetrahydrofolate in a reaction 
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dihydrofolate reductase respectively. They are effective by being substrate 
analogues of p-aminobenzoate (PABA)/p-aminobenzoylglutamate (PABG) 
and dihydrofolate respectively. 
The source of the pteridines is believed to be guanosine 5'-
triphosphate (GTP). The enzyme, GTP cyclohydrolase which catalyses the 
conversion of GTP to dihydroneopterin triphosphate has already been 
isolated from P. falciparum (Krungkrai et al., 1985). Furthermore, a number 
of the pterin intermediates from the pteridine synthesis pathway have been 
demonstrated (Krungkrai et al., 1989a). 
1.3.2 Folate Metabolism- Salvage Pathway 
There is growing recognition of the importance of a salvage pathway 
in folate metabolism in plasmodia. It is evident from the ability of exogenous 
folate to reverse the antagonistic effects of pyrimethamine and sulphonamides 
(Chulay et al., 1984; Sixsmith et al., 1984; Milhous et al., 1985; Watkins et al., 
1985) and the direct demonstration of incorporation of 3H-labelled folate into 
5-methyltetrahydrofolate (Krungkrai et al., 1989a; 1990). The salvage pathway 
is shown to be preferentially utilized in vitro (Krungkrai et al., 1989a; 1990). 
It is proposed that folate can either be used intact or in degraded forms, as 
pterin aldehyde or as p-aminobenzoylglutamate (PABG) (Fig. 1.7). PABG 
is known as an alternative but less efficient substrate than PABA for 
dihydropteroate synthetase (Ferone, 1973; Shiota, 1984) which, when using 
PABG as substrate, converts pteridine to dihydrofolate without the 
intermediate step of dihydropteroate synthesis (Shiota, 1984). 
The bulk of the intraerythrocytic folate pool is comprised of 5-
methyltetrahydrofolate (Blakley, 1969). It is speculated that malaria parasites 
can salvage the substrate 5-methyltetrahydrofolate from the host plasma in 
methionine synthesis (Fig. 1.7). The enzyme, methionine synthase, catalysing 
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the conversion of homocysteine to methionine has been identified (Krungkrai 
et al., 1989b). This may be an alternative route by which salvaging pre-
formed 5-methyltetrahydrofolate provides the folate co-factors needed by the 
parasites (Krungkrai et al., 1990). 
1.3.3 Mechanism of Resistance to Pyiimethamine- Single Base Changes 
Biochemical studies on P. falciparum provide direct evidence that 
pyrimethamine blocks DHFR in vivo (Sirawaraporn & Yuthavong, 1984; 
Walter, 1986). From these studies, it is also evident that plasmodial DHFR 
differs from mammalian DHFR both in kinetic properties and structure 
(Ferone, 1977; Kan & Siddiqui, 1979). Thus, it is thought that pyrimethamine 
exerts its anti-malaria action by selective inhibition of DHFR since 
plasmodial DHFR binds to pyrimethamine 102103  times more tightly than 
mammalian DHFR. 
The greater concentration of pyrimethamine needed to inhibit the 
DHFR activity in strains resistant to pyrimethamine has led to speculation 
that resistance to pyrimethamine arose from a structurally altered enzyme 
with reduced affinity for pyrimethamine (McCutchan et al., 1984b, Dieckmann 
& Jung, 1986a; Walter, 1986; Chen et al., 1987; Zolg et al., 1989). 
To understand the mechanism of pyrimethamine resistance at the 
molecular level, the P. falciparum gene encoding DHFR was cloned and 
sequenced (Bzik et al., 1987). In contrast to the DHFR in vertebrates, 
bacteria, yeast, bacteriophages and mammalian viruses which exist as distinct 
and separable proteins (Baccanari et al., 1975; Blakley, 1984; Trimble et al., 
1988), DHFR is translated with thymidylate synthetase (TS) uninterruptedly 
from a single reading frame in P. falciparum (Bzik et al., 1987). The first 
group of 228 amino acids denotes an amino-terminal DHFR-domain 
(.27kDa) which is joined to a carboxyl-terminal TS-domain (residues 323- 
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608) by a junctional domain (residues 229-322). 
The bifunctional proteins are dimers of identical subunit (Chen & 
Zoig, 1987). Both DHFR and TS are more related to their monofunctional 
counterparts in eukaryotes than in prokaryotes or bacteriophage T4. The TS 
domain is more conserved than the DHFR domain. The bifunctional nature 
of the protein is common to all protozoa studied so far (Ferone & Roland, 
1980; Garrett et al., 1984; Beverley et al., 1986; Grumont et al., 1986). The 
bifunctional enzyme offers the advantage of more efficient channeling of 
dihydrofolate produced in the TS reaction to the substrate binding site of 
DHFR (Meek et al., 1985). On the other hand, the two enzymes retain a 
measure of independence as indicated by the possession of autonomous folate 
binding sites which are susceptible to different metabolic inhibitors (Meek et 
al., 1985). In addition, expression of DHFR activity independently of the TS 
activity has been achieved in Escherichia coli from a recombinant plasmid 
carrying the DHFR region only (Hall et al., 1991). 
Sequence comparison of the dihydrofolate reductase-thymidylate 
synthetase (DHFR-TS) gene from geographically isolated strains resistant or 
sensitive to pyrimethamine has pinpointed conserved base changes in all the 
resistant strains (Table 1.1). The most highly conserved change is a 
serine/threonine residue to an asparagine residue at codon 108 (Cowman et 
al., 1988; Peterson et al., 1988; Hyde, 1989; Snewin et al., 1989; Zoig et al., 
1989). Additional changes of Asn-51 to Ile-51 or Cys-59 to Arg-59 were 
found associated with increased levels of resistance (Cowman et al., 1988; 
Peterson et al., 1988). Substitutions in all three positions confer high 
resistance to pyrimethamine for the parasites. In P. c/zabaudi, in vitro 
selected pyrimethamine resistant (pyrR) mutants show a single mutation from 
serine to asparagine at position 106 which is equivalent to the mutation at 
codon 108 in P. falcipantm (Cowman & Lew, 1990). 
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Table 1.1 A list of parasites, the levels of resistance to pyrimethamine, 
cycloguanil and the associated amino acid changes in the dihydrofolate 
domain 






Amino Acid residues References 
16 51 
- 1 	54 - 59 - 108 164 223 
Csi-2 Thailand 40 R Ala Asti Asp Arg Am Leu Phe 1 
V1/S Vietnam R R Ala lie Asp Arg Am Leu Phe 8 
0d2 Indochina 25 n.r. Ala lie Asp Aeg Asn lie Phe 2 
V-I Vietnam 20 S Ala Asti Asp Aeg Asti lie Plie 
Ki Thailand 20 S Ala Am Asp Azg Am lie Phe 13 
708 Brazil 12 S Ala lie Asp Cys Aso lIe Phe 1.2.4 
it.1312 Brazil 4 S Ala lie Asp Cys .Asn n.y. n.r. 2 
HB3 Honduras 13 S Ala Aso Asp Cys Am lie Phc 1.2.4 
Hond.-1 Honduras R n.r Ala Asn Asp Cys Asn Ile Phe 5 
Camp Malaysia 1.0 n.y. Ala Am Asp Cys Am n.y. n.r. 2 
Palo Alto I Uganda S n.y. Vat Aso Asp Cys Thy lie Phe 
Palo Alto 2 Uganda R S Ala Am Asp Cys Asti lie Phe 6 
3D7 Netherlands 0.025 S Ala Asti Asp Cys Sec lie Pbe 1.13 
UPA Uganda S R Vat Asti Asp Cys Thr lie Phe 8 
FCB Columbia S R Vat Aso Asp Cys Thr He Phe 8 
W2 Indochina R S Ala lie Asp Arg Am lie Phe S 
it.G2.F6 Brazil 0.006 R Ala Am Asp Cys Thr n.r. n.r. 2 
SL/136 Sierra L.eone 0.004 5 Ala Asn Asp Cys Sec lie Phe 2 
LES Liberia 0.004 n.y. n.r. Asti Asp Cys Set or. n.y. 2 
FC27 Papua-NG S S Ala Aso Asp Cys Set lie Phe 6 
FAa Brazil S R Vat Asti Asp Cys Th lie PIN: 6 
FCR3 Gambia 0.020 R Vii Asn Asp Css Thr lie Phe 2.43.6 
FCR3/D4-D7 R n.y. Vii Am Asp Cys Thr lie 5cr 5 
FCR3/D8i Expt. mutants R n.r Vat Am Asti Cys Thr lie Ser 73 
FCR3/D8ii R n.r. Val Am Asp Cys Thr lie Set S 
Legend to the table 
n.r. not reported 
S = sensitive, R = resistant 
V1/S is a cloned line of V-i 
FAC8 is a subclone of It.G2.F6 
FCR3/D8i is the originally isolated mutant 
FCR3/D8jj is the mutant maintained in culture in the absence of 
pyrimethamine 
References: 1 = Cowman et al., 1988; 2 = Peterson et al., 1988; 3 = Snewin et 
al., 1989; 4= ZoIg etal., 1989; 5= Tanaka et al., 1990b; 6= Foote et 
al., 1990; 7= Inselburg et al., 1988; 8= Peterson et al., 1990. 
Adapted from Hyde (1990) 
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I will outline the relevance of each of these changes in turn. Thus far 
there is no structural analysis on Plasmodium DHFR-TS protein. The 
functional significance of the nucleotide changes could only be deduced from 
the role of equivalent residues in substrate/inhibitor binding in other 
organisms. Residue 108 in P. falcipaium is conserved as a threonine in all 
other organisms examined and occurs in a region analogous to the C a-helix 
bordering the active site cavity of bacterial, avian and mammalian enzymes 
(Blakley, 1984). In Lactobacillus ca.sei, it was shown that residues lying in this 
helix interact with methotrexate- another antifolate drug (Blakley, 1984). It 
is therefore likely that replacement of serine/threonine with asparagine in P. 
falciparum may affect inhibitor binding due to the different spatial and 
chemical characteristics acquired by the side chain groups. 
The residue Cys-59 is equivalent to a glutamine residue in eukaryotes 
and a lysine/arginine residue in prokaryotes. These residues lie in the aB 
helix which contributes to the substrate binding pocket. The residue is 
apparently functionally unimportant in prokaryotes since the side chain of the 
residue is directed out towards the solvent. However, when the mouse 
DHFR interacts with the antifolate drug trimethoprim, glutamine is in contact 
W-Ith highly conserved neighbouring residues directly involved in inhibitor 
binding (Stammers et al., 1987). Thus, conversion of cysteine to a bigger and 
more polar arginine would significantly modify such interactions with a 
concomitant effect on inhibitor binding. 
The functional significance of Ile-51 is uncertain since the equivalent 
leucine residue found in most other DHFR molecules is predicted to lie at 
the amino-terminal extremity of the aB helix at some distance and directed 
away from the active site cavity. 
Recently, the significance of Asn-108 and Ile-51 mutations has been 
confirmed by the inhibition properties of pyrimethamine toward the 
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recombinant enzymes purified from an expression system (Sirawaraporn et al., 
1990). Mutations in these two positions in vitro alter the sensitivities of the 
enzymes to pyrimethamine. 
1.3.4 	Mechanism of Resistance to Pyrimethamine- Other Possible 
Mechanisms 
The existence in nature of a wide range of resistance to 
pyrimethamine, from very low level of resistance to as much as 10 6-fold more 
resistant than the sensitive organism suggests a multitude of factors operating 
together, in different combinations to confer different degrees of resistance 
on different parasites. In the rodent malaria parasite, P. berghei, both 
increased enzyme levels and decreased affinity for inhibitor are important 
factors in determining the degree of resistance in both field isolated 
pyrimethamine resistant (pyrR) strains and in vitro selected mutants (Diggens 
et al., 1970; Ferone, 1970; Ferone et al., 1970). There is already a 
documented case in P. falc4arum in which the specific activity of DHFR 
increases 30- to 80-fold (Kan & Siddiqui, 1979). Other possible mechanisms 
such as gene amplification and altered membrane permeability have not been 
detected in field isolates (Dieckmann & Jung, 1986a; Cowman et al., 1988). 
In the kinetoplastids, reduction of uptake of folate antagonists has been 
implicated as one mechanism for drug resistance (Dewes et al., 1986; 
Ellenberger & Beverley, 1987). This, in conjunction with gene amplification, 
contributes resistance to another DHFR inhibitor, methotrexate in 
Leishmania major (Coderre et al., 1983; Beverley et al., 1984; 1986; Washtien 
et al., 1985; Ellenberger & Beverley, 1987). Gene amplification is also one 
of the mechanisms contributing to methotrexate resistance in cultured 
mammalian cells (Schimkeet al., 1978). 
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Analysis of pyrR mutants selected in vitro from P. falciparum 
(Inselburg, 1984; Banyal & Inselburg, 1986; McCutchan, 1988) revealed 
several possible novel mechanisms of pyrimethamine resistance which have 
not been reported to operate in vivo in this organism. The change at codon 
108 found in all pyrR field isolates has not occurred in in vitro selected 
mutants. In one set of experiments a nucleotide change resulting in a novel 
amino acid change from phenylalanine to serine at codon 223 was detected 
(Table 1.1) (Tanaka et al., 1990b). This point mutation may be significant in 
conferring resistance to some of the mutants since other changes such as the 
enzyme content and activity, the accumulation of drug, gene copy numbers 
and chromosome sizes have not been detected in them. However, it is 
impossible to predict the effect of this mutation on substrate/inhibitor binding 
because the equivalent residues in prokaryotic/eukaryotic systems are not 
known to be involved in binding these ligands (Hyde, 1990). 
An additional mutation of Asp-54 to Asn-54 was detected in one of 
the mutants (Tanaka et al., 1990b; Inselburg et al., 1988) which may be 
responsible for the higher degree of resistance in this mutant. However, this 
mutation is unstable and revertants were found in prolonged culturing in the 
absence of drug pressure (Tanaka et al., 1990a). 
Chromosomal size polymorphisms and gene amplification may be 
partly responsible for the tolerance to a higher level of pyrimethamine in 
some mutants (Tanaka et al., 1990a; b). In one case mutants were associated 
with a 10-fold over-production of the enzyme (Inselburg et al., 1987). Gene 
duplication and chromosomal rearrangement have also been observed in in 
vitro selected pyrR P. chabaudi (Cowman & Lew, 1989). 
One mutant accumulates about 5 times more drug than wild type with 
a normal level of DHFR activity (Banyal & Inselburg, 1986). It is speculated 
that resistance to pyrimethamine in this mutant is partly due to titration of 
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the drug by the higher level of protein expressed in this mutant (Banyal & 
Inselburg, 1986; Inselburg et al., 1987). 
1.3.5 Proguanil Resistance and Its Relationship to Pyrimethamine Resistance 
Proguanil (Fig. 1.4) is an antifolate with a known target pHFR. It has 
been used as an antimalarial drug in combination with pyrimethamine and 
sulphonamides in prophylaxis and treatment of P. falciparum infection. 
Resistance to cycloguanil (Fig. 1.4), the active metabolite of proguanil and 
pyrimethamine occur independentf each other (Thompson & Bayles, 1968; 
Vestergaard, 1983; Milhous et al., 1985). 
Analysis of field isolates or clones from geographically distinct areas 
shows no linkage between pyrimethamine and cycloguanil resistance (Table 
1.1). Parasites resistant to cycloguaml only show a change of Ser-108 to Thr-
108 and another change of Ala-16 to Val-16 (Foote et al., 1990a; Peterson et 
al., 1990). In parasites that are highly resistant to both drugs, there is a 
unique change of Ile-164 to Leu-164 in conjunction with the changes 
associated with pyrimethamine resistance at other positions. These mutations 
are located in conserved regions bordering the active site cavity of the 
enzyme. Equivalent residues have been shown to be involved in the binding 
of various inhibitors to avian, bacterial and mammalian DHFR. It is 
postulated that the degree of resistance to these drugs is due to accumulation 
of changes in the DHFR gene leading to increased resistance to 
pyrimethamine or cross-resistance to cycloguanil. 
1.3.6 Sul pIadoxine (Sul pkonamide) Resistance 
.5 u I phonamides are substrate analogues competing with p-aminobenzoate 
(PABA) for binding to dihydropteroate synthetase. 	Metabolism of 
sulphonamides to the su1M-analogues of dihydropteroate will subsequently 
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inhibit the synthesis of dihydropteroate which is the precursor of 
dihydrofolate. Three mechanisms have been proposed to operate together 
to account for the suIonamide resistance in P. falciparum (Dieckmann & 
Jung, 1986b). 
P. falciparum does not metabolically inactivatesi.4p(adoxine (Fig. 1.4). 
However, metabolism ofsulFkadoxine  to the toxic analogue of dihydropteroate 
is reduced in resistant plasmodia. 
Uptake ofsuiphadoxine is markedly decreased in resistant parasites. 
Contrary to the sensitive parasites which acquire PABA exogenously, PABA 
is not an essential nutrient for suiphadoxine resistant parasites. The potential 
for the parasite to synthesize PABA de novo is highlighted by the 
demonstration of four of eight enzymes for the de novo synthesis of PABA 
in both sensitive and resistant parasites. It is therefore possible that by 
shifting to de novo synthesis of PABA, exogenous supply of PABA is no 
longer required and hence the uptake of PABA which may be coupled to 
uptake of suiphonamide will be markedly reduced. 
1.4 THE PLASMODIUM GENOME 
The haploid genome size of Plasmodium is in the range of 2-4xlO 7bp (Goman 
et al., 1982). The complexity of the Plasmodium genome is similar to that of 
yeast (2x107) and slightly greater than that of E. coli (5x106) but is only one 
hundredth that of man (3x109). 
It is estimated that the parasite possesses in the range of 2,700-5,400 
genes, based on the calculation from the size of the genome, the large 
difference in base composition between coding and non-coding regions and 
the average length of P. falciparum mRNA transcripts (Hyde et al., 1984). 
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The Plasmodium genome exhibits a number of features characteristic 
of the genus. They are summarized in the following sections. 
1.4.1 N ikd e ck~ Ae_ Cos4ov 
Analysis of a number of P. falciparum genes revealed an average AT 
content of 69% for the coding region flanked by even more AT rich regions 
of 86% (Hyde & Sims, 1987; Weber, 1987; Saul & Battistutta, 1988). The A 
residue is predominant over T in the mRNA synonymous strand. The coding 
sequence preference for A and T increases in the order of 1st, 2nd and 3rd 
bases of the codon (Weber, 1987). In addition, A and G are preferred in the 
first position whereas T is preferred in the last position. The C residue is 
under-represented throughout the coding region. The frequencies of the 
dinucleotides TG and CC are elevated while those of CG, TA and AC are 
suppressed. No CGG codon has been found in any of the P. falciparum 
genes sequenced so far (Weber, 1987). The stop codon TAA is preferred 
among the genes sequenced to date although the other two stop codons are 
also found. 
In the non-coding region, there is no consistent purine or pyrimidine 
asymmetry. The 5' flanking region shows dinucleotide preferences involving 
C and G residues. All four C/G containing doublets GG/CC/GC/CG are 
over-represented with nearly half the C's and G's in these highly AT rich 
regions being in a C/G pairing (Hyde & Sims, 1987). 
Analysis of sequences surrounding the ATG start codon revealed a 
consensus sequence AAAAATG (Saul & Battistutta, 1990). A functional 
significance of the A residues in the initiation of translation is suggested by 
the significantly more frequent occurrence of A in the four positions 
preceding the initiation ATG than in adjacent non-translated DNA. 
Methylation of the cytosine residues has not been detected in the 
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Plasmodium genome (Pollack et al., 1982; McCutchan et al., 1984a), thus it 
is unlikely that methylation of the cytosine residues will play a role in gene 
regulation in Plasmodium. 
1.4.2 Introns 
Most of the Plasmodium genes examined so far are devoid of introns. 
Even when present, the number is small, usually restricted to one, which 
separates a short 5' exon from the main body of the 3' exon (Favaloro et al., 
1986). Genes containing more than one intron appear to be rare, although 
an a-tubulin gene (Holloway et al., 1989) and a 3-tubu1in gene (Delves et al., 
1989) containing two introns and antigen genes containing two (Simmons et 
al., 1987) and three introns (Knapp et al. 1989) have been described. DNA 
sequence analysis of the hypoxanthine-guanine phosphoribosyltransferase 
(HGPRT) gene revealed the presence of three introns (A. Khan, personal 
communication). The sizes of the introns are small, usually in the range of 
a few hundred bases. The intron-exon boundary contains the consensus splice 
sites sequence GT ---- AG (Kemp et al., 1987a). An unusual case is denoted 
.YC..Oc(i 
in an aldolase gene which is predicted to have a 5' exon t a single 
methionine residue (Knapp et al., 1990). 
1.4.3 Repeats 
Considerable interest in vaccine development in recentyears together 
with progress in recombinant DNA technology allowed the isolation and 
cloning of a number of genes from P. falciparum (for review see Scaife, 
1988). Surprisingly, repeats are common features in these antigen-
determining genes e.g. the genes encoding for the circumsporozoite protein 
(CSP) (Dame et al., 1984; Enea et al., 1984), the S-antigen (Coppel et al., 
1983; Cowman et al., 1985; Stahl et at., 1985a), the glycophorin-binding 
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protein (Perkins, 1984), the merozoite surface antigens (Mackay et al., 1985; 
Tanabe et al., 1987), the knob-associated histidine-rich protein (KAHRP) 
(Tnglia et al., 1987), the ring-infected erythrocyte surface antigen (RESA) 
(Cowman et al., 1984; Favaloro et al., 1986) and the small histidine-alanine 
rich protein (SHARP) (Stahl et al., 1985b). Since the repeats are 
immunodominant parts of the molecule, they may play an important role in 
evasion of the immune system. By stimulating the immune system to over -
produce antibodies against these regions, they may act as a 'smokescreen' to 
camouflage essential parasite proteins from the host immune system (Kemp 
et al., 1987b). It is also likely that the tandem repeats actually mimic host 
protein epitopes to avoid their immunological recognition as foreign proteins 
(Kobayashi et al., 1986). 
1.4.4 Chromosomal Heterogeneity of the Genome 
At least 14 chromosomes ranging in size from 800-3,500kb are 
detected in the P. falciparum genome (Kemp et al., 1987b; L.angsley et al., 
1987; Wellems et al., 1987; Prensier & Slomianny Ch., 1986). Alteration, in 
the molecular karyotypes of geographically different isolates and clones is a 
common feature of P. falciparum in natural infections (van der Ploeg et al., 
1985; Kemp et al., 1985; Corcoran et al., 1986). Chromosome size 
polymorphisms are most commonly attributed to differences in the 
subtelomeric regions encompassing repetitive DNA (Foote & Kemp, 1989), 
which probably arise by chromosomal rearrangement during meiotic or 
mitotic divisions e.g. polymorphism in the subtelomeric regions containing 
repetitive DNA can occur in progeny of a genetic cross or in cloned parasites 
grown in culture (Oquendo et al., 1986; Walliker et al., 1987; Corcoran et al., 
1988; Patarapotikul & Langsley, 1988). 
In some cases, polymorphisms arose from the loss of protein-coding 
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genes. The three histidine-rich-protein (HRP) genes can each be deleted 
without loss of parasite viability in vitro (Kilejian et al., 1986; Pologe & 
Ravetch, 1986; Kemp et al., 1987b; Wellems et al., 1987; Biggs et al., 1989), 
so can the RESA gene (Pologe & Ravetch, 1988; Cappai et al., 1989). 
Drug resistance may be an important factor contributing to 
chromosome size polymorphisms. Changes in karyotypes were documented 
in P. falciparum and P. chabaudi after pyrimethamine selection. The 
alterations putatively involve duplication of the targeted genes together with 
subsequent chromosomal rearrangements (Tanaka et al., 1990a; b; Cowman 
& Lew, 1989; 1990). In addition, size heterogeneity of chromosome 5 has 
been observed in some multi-drug resistant isolates. This is thought to be 
due to the variation in numbers of different-sized pftndrl -containing 
amplicons which are arranged in a tandem array (Foote et al., 1989). 
1.5 REGULATION OF GENE EXPRESSION IN EUKARYOTIC CELLS 
Most genes, when in an inert state, are tightly packaged with histones into 
chromatin. Transcriptional activation involves decondensation of this inert 
structure, making transcriptional control sequences available to regulatory 
proteins. The mechanism. for this decondensation is unclear but it may 
involve binding to the nucleoskeleton through DNA sequences that function 
as attachment sites. Active genes are characterized by chromosomal changes 
that include undermethylation (Bird, 1986; Yisraeli et al., 1988) and a looser 
packing of the nucleosomal DNA (Weisbrod, 1982; Reeves, 1984); the latter 
change was revealed by the increased nuclease sensitivity of the active genes. 
The onset of transcription takes place through the interaction of 
defined proteins (transcription factors) with specific DNA sequences 
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(promoters) adjacent to the gene which is analogous to the regulation of gene 
expression in prokaryotes. In bacteria conserved RNA polymerase-binding 
sites are located Wand 35bp upstream of the initiation point (Rosenberg & 
Court, 1979). In contrast to prokaryotes where a single RNA polymerase 
enzyme is responsible for the transcription of DNA into RNA, three enzymes 
are involved in eukatyotes. RNA polymerase II is utilized to direct 
transcription of all protein-coding genes and some small nuclear RNA 
involved in RNA splicing whereas RNA polymerase I and III are used to 
transcribe ribosomal RNA and tRNA. There is no reason to suggest a 
classical eukaryotic system is not operating in Plasmodium. The gene 
encoding the largest subunit of RNA polymerase II was isolated and it shows 
homology to the enzyme from higher eukaryotes (Li et al., 1989). Therefore, 
the following sections will only describe control of transcription by RNA 
polymerase II. 
1.5.1 Promoters Involved in Regulation of Transcription by RNA Polymerase 
II 
Transcription begins at a certain distance 5' to the translation start 
site. The mRNA start sites do not display extensive homology of sequence. 
However, there is a tendency for the start site to be 'A' flanked on either 
side by pyrimidines (Breathnach & Chambon, 1981). 
Promoter elements 'TATA', 'CAAT' boxes and GC-rich elements are 
generally required for specific transcription by RNA polymerase II. They can 
occur in different combinations in different genes. The 'TATA' boxes occur 
more proximally and the other two are often contained within sequences from 
40-110bp from the transcriptional start site. The main characteristics of 
promoter motifs are distance-dependent activation and the requirement for 
location 5' to the transcriptional start site. Some moti 5 e.g. 'CAAT' 
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boxes and GC-rich motifs are functional in both orientations. It is postulated 
that the distal control region comprising the 'CAAT box and the GC 
elements facilitates initial entry of RNA polymerase II onto the gene to make 
contact with the proximal 'TATA' sequence. The interaction of RNA 
polymerase II and the 'TATA' motif results in specific initiation. 
The 'TATA' motif is shared by many but not all promoters, having a 
consensus TATAA/TAA/T sequence surrounded by GC rich sequence 
(Breathnach & Chambon, 1981). The 'TATA' boxes are required for 
accurate initiation of transcription 25-30bp downstream. In the absence of 
the 'TATA' sequence, mRNA with heterogeneous 5' termini would be 
synthesized (Grosschedl & Birnstiel, 1980; Benoist & Chambon, 1981). 
The 'CAAT boxes are found upstream of virtually all globin genes 
and in several other genes (Efstratiadis et al., 1980; Grosveld et al., 1982; 
McKnight et al., 1985). GC-rich elements containing the consensus 
GGGCGG sequence have been found in a number of genes including the 
thymidine kinase gene of herpes simplex virus (McKnight & Kingbury, 1982; 
McKnight et al., 1984), the SV40 early promoter region (Byrne et al., 1983; 
Everett et al., 1984) and many 'housekeeping' genes. This GGGCGG 
sequence has been shown to bind to the promoter-specific transcription factor 
Spi (Dynan & Tjian, 1983). 
1.5.2 Enhancers of Eukaryotic Genes 
An enhancer is a short, cis-acting regulatory sequence. The activity of 
a promoter is enormously increased by the presence of an enhancer sequence. 
An enhancer is functionally independent of distance and orientation and can 
be located either upstream or downstream of a promoter. Moreover, an 
enhancer can activate a heterologous promoter of a remote gene (Banerji et 
al., 1981; Khoury & Gruss, 1983; Serfling et al., 1985). The role of enhancer 
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elements in stimulating transcription is unknown. They may serve as an 
initial entry site for transcription factors or may bring about structural 
changes of the DNA to facilitate binding of RNA polymerase with the DNA. 
Enhancer elements are found in the 72bp repeat of the SV40 early 
promoter (Banerji et al., 1981) and also in cellular genes such as 
immunoglobulin gene (Banerji et al., 1983; Serfling et al., 1985; Wirth et al., 
1987). In the latter case, the enhancer stimulates transcription in a cell-
specific manner. 
1.5.3 The Putative Role of an Altered DNA Configuration on Gene Activation 
DNA molecules having an unusual base composition can adopt 
configurations other than the conventional right-handed B-form e.g. Z-DNA 
which, in crystals, is left-handed. Formation of Z-DNA is favoured in 
nucleotide sequences that have alternating purines and pyrimidines i.e. poly 
d(GC), poly d(CA), poly d(GT), d(CGCG), d(CGCGCG), poly d(CA/TG) 
(Hamada et al., 1982; Dickerson et al., 1982; Nordheim & Rich, 1983a; Rich 
et al., 1984) and short stretches (8-13) of alternating purine-pyrimidine base 
pairs and also in sequences in which some base pairs are found out of purine-
pyrimidine alternations (Nordheim & Rich, 1983b). 
Z-DNA forming sequences are found in a number of viral system 
transcriptional enhancers, the 5' flanking sequence of some genes in yeast and 
in the promoter region of other eukaryotic genes (Cantor, 1981; Nordheim 
& Rich, 1983b; Kann et al., 1984; Rich et al., 1984). This class of sequence 
may be involved in some fundamental functions such as activation or 
inactivation of the gene by directing interconversion between the B- and Z-
forms. One piece of evidence comes from the adoption of a Z-form by poly 
(dG.dm5C) at near physiological salt concentration when the C residue is 
methylated (Cantor, 1981). Simultaneously, methylation of cytosine in vivo 
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is associated with gene inactivation in eukaryotes (Bird, 1986; Yisraeli et al., 
1988). It is therefore possible that these two phenomena are related. 
Association of the formation of Z-DNA with transcriptional activity is 
evident from the staining of the heat-inducible puffs in Drosophila polytene 
chromosomes (Nordheim et al., 1981; Pardue et al., 1983) and the 
transcriptionally active macronucleus of the ciliated protozoan Stylonichia by 
Z-DNA specific antibodies (Lipps et al., 1983). Similarly, Z-DNA forming 
sites are found closely associated with DNase I hypersensitive regions within 
the enhancer element that regulates transcription of the eukaryotic virus 
SV40 (Cantor, 1981; Nordheim & Rich, 1983b; Rich et al., 1984). DNase I 
hypersensitive regions are often associated with transcriptionally active 
chromatin. Regulation through specific interactions with Z-DNA binding 
proteins is suggested by the isolation of such proteins from SV40 (Nordheim 
& Rich, 1983b) and Drosophila (Nordheim et al., 1982). 
1.5.4 Regulation of DHFR Expression in Mammalian Species 
DHFR belongs to a class of 'housekeeping' enzymes whose products 
are necessary for growth of all cell types. Unlike tissue-specific genes, the 
'housekeeping' genes are transcribed at a low level. Expression of the DHFR 
gene is cell cycle regulated at the transcriptional level. A low rate of 
transcription from a constitutive promoter is maintained throughout the cell 
cycle apart from a very brief increase in transcription rate at the onset of 
DNA synthesis (Farnham & Schimke, 1985). 
Presence of multiple mRNA species is a common feature of the 
mammalian DHFR genes. This results from utilization of different 3' 
polyadenylation sites and heterogeneous 5' termini (McGrogan et al., 1985; 
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Mitchell et al., 1986). The major transcriptional start sites have been mapped 
to -55, -63 and -71 from the translation start sites in mouse, hamster and 
human DHFR genes (Chen et al., 1984; Mitchell et al., 1986; Sazer & 
Schimke, 1986). Utilization of minor start sites further upstream has been 
observed in mouse and hamster DHFR genes in vitro and in vivo giving rise 
to bigger transcripts (Mitchell et al., 1986; Sazer & Schimke, 1986). 
The DHFR promoter regions do not contain consensus 'TATA' or 
'CAAr boxes as in other eukaryotic genes. However, GC-rich elements 
containing the consensus Spl binding site sequence GGGCGG and another 
consensus sequence CACAAATA are represented in different copies in 
tandem repeat in the upstream region in all three genes mentioned above 
(Chen et al., 1984; McGrogan et al., 1985; Farnham & Schimke, 1986; 
Mitchell et al., 1986; Ciudad et al., 1988). Binding of the transcription factor 
Spi to the GC elements (Dynan et al., 1986) is shown to be essential for 
DHFR promoter activity in the mouse and in Chinese hamster ovary cells 
(Dynan et al., 1986; Swick et al., 1989). Functional analysis indicated that the 
sequence surrounding the GC elements could specify transcription 40-60 
nucleotides downstream. One GC element is required for accurate 
transcription from the major start site in mouse DHFR gene (Farnham & 
Schimke, 1986) whereas three are needed for transcription of the hamster 
DHFR gene in vitro (Swick et al., 1989). 
Another transcription factor E 2F binds 3' to the major transcription 
aM, 
start site Ais required for efficient expression of the hamster DHFR gene in 
vitro and in vivo (Blake & Azizkhan, 1989). 
Apart from the GC elements, the striking homology between the 5' 
flanking sequences of the three mammalian DHFR genes up to 900 bases 
from the coding region may imply a functional significance of this region in 
regulation of gene expression in these species (Chen et al., 1984; McGrogan 
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et al., 1985; Azizkhan et al., 1986). A functional region is located 700bp 
upstream of the coding region of the mouse DHFR gene which contains a 
CAACT sequence separated by SObp from a TAATAA sequence. However, 
it is unclear whether they are functional in vivo since they are about 200bp 
upstream from the longest transcript detected by Si mapping. 
A class of small, nuclear, poly K RNA orientated in the opposite 
direction to that of DHFR mRNA has been identified (Farnham et al., 1985; 
Mitchell et al., 1986). They are short, 180-240 nucleotides in length with 
heterogeneous 5' termini mapped adjacent to the DHFR promoter region. 
Probably they arise by bi-directional transcription from the promoter region. 
The functional significance of these opposite-strand RNAs is untested 
but they may be involved in translational regulation of DHFR expression as 
in the E. coli ompC and ompF system involving expression of outer 
membrane proteins (Mizuno et al., 1984). The OmpF production is regulated 
by the transcription of an opposite-strand micRNA (mRNA-interfering 
complementary RNA) from an independent transcriptional unit of the ompC 
locus which shows hOmology to the 5' end of the ompF mRNA. 
Hybridization of micRNA to ompF nIRNA may inhibit translation of the 
ompF mRNA. This type of antisense regulation may be plausible in mouse 
DHFR since the opposite-strand RNA sequence shows complementarity to 
the first ten nucleotides of the major DHFR transcript and a short region of 
the DHFR mRNA immediately following the translation stop codon. 
1.5.5 Regulation of DHFR Expression in Kinetoplastids 
Transcription of L. major DHFR gene starts at major sites of -245/-
375 and minor sites of -195/-295/-440. The 5' end profile remains unchanged 
in amplified or wild type genes and in different growth and developmental 
stages (Kapler et al., 1987). 
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Examination of the 5' flanking sequence does not reveal any 
homologies with other trypanosomal genes, eukaryotic consensus promoter 
elements or mammalian DHFR promoter elements. Immediately 5' of the - 
375 sites there are two positions displaying sequence homology with L. major 
mini-exon; otherwise, sequences upstream of the start sites do not exhibit 
significant homology to each other. 
It is possible that the L. major DHFR gene utilizes different regulatory 
signals which may be cryptic or may be located far away from the body of the 
mRNA. One feature of the flanking sequence is the common occurrence of 
dinucleotide repeats. A (T)4 tract followed by a (CA) 20 tract is located at - 
301 to -348. Poly (CA) has the capacity to adopt a Z-DNA configuration 
(Nordheim & Rich, 1983a) and has been shown to enhance gene expression 
in cultured mammalian cells (Hamada et al., 1984). 
In contrast to L. major, the 5' flanking sequence of the DHFR-TS 
gene of a closely related kinetoplastid protozoan, Crithidiafasciculata displays 
striking homology to mammalian DHFR promoter element including a 70% 
identity with a repetitive sequence element that functions as the mouse 
DHFR promoter and a potential Spi binding site CGCCCC (Hughes et al., 
1989). The putative promoter element is contained within -366 to -272 with 
no apparent 'TATA' or 'CAAT-like elements. 
It is possible that while C. fasciculata uses promoter elements similar 
to those of the mammalian system, L. major uses completely different control 
signals. Alternatively, the consensus CGCCCC may not represent a true 
promoter for C. fasciculata. The 90% amino acid identity in the coding 
regions of the two kinetoplasti4 Asuggests  that they may utilize similar 
regulatory elements such as the conserved sequence PyrPyrCCCTCTC found 
in both species. 
As with the mammalian system, in C. fasciculata, divergent 
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transcription from similar promoters of the DHFR-TS gene generates 
opposite-strand RNA. A sequence downstream from the promoter consensus 
region is complementary to the 3' end of the C. fasciculata mini-exon-derived 
RNA, suggesting a possible role of trans-splicing to form the mature RNA. 
1.6 REGULATION OF GENE EXPRESSION IN SPOROZOA 
1.6.1 Transcriptional regulation 
Little is known about regulation of gene expression in sporozoa at the 
transcriptional level. Although functional transcripts can be mapped by 
techniques such as Si mapping and primer extension, identification of 
putative promoters relies on the development of functional tests and 
consensus analyses of a number of upstream sequences. Thus far only the 
transcriptional unit of the circumsporozoite (CS) gene of Plasmodium knowlesi 
is well characterized. The transcriptional start sites for a few Plasmodium 
genes and the a -tubulin gene of Toxoplasma gondii have been mapped( wabtk  
The P. knowlesi CS gene (Ozaki et al., 1983) is the first and most 
thoroughly studied Plasmodium gene at the transcriptional level (Ruiz I 
Altaba et al., 1987). CS protein constitutes 5-20% of the total protein 
product synthesized by the mature sporozoite (Cochrane et al., 1982). The 
gene is developmentally regulated and is only expressed in the sporozoite 
stage as a 2,050 bases transcript (Ruiz I Altaba et al., 1987) which cannot be 
detected in the blood stage (Ellis et al., 1983). However, the transcriptional 
unit is maintained intact in these two stages with identical DNA sequences 
across 1.5kb on the 5' side, 0.5kb on the 3' side and the entire coding region. 
There is no DNA rearrangement within 15kb of chromosomal DNA and 
there is no obvious gene amplification (Ruiz I Altaba et at., 1987). 
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Regulation is therefore likely at the level of transcription or RNA stability. 
Si nuclease and primer extension analyses have identified intronless 
transcripts with multiple start sites spanning a 100-base region. Consensus 
analysis of the 5' upstream region with prokaryotic, eukaryotic and viral 
systems has identified several potential regulatory elements including the 
'TATA' and 'CAAT' boxes, repeat sequences resembling prokaryotic 
attenuators and terminators and sequences highly homologous to SV40 
enhancer and reiterated core sequences (Laimins et al., 1982; Weiher & 
Botchan, 1984). 
The abundance of CS protein synthesized in a stage-specific manner 
suggests that the promoter is strong and tightly regulated. Its regulation may 
be similar to mechanisms regulating tissue-specific gene expression in higher 
eukaryotes. 
Similarly, the expression of the precursor to the major surface antigens 
(gp195) gene in P. falciparum is stage-specific (Myler, 1990). The mRNA is 
detected most abundantly at the late trophozoite and early schizont stages but 
at much reduced level at the ring stage. This implies that the gene is most 
likely regulated at the level of transcription or mRNA stability. The major 
transcriptional start site is mapped to about 520bp upstream within a long 
oligo dT tract. Potential transcription regulatory sequences ('TATA' and 
'CAAT boxes) have been identified upstream of this region. 
In analogy to the gp195 gene in P. falczarum, it is thought that 
transcription of the equivalent gene in Plasmodium yoelii- the gene of the 
precursor to the major merozoite surface antigens (PMMSA) (Lewis, 1989)-
is regulated in a stage-specific manner during the asexual erythrocytic cycle. 
Primer extension analysis has mapped multiple 5' termini to 377-417 bases 
from the AUG codon (Lewis, 1990). Consensus analysis with eukaryotic and 
viral systems has identified potential promoter regulatory elements including 
the 'TATA' boxes and an immunoglobulin octamer sequence. Possession of 
several Z-DNA forming regions may imply a role of enhancer function since 
formation of Z-DNA may be related to transcriptional activation (see Section 
1.5.3). 
The transcriptional start sites of two other P. falcipaium genes were 
also mapped. The 5' non-coding region of the mRNA extends to at least 
322bp from the coding region of the aldolase gene (Knapp et al., 1990). 
However, the calmodulin mRNA has a major start site 62bp upstream of the 
initial AUG codon (Robson & Jennings, 1991). Consensus eukaryotic 
'TATA' and 'CAAT boxes are found upstream of the major transcriptional 
start site in P. falciparum calmodulin gene. 
The transcriptional unit of the a-tubulin gene of T. gondii, a parasite 
closely related to P. falciparum, has been examined (Nagel & Boothroyd, 
1988). The gene contains multiple introns which are spliced to form the 
mature mRNA with a 5' terminus at -269 from the coding region as mapped 
by primer extension. Trans-splicing is not involved in the formation of the 
mature a-tubulin transcript. Examination of the sequence upstream of the 
start site does not reveal any homologies to known eukaryotic promoter 
elements. 
1.6.2 Differential Expression, RNA Processing and RNA Stability 
The small subunit rRNA genes of P. berghei and P. falciparum occur 
as low copy number genes dispersed throughout the genome, without any 
amplifications of the genes. There are two classes of structurally distinct 
rRNA genes 'A' and 'C' (Dame & McCutchan, 1983; Gunderson et al., 1986; 
1987; McCutchan et al., 1988) that are developmentally regulated (Waters et 
al., 1989). Developmental regulation of the two gene units illustrates a 
combination of differential expression of the genes, RNA processing and 
RNA stability. 
Transcription of the two genes is stage-specific with transcript from the 
'A' gene predominating in the asexual blood stage and transcript from the 'C' 
gene found almost exclusively in the mosquito stage. Studies on P. falciparum 
demonstrated that a switch from 'A' to 'C' gene expression resulted in 
accumulation of the 'C' gene precursor RNA in gametocytes (Waters et al., 
1989). Increased transcription associated with accelerated processing of 
precursor RNA to mature RNA of the 'C' gene occurs in the zygote and the 
early ookinete stages. This is accompanied with the breakdown of the 'A' 
gene rRNA so that by the late oocyst stage, the 'A' gene transcripts are 
virtually replaced by mature 'C' gene transcripts. 
1.6.3 Gene Amplification 
Certain genes exist in multiple copies to meet the great demand for 
protein synthesis e.g. the rDNA gene is amplified in number from 50-10,000 
in some eukaryotic organisms (Long & Dawid, 1980). Likewise, increased 
expression and amplification of the human mdr 1 gene is related to multi-
drug-resistance in cancer cells (Shen et al., 1986). In Plasmodium, gene 
amplification accompanied by over-production of the gene product has also 
been found associated with drug resistance both naturally occurring and under 
in vitro conditions (Inselburg et al., 1987; Cowman & Lew, 1989; Foote et al., 
1989; Tanaka et al., 1990a). It is tempting to speculate that parasite strains 
containing certain amplified genes may be selected under the pressure of 
drugs. 
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1.7 SCOPE OF THE PRESENT STUDY 
Resistance to antimalarial drugs has become a common clinical problem in 
malaria endemic areas. Despite this, little is understood about the 
mechanisms underlying drug resistance in malaria. In the present study our 
interest focuses on pyrimethamine which is thought to have a defined drug 
target, the enzyme DHFR. The gene for DHFR-TS has been cloned from 
P. falciparum and sequenced. A genetic cross between a pyrimethamine 
sensitive cloned line 3D7 and a pyrimethamine resistant cloned line HB3 has 
also been carried out and was made available for this work. Knowledge of 
the gene sequence together with the availability of genetic cross data allows 
us to decide whether or not pyrimethamine acts on DHFR and may help us 
formulate models for the mechanisms underlying resistance to pyrimethamine. 
The objective of the first part of the study was to define an RFLP 
associated with the DHFR-TS gene. This RFLP was then used as a marker 
in a genetic study. 
The objective of the second part of the study was to investigate over -
production of the enzyme as a possible mechanism of pyrimethamine 
resistance, employing an assay to measure the amount of DHFR-TS enzyme 
in different parasite strains. 
The consequent results prompted the initiation of a study of the 
significance of transcriptional regulation in pyrimethamine resistance. This 
involved sequencing the 5' non-coding regions of the DHFR-TS genes from 
3D7 and HB3 and mapping of the transcriptional start sites. 
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CHAPTER TWO 
MATERIALS AND METHODS 
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2.1 MATERIALS 
2.1.1 Bacterial Strain, Bacteriophages and Plasmid 
All Escherichia coli strains, bacteriophages and plasmid used in this 
study are listed below with their genotypes. 
E. coli strain 	Genotvne and Reference 
NM494 hfrhsdMSA 
(N.E. Murray, personal communication) 
TG1 K12, 1(lac-proAB), supE, thi, hsd5, 
F' [traD36,proA B 	M 15] 
(Gibson, 1984) 
JM83 ara, A(lac-proA,B), rpsL, t80, lacZ, AM15; 
(Vieira & Messing, 1982) 
BHB2690 Lysogen of )2690.imm434cIred3Dam15Sam7 
(Hohn & Murray, 1977; Hohn, 1979) 
BHB2688 Lysogen of ).2688.imrn434cI 26jed3Eam4Sam7 
(Hohn & Murray, 1977; Hohn, 1979) 
Bacteriophage 	Genotype and Reference 
ANM1149 	'XIMM434 b(538); (Murray, 1983) 
M13mp18/mp19 	(Yanisch-Perron et al., 1985) 
Plasmid 	Reference 
pUBS 1 	 (G. Murphy, personal communication) 
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2.1.2 Media and Solutions 
All bacteriological media were sterilized by autoclaving. 
L Broth: 	 Difco Bacto Tryptone log; Difco 
Bacto yeast extract 5g; NaCl 5g; 
per litre adjusted to pH 7.2. 
L Agar: 	 Difco Bacto Tryptone lOg; Difco 
Bacto yeast extract 5g; NaCl log; 
Difco agar 15g; 
per litre adjusted to pH 7.2. 
BBL Agar: 	 Baltimore Biological Laboratories 
trypticase log; NaCl 5g; Difco 
agar log; per litre 
(pH unaltered). 
BBL Top Agar: 	As for BBL Agar, but only 6.5g 
Difco agar per litre. 
Phage Buffer: 	 KH2HPO4 3g; Na2HPO4 (anhydrous) 7g; 
NaCl 5g; 1mM MgSO4; 0.1mM CaCl2 ; 
imI 1% gelatin solution per litre. 
5x(Spitizizen salts): 	(NH4)2SO4 2g; K2HPO4 14g; KH2PO4 
6g; trisodium citrate ig; MgSO4 
0.2g/ per litre. 
Minimal Medium: 	Difco Bacto Agar 15g; lOOnil 
Spitizizen salts (5x); lOmi 
20%(w/v) glucose; 50mg Vitamin 
B1/ per litre. 
Antibiotics: 	 L-Broth or molten L-Agar was 
supplemented with an appropriate 
antibiotic when necessary. 
Ampicillin was added to 
50jd-100g/mi, kanamycin to 
430/Ag/ml and tetracycline to 
10ig/m1. 
X-Gal Indicator Plates: 	Molten L-Agar, supplemented with 
an appropriate antibiotic if 
necessary, was poured into a plate 
and allowed to solidify. After 
drying at 37°C, 200l of L-Broth 
containing 301 of X-Gal (20mg/nil, 
5-bromo-4-chloro-3-indoyl 0 
-galactosidase in 
dimethylformamide) and 20j1 of 
IPTG (100mM, isopropylp-3-D 
-thiogalactoside in double 
distilled water) was spread onto 
the plate. 
TE(lx): 	 10mM Tris-HCI pH 8.0; 
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1mM EDTA pH 8.0. 
20xSSC: 	 175.3g NaCl; 
88.2g sodium citrate; 
pH to 7.0 with concentrated HC1; 
adjust volume to 1 litre. 
PBS: 	 NaC1 8.76g; 
Na2HPO4 .21-120 17.8g; 
NaH2PO4.21420 7.8g/ per litre; 
pH 7.2. 
TBE( lOx): 	 108g Tris base; 
55g boric acid; 
40m1 0.5M EDTA pH 8.0. 
TAE(50x): 	 242g Tris base; 
57.1ml glacial acetic acid; 
lOOmi 0.5M EDTA pH 8.0. 
2.2 PARASITOLOGY METHODS 
2.2.1 Culture Media 
Two types of medium were used depending upon the purpose of the 
experiment. The standard RPMI medium (Trager & Jensen, 1976), consisting 
of 10.39g/1 RPMI 1640 (Gibco), 5.94g/l HEPES buffer (Sigma), 100mg/i 
gentamycin sulphate (Sigma) and 2.5g/l NaHCO 3 (BDH), was used to culture 
parasites before they were tested for drug sensitivity. 
The modified RPM! medium (Zoig et al., 1982; 1984) was used for 
maintaining stock cultures and large scale cultivation. It consists of 10.4g/i 
RPM! 1640 (Gibco), 6.87g/l TES buffer (Sigma), 2g/i glucose (Sigma), 
50mg/i gentamycin sulphate (Sigma), 50mg/i hypoxanthine (Sigma) and 
2.25g/l NaHCO 3 (BDH). The pH was adjusted to 7.25 with 1M NaOH. The 
media were filter sterilized using Millipore 0.22gm filters and then stored at 
4°C until required. 
2.2.2 Preparation of Human Red Blood Cells and Human Serum 
Human red blood cells obtained from Edinburgh Blood Transfusion 
Service were washed 3 times in modified RPM! medium with centrifugation 
(3,500rpm/15min./4°C). Washed red blood cells could be kept at 4 °C for up 
to two weeks. Pooled human serum obtained from Edinburgh Blood 
Transfusion Service was kept at -20 °C. Before use, the serum was heat 
treated at 56 °C for 30mm. 
2.2.3 In vitro Cultivation of Plasmodium falciparum 
Stock cultures of P. falciparum were maintained at low parasitaemia 
in 5ml of modified RPM! medium supplemented with 10% pooled human 
serum and 0.25m1 packed human red blood cells in 50m1 culture flasks 
(Falcon) under an atmosphere of 95% N2, 3% 02  and 2% CO,. The cultures 
were incubated at 37°C with daily medium changes. The growth of the 
parasites were monitored by making thin smears on microscopic slides which 
were then examined by light microscopy after fixing in methanol and staining 
with 10% Giemsa stain (BDH). At least 1,000 red blood cells were counted 
and the percentage infected gave the parasitaemia. The cultures were diluted 
with fresh uninfected red blood cells when the parasitaemia reached 5% or 
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higher. 
Parasite cultures were expanded from small 50m1 flasks into large 
250m1 flasks for large scale cultivation. To start off with, each 250m1 flask 
contained 50m1 of modified RPM! medium supplemented with 10% of human 
serum and imi of packed red blood cells. An equal volume of fresh red 
blood cells was added to the culture once the parasitaemia reached 5% or 
higher. This procedure was repeated until there were 5m1 of packed red 
blood cells in each flask. The parasites were usually harvested when the 
parasitaemia reached 10%. 
2.2.4 Saponin Lysis of Red Blood Cells 
Parasites used as the source for preparation of DNA and RNA were 
released from red blood cells by saponin lysis. All the washing were 
performed in 1xSSC (standard saline citrate 20x: 3M NaCl, 0.45M sodium 
citrate, pH 7.0) or modified RPMI medium. Parasitized red blood cells were 
washed 3 times with centrifugation (3,SOOrpm/l0min./4 °C) and lysed with 
0.1% saponin in RPMI medium at room temperature for 10mm. The 
pelleted cells were washed once and lysed once again with 0.1% saponin. 
The free parasites obtained by centrifugation (3,500rpm/lOmin./4 °C) were 
washed 3 times before being used in nucleic acid preparation. 
2.2.5 Freezing of P. falciparum Culture 
Cultures of P. falciparum were frozen down and stored in liquid 
nitrogen as stocks. Since schizonts would be destroyed in the freezing 
process, cultures of approximately 5% parasitaemia with a high proportion of 
ring-forms were chosen. Deep-freeze solution (28% glycerol/3% sorbitol or 
mannitol/0.65% NaCl) was prepared by adding 28m1 glycerol to 72ml of 4.2% 
sorbitol or mannitol in 0.9% NaCl. Infected red cells were pelleted 
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(2,000rpm/5min.) and an equal volume of sterile deep-freeze solution was 
added to the packed blood cells slowly, drop by drop, with mixing. The 
preparation was left at room temperature for 5mm. to allow the glycerol to 
penetrate the cells. Aliquots of 0.5 ml were frozen down as stocks in liquid 
nitrogen. 
2.2.6 Thawing of Cryopreserved P. falciparum 
Frozen ampoules were returned to culture by rapidly thawing at 37 °C 
and pelleting the blood cells (2,000rpm/5min.). The packed cells were mixed 
slowly with one-fifth volume of sterile 12% NaCl and left at room 
temperature for 3mm., without stirring, before mixing slowly with ten volumes 
of sterile 1.6% NaCl. The blood cells were pelleted and again mixed slowly 
with ten volumes of sterile 0.2% dextrose and 0.9% NaCl. After 
centrifugation at 2,000rpm/5min., the pellet was resuspended in modified 
RPM! medium and cultured under the usual conditions except that initially 
the culture medium was supplemented with 15-20% human serum until the 
culture had well established. 
2.2.7 Synchronization of Parasite Stages 
Sorbitol treatment destroys trophozoite and schizont stages leaving the 
ring forms intact. An asynchronous culture of P. falciparum with a high 
percentage of rings was synchronized by sorbitol treatment as in Lambros & 
Vanderberg (1979). Infected red blood cells were pelleted (2,000rpm/5min.) 
and resuspended in five volumes of sterile 5% D-sorbitol for 5mm. at room 
temperature. After removing the sorbitol by centrifugation and washing once 
in modified RPM! medium, the culture was re-established under usual 
conditions. 
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2.2.8 Drug Sensitivity Tests 
Drug sensitivity tests were performed by Professor David Walliker. 
They were carried out using parasites cultured in standard RPMI medium. 
The haematocrit of the culture was adjusted to 5% with fresh red blood cells. 
Dilution to the desired parasitaemia (1%/0.3%/0.1%) was made with 5% 
haematocrit medium. The final cell suspension was dispensed into microtitre 
plates (100 1u1/well). After lhr, the medium was replaced by medium 
containing the test drug at serial dilutions of 10 5M, 10M, 10 7M, 10M, 10 
9M etc. Control wells without addition of the drug were included in each 
assay. Incubation was continued at 37 °C in a gassed container for 72hrs with 
daily changes of medium with drug before thin blood smears were taken from 
each well for microscopic examination. The growth of the parasites was 
graded from -(no growth) to + + + + (very healthy growth with high number 
of parasites in good morphology). The minimum inhibitory concentration 
(MIC) was defined as the lowest concentration of drug that will kill all or 
nearly all the parasites after exposure to drug containing media for 72hrs. 
2.3 CHEMISTRY OF THE ENZYME REACTIONS 
A brief account is given concerning the chemistry of the various enzyme 
reactions which were used in the method sections. 
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Restriction Endonucleases (Type II) obtained chiefly from prokaryotes cut 
double-stranded DNA at or near to their particular recognition sequences, 
which typically are 4-6 nucleotides in length with a two-fold axis of 
symmetry, and thus create sticky or blunt ends to be used in molecular 
cloning. 
T4 DNA Ligase obtained from T4-infected E. coli is used to catalyse the 
formation of a phosphodiester bond between adjacent 3'OH and 5'-
phosphate termini in DNA during ligation of cohesive or blunt ends in 
molecular cloning. 
DNA Polymerase I is obtained from E. coli. Its 5'-3' polymerase and 5'-3' 
exonuclease activities are utilized to catalyse labelling of DNA by nick 
translation which involves the elimination of nucleotides from the 5' side 
and the sequential addition of nucleotides to the 3' side. 
Kienow is a large fragment of DNA polymerase I. It possesses 5'-3' 
polymerase activity which is used to catalyse the synthesis of a labelled 
DNA from single-stranded template with 3'OH. It is commonly used in 
labelling of randomly primed DNA and in synthesis of DNA probe from 
primed M13 templates. 
fq Polymerase is isolated from the thermophilic bacteria Therm us 
aquaticus. It is extensively used in amplification of DNA segments in 
polymerase chain reactions by virtue of its 5'-3' DNA polymerase activity 
and its thermostability. 
Sequenase derives from bacteriophage T7 DNA polymerase. It is a 5'-3' 
DNA polymerase, used in catalysing sequencing reactions. 
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DNase I (RNase-free) obtained from bovine pancreas is a double-stranded 
specific endonuclease. It degrades DNA by catalysing hydrolysis of double-
stranded DNA to a complex mixture of mono- to oligonucleotides. 
RNase A obtained from bovine pancreas is an endo-ribonuclease. It 
degrades RNA to oligonucleotides. 
T4 Polynucleotide Kinase obtained from T4-infected E. coli catalyses the 
transfer of -y-phosphate of ATP to a 5'OH terminus in single-stranded or 
double-stranded DNA. It is commonly used in end-labelling of 
oligonucleotides. 
Alkaline Phosphatase (CAP) obtained from calf intestine catalyses the 
removal of 5'-phosphate residues from DNA prior to labelling the 5' end 
with [y-32P]. 
Reverse Transcriptase is obtained from E. coli expressing a portion of the 
p0l gene of M-MLV (Moloney Murine Leukemia Virus) on a plasmid. It 
has an RNA-dependent 5'-3' DNA polymerase activity which uses single-
stranded RNA or DNA template in the presence of a primer to synthesize 
a cDNA strand. 
2.4 DNA METHODS 
2.4.1 Phenol Extraction and Precipitation of DNA Preparations 
DNA preparations were usually extracted in phenol to remove 
contaminating protein which would otherwise degrade the DNA or inhibit 
enzymatic reactions. The extraction process was usually carried out in 
eppendorf tubes. Unless otherwise stated, phenol was made up as phenol: 
chloroform: isoamyl alcohol (25:24:1). An equal volume of phenol was mixed 
with the aqueous DNA solution and then separated by centrifugation in a 
microfuge for 2mm. The top aqueous phase was collected and extracted a 
further 2-3 times. This was followed by extraction 1-2 times with chloroform 
to remove the phenol and then extraction once by ether to remove the 
chloroform. Chloroform was normally made up as chloroform: isoamyl 
alcohol (24:1). Traces of ether were allowed to evaporate from the surface 
by opening the lid of the eppendorf for a few mm. The DNA in the bottom 
aqueous phase after the ether wash could now be precipitated by adding 1/10 
volume of 3M sodium acetate pH5.2 and 2 volumes of absolute ethanol. This 
was quick frozen in liquid nitrogen and the DNA collected by centrifugation 
(microfuge/20min.). It was then washed •once by resuspending in 70% 
ethanol and collected by centrifugation in a microfuge for 15mm., the DNA 
pellet was dried under vacuum and then resuspended in TE (10mM Tris-HC1 
pH 8.0; 1mM EDTA pH 8.0). 
2.4.2 Proteinase K Treatment of DNA Preparations 
Proteinase K was used to digest contaminating protein from DNA 
preparations which would otherwise inhibit enzymatic reactions. 
To imi of the DNA sample was added 40u1 1M Tris-HC1 pH 8.0, 25ul 
20% SDS and lOjtl 50mg/mi Proteinase K (Boehringer). After incubation at 
37°C for lhr, the Proteinase K was removed by phenol extraction and the 
DNA recovered by ethanol precipitation (Section 2.4.1). 
2.4.3 Estimation of DNA Concentration 
The DNA sample was diluted in imi of distilled water and the OD at 
wavelengths 260nm and 280nm was measured by a spectrophotometer. An 
OD2. of 1.0 is equivalent to a concentration of 50,ug/ml for DNA and 
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20g/m1 for oligonucleotides. The ratio OD/OD provides an estimate 
for the purity of the nucleic acid. A value around 1.8 indicates pure 
preparations of DNA. 
2.4.4 Preparation of DNA from P. falciparum 
2.4.4.1 Maxi-prep of P. falciparum DNA: Packed red blood cells 
(50m1) at 10% parasitaemia were used for one DNA preparation. The 
parasites obtained by lysing the red blood cells as described in Section 2.2.4 
were lysed with 2rnl of 20% sodium lauroyl sarcosine (Sigma) in 20m1 of 
lxSSC. The parasite DNA was then banded in a caesium chloride (CsC1) 
gradient. To the preparation was added 20.9g CsC1 and 0.2m1 of 10mg/mi 
ethidium bromide. The whole mixture was centrifuged at 38,000rpm, 18 °C 
for 48hrs (Ti50 rotor, Beckman). The DNA band was collected and the 
ethidium bromide removed by extracting several times with water-saturated 
iso-propanol. After dialysing against several changes of TE, the DNA was 
recovered by phenol extraction and ethanol precipitation (Section 2.4.1). 
2.4.4.2 Mini-prep of P. falciparum DNA: Genetic analysis of P. 
falciparum involves screening a large number of progeny for certain genotypes 
which in turn requires preparation of DNA from them. Extraction of DNA 
from parasites by the conventional maxi-prep method is a time consuming 
and laborious process, involving weeks of large scale cultivation with daily 
medium changes. At least 50m1 of packed red blood cells at 10% 
parasitaemia is needed for one preparation. It was therefore very important 
to work out a simple and rapid protocol for the isolation of DNA from a 
small quantity of blood. I thereby devised the following mini-prep method 
which was frequently used instead of the maxi-prep method throughout this 
study. 
Parasitized human red blood cells (lOOj.tl) were washed 3 times with 
LSI. 
0.5m1 of buffer (150mM NaCl, 25mM EDTA) and resuspended in 0.4m1 of 
the same buffer. The parasites were lysed by adding 10% SDS (5,01) and 
incubated with 50/2g Proteinase K (Boehringer) at 37 °C overnight. Parasite 
DNA was obtained after phenol extraction and ethanol precipitation (Section 
2.4.1). The final DNA was resuspended in 50 4ul of TE. 
2.4.5 Preparation of DNA from A 
2.4.5.1 Maxi-prep of A DNA: This method was used for large-scale 
preparation of DNA from recombinant clones. An exponential culture of 
NM494 was obtained by growing lOmi of an overnight culture in 500m1 L-
broth containing 10mM MgSO4 and 0.2% maltose at 37°C for 2-3hrs. The 
cells were mixed with 2m1 of phage stock and stood at 37 °C for 10mm. to 
allow adsorption of the phage particles to the bacteria. Incubation at 37 °C 
was then continued with shaking for 4-6hrs to lyse the bacteria. The bacterial 
debris was removed by centrifugation at 9,000rpm, 19 °C for 20mm. (Sorvall 
GSA rotor) before pelleting the phage at 19,000rpm, 19 °C for 3hrs (Type 19 
rotor, Beckman). The phage was resuspended in lOmi of phage buffer by 
shaking at 4°C overnight. To this was added 8.03g CsCl and the phage were 
then banded by centrifugation at 38,000rpm, room temperature for 24hrs 
(Ti50 rotor, Beckman). The band containing the phage was collected and 
dialysed against several changes of TE at 4 °C overnight. The DNA was 
treated with Proteinase K (Section 2.4.2) and phenol extracted and ethanol 
precipitated as described in Section 2.4.1. 
2.4.5.2 Mini-prep of A DNA: This method adapted from Grossberger 
(1987) was used to prepare DNA from a number of putative positive clones 
from a library as a quick check of the size and nature of the cloned inserts 
by restriction analysis. A plaque was picked into 0.3m1 of adsorption buffer 
(10mM MgC12 and 10mM CaCl2) and incubated with 0.2mi of an exponential 
culture of NM494 grown in L-broth containing 0.4% maltose at 37 °C for 
10mm. Then, lOmi of L-broth containing 10mM MgC12 and 0.1% glucose was 
added and incubation was continued overnight. The bacterial debris was 
removed by centrifugation at 3,000rpm for 15mm. The supernatant 
containing the phage was collected. DNase and RNase were added to the 
supernatant at concentrations of 10ug/ml and incubation was continued at 
37°C for 30mm. The phage were pelleted by centrifugation at 27,000rpm for 
2.5hrs, resuspended in 200,41 of phage buffer and treated with 200.t1 of 
1mg/mi Proteinase K at 37 °C for 2hrs. The mixture was extracted once with 
phenol and once with chloroform (Section 2.4.1) and the DNA precipitated 
by adding 1001 of 7.5M ammonium acetate and imi of absolute ethanol. 
After washing once with 100% ethanol, the DNA was dried and resuspended 
in 100l of TE. 
2.4.6 Preparation of DNA from Plasmid 
DNA was prepared from an overnight culture of bacteria which was 
prepared by inoculating a single colony into L-broth (250m1 for maxi-prep, 
5m1 or 50m1 for mini-prep) containing 50kg/mi ampicillin. 
2.4.6.1 Maxi-prep of Plasmid DNA: The bacterial cells were pelleted 
(6,000rpm/lOmin./4 °C, Sorvall GSA rotor), then washed with 50m1 cold 
10mM Tris-HCJ, 1mM EDTA pH 8.0 with centrifugation. The pellet was 
resuspended in 18m1 ice-cold 50mM glucose, 25mM Tris-HC1, 10mM EDTA 
pH 8.0. The cells were lysed with 2.5m1 fresh cold lysozyme (20mg/mi) at 
room temperature for 10mm., then 0 °C for 5mm. A further incubation with 
40mi fresh cold 0.2M NaOH, 1% SDS at 0°C for 5mm. was used to disrupt 
the chromosomes. The preparation was then mixed with 20mi 5M potassium 
acetate (pH 4.8), left at 0 °C for 15mm., and centrifuged 
(10,000rpm/lomin./4°C, Sorvall SS-34 rotor). The supernatant was collected. 
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The product was precipitated by adding 45m1 (0.6 volume) of propan-2-ol and 
leaving at -20°C for 30mm. The precipitate was spun down 
(8,000rpm/5min./4°C, Sorvall SS-34 rotor), washed with cold 95% ethanol 
and resuspended in TE. The nucleic acids were re-precipitated once with 
1/10 volume of potassium acetate and 2.5 volumes of absolute ethanol at - 
20°C overnight. After centrifugation and drying under vacuum, the nucleic 
acids were redissolved in 20m1 0.1M Tris-HC1, 0.01M EDTA pH 8.0. CsCl 
(19g) was added followed by inil of 10mg/mi ethidium bromide and the 
DNA purified on a CsC1 gradient at 38,000rpm for 48hr/18 °C (Ti50 rotor, 
Beckman). After banding, the lower band which contains the supercoiled 
forms was collected and the ethidium bromide removed by extraction with 
water-saturated butan-1-ol. The DNA was dialysed against several changes 
of TE and the DNA precipitated with ethanol. 
2.4.6.2 Mini-prep of Plasmid DNA- Boiling Method: Small quantities 
of plasmid DNA were prepared to allow a rapid screen of the insert size of 
cloned DNA fragments. 
The cells from a 5m1 overnight culture were pelleted by centrifugation 
in a microfuge for 1mm. After removing the medium by aspiration, the pellet 
was resuspended in 0.35m1 of 8% sucrose, 0.5% Triton X-100, 50mM EDTA, 
10mM Tris HC1 pH 8.0 and lysed by vortexing with 25ul of lysozyme 
(10mg/mi in 10mM Tns HC1 pH 8.0) for 3 seconds. The preparation was 
boiled for 2mm. and centrifuged in a microfuge for 10mm. After removing 
the slimy pellet with a toothpick, the supernatant was incubated with 50.tg/ml 
RNase A at 37°C for 30mm. The DNA was recovered by the standard 
procedures of phenol extraction and ethanol precipitation (Section 2.4.1). 
After resuspending in TE, the DNA preparation was treated with Proteinase 
K (Section 2.4.2), re-extracted with phenol and re-precipitaed with ethanol as 
before. 
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2.4.6.3 Mini-prep of Plasmid DNA for Double-stranded Sequencing: 
This method was used to generate DNA in sufficient quality and quantity to 
be used in double-stranded sequencing without going through the laborious 
steps of the maxi-prep method. 
Pelleted cells from a 50m1 overnight culture were resuspended in 3.5m1 
of 25mM Tris-HC1 pH 8.0, 10mM EDTA and 15% sucrose. After addition 
of 8mg of lysozyme in 0.5 ml of the same buffer, the preparation was left on 
ice for 20-40mm. Chromosomal DNA was disrupted by adding 8m1 of fresh 
0.2M NaOH, 1% SDS on ice for 30mm. and then 5m1 of 3M sodium acetate 
pH5.2 on ice for 10mm. The bacterial debris was removed by centrifugation 
at 15,000rpm for 30mm (Sorvall SS-34 rotor). After incubation with 20ul of 
10mg/mi RNase A at 30°C for 20mm., the supernatant was extracted once 
with phenol: chloroform. The DNA was precipitated with 1/10 volume of 
3M sodium acetate pH 5.2 and 2 volumes of absolute ethanol at -20 °C 
overnight. The pellet obtained, after centrifugation at 15,000rpm/30min., was 
resuspended in 0.5m1 water and treated with 5ul of 10mg/mi RNase at 37 °C 
for 20mm. The DNA preparation was phenol extracted (Section 2.4.1) and 
re-precipitated as before. Dried DNA pellet was resuspended in TE. 
2.4.7 Preparation of Replicative Forms (RF) from M13 Vectors 
M13 is a male-specific filamentous bacteriophage of E. coli. It is 
composed of circular DNA, which can exist in an infectious single-stranded 
form or a double-stranded replicative form. The replicative forms are those 
used as cloning vectors. Usually, DNA of high purity is required for cloning 
purposes and this is done by the maxi-prep method. For a simple and quick 
check of the subcloned insert size, DNA is prepared by the mini-prep 
method. 
2.4.7.1 Maxi-prep of M13 RF DNA: A phage stock was prepared by 
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incubating a single plaque of M13mp vectors with 5m1 TG1 cells at 
logarithmic phase of growth for 6hrs at 37 °C. The cells were spun down 
(5mm., microfuge) and the supernatant was stored at 4 °C as stock. 
The phage stock (imi) was added to 250m1 TG1 cells in logarithmic 
phase of growth and incubated for 4.5hrs at 37 °C. Preparation of the 
replicative form DNA from the phage-infected cells then proceeded as for the 
maxi-prep method of plasmid DNA in Section 2.4.6.1. 
2.4.7.2 Mini-prep of M13 RF DNA: An aliquot (10ul) of the phage 
stock was incubated with an overnight culture of TG1 diluted 1150 in 5m1 L-
broth at 37°C for 4-6hrs, with shaking. Preparation of the replicative form 
DNA from the phage then proceeded as for the boiling method for 
preparation of plasmid DNA (Section 2.4.6.2). 
2.4.8 Restriction Enzyme Digestion 
Restriction enzyme digestion of DNA was carried out in the 
appropriate buffer at the optimal temperatures for times varying from a 
couple of hours to overnight. The Boehringer Mannheim's incubation buffer 
system for restriction enzymes was followed (Table 2.1). Double or multiple 
digestions were performed simultaneously in compatible buffers. The 
reactions were terminated by heating at 65 °C for 10mm. 
2.4.9 Agarose Gel Electrophoresis 
2.4.9.1 Mini-gels: A rapid way to check the integrity and the purity 
of DNA preparations, the completion of enzymatic digestions etc. was to run 
the samples on mini-gels which were prepared as 0.7% agarose in 1xTBE 
(0.089M Tris-borate; 0.089M boric acid; 0.002M EDTA). Ethidium bromide 
was added at a final concentration of 1jg/ml to the gel and the running 
buffer (1xTBE). An appropriate amount of DNA was mixed with 1ul of 
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Table 2.1 The Boehringer Mannheim incubation buffer system 
for restriction enzymes. 
Buffer composition 
Final concentration in (mmoIll) 
Buller components 	 (1 	10 diluted set Duller) 
	
A 	B 	1 LMIHI 
Tris acetate 33 - - - 	1 - 
Tris-HCJ - 10 10 10 50 
Mg-acetate 10 - - - - 
MgCl2 - 5 10 10 10 
K-acetate 66 - - - - 
NaCt - 100 - 50 100 
Dithioerylhritol (OTE) - - 1 1 1 
OithiothreitOl (OTT) 0.5 - - - 
2-Mercaptoethanol - I - - - 
pH at 37C iS &0 7.5 7$ 7$ 
Correct buffer to be used with each restriction enzyme. 
A B I U 
[ 	
H 
Acc I -'cy I (50C) ApyI (30C) Bc/I Bgl I A/u I Asp 700 (Xmn I) CIO I (Nh. I) Bgl II C/a I Ada I Asp 718 Dra II Ora I (A/ia Ill) Dde  I Ava A.aI Hp. II FokI Die Ill Op., I Sam HI lCp., I Ha. Ill Eco RI Eae I (CIrI) Ban II Map I Hind II (Hinc II) Hint I Hae If SW Eli Nc/ I Mv., I (Tha I) Ksp 6321 lip. I EcoRV Rsa I Nh. I Mae If (50 *C) Na. I Hind III Xho II Pvu (I MIu I sac I (Sail) Nn., I Sn. BI Nco I Sau3A Saul Sp/it fidel 	-- Sam 96 Scr 	I 













All enzymes should be incubated at 370C unless otherwise stated 
in brackets after the enzyme name. 
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8 I. U H 
0-10 75-100 0-10 0-10 
0-10 10-25 0-10 0-10 
100 10-25 50-75 25-50 
50-75 25-50 25-50 0-10 
10-25 50-75 50-75 0-10 
50-75 100 50-75 0-10 
100 10-25 50-75 0-10 
100 0-10 25-50 50-75 
100 10-25 50-75 10-25 
50-75 75-100 tOO 10-25 
100 75-100 100 25-50 
0-10 25-50 0-10 0-10 
100 50-75 50-75 25-50 
100 25-50 100 100 
50-75 10-25 25-50 100 
100 25-50 100 100 
100 25-50 50-75 50-75 
50-75 100 50-75 25-50 
100 75-100 100 100 
75-100 25-50 25-50 100 
75-100 50-75 75-100 75-100 
75-100 100 100 50-75 
50-75 100 50-75 0-10 
75-100 50-75 75-100 100 
25-50 75-100 50-75 10-25 
100 25-50 50-75 100 
100 0-10 25-50 50-75 
50-75 75-100 100 25-50 
50-75 25-50 50-75 10-25 
50-75 75-100 100 25-50 
100 25-50 100 50-75 
100 25-50 100 10-25 
100 50-75 75-100 100 
25-50 25-50 50-75 25-50 
25-50 100 50-75 10-25 
10-25 100 25-50 0-10 











































































• Kpn I 75-100 
Ksp 6321 75-100 
C) 
	








o-io 10-25 Mae I 
Mae It 0-10 25-50 0-10 25-50 100 	1 
Mae III 1 	0-10 10-25 0-10 0-10 10-25 
MIt, I 10-25 25-50 0-10 10-25 100 
Msp I 100 100 100 100 50-75 
Mvn I 50-75 0-10 50-75 100 10-25 
Nat I 100 0-10 100 0-10 0-10 
Ncii 75-100 50-75 100 10-25 0-10 
NCO I 50-75 50-75 50-75 50-75 100 
tide I 25-50 100 10-25 50-75 100 
Nde Ii 10-25 10-25 0-10 0-10 10-25 
Nhe I 100 25-50 100 100 10-25 
Not I 10-25 50-75 0-10 25-50 100 
Nru I 10-25 100 0-10 10-25 75-100 
NsiI 50-75 100 10-25 50-75 100 
Pat I 25-50 25-50 10-25 25-50 100 
Pvu I 50-75 75-100 25-50 50-75 100 
Pvu II 25-50 25-50 25-50 100 25-50 
As.. I 100 50-75 100 50-75 0-10 
Sac I 100 0-10 100 50-75 0-10 
Sal I 0-10 25-50 0-10 10-25 100 
Sau I 50-75 100 0-10 50-75 10-25 
Sau 3A 100 25-50 25-50 75-100 0-10 
Sau96 100 50-75 25-50 25-50 25-50 
Sc.. I 0-10 100 0-10 75-100 100 
ScrFI 10-25 100 10-25 10-25 50-75 
Sma I 100 0-10 0-10 0-10 0-10 
S..131 75-100 25-50 100 100 10-25 
Spe I 75-100 75-100 75-100 100 100 
Sph I 150-75 75-100 25-50 100 75-100 
Sap I 75-100 100 10-25 100 100 
Stu I. 1 	100 100 100 75-100 50-75 
sty 1 50-75 100 10-25 75-100 100 
Taq I 50-75 100 25-50 50-75 50-75 
Xba I 100 75-100 100 100 100 
Thu 1 25-50 75-100 10-25 25-50 100 
Tho Ii 50-75 25-50 100 75-100 0-10 
Boehringer Mannheim's recommended incubation 
buffer is indicated in bold type. 
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loading buffer (95% fromamide; 20mM EDTA pH 8.0; 0.05% bromophenol 
blue; 0.05% xylene cyanol) and the volume was made up to 10l with 
distilled water. Electrophoresis was carried out at 200V constant voltage. 
The gel was then checked or photographed upon UV illumination. 
2.4.9.2 Horizontal Slab Gels: Horizontal slab gels were used to 
fractionate enzyme restricted DNA before Southern blotting or for their 
purifications. The gels were made up in lx TAB or in 1/2x TBE. 
TAB gels (28x 14x 0.5cm) were prepared by dissolving 0.7%-1.0% 
agarose in lx TAB. Ethidium bromide was added to a final concentration of 
1kg/mi in both the gel and the running buffer (lx TAB). The samples were 
mixed with 1/10 volume of loading buffer, which were then heated at 65 °C 
for 10mm. before loading. Electrophoresis was carried out at low voltage 
(70-120V) overnight with the gel connected by wicks at each end of 500mi 
tanks containing gel buffer (lx TAB). The two tanks were also connected by 
a salt bridge. At the end of the run, the gel was photographed upon UV 
illumination. Fractionated DNA could then be blotted for Southern 
hybridization or isolated for purification. 
TBE gels (20x 14cmx 0.5cm) were prepared as 0.8% agarose in 1/2x 
TBE. Ethidium bromide was added at a final concentration of ljzg/ml to the 
gel and the running buffer (1/2x TBE). The samples were mixed with 1/10 
volume of loading buffer which were then heated at 65 °C for 10mm. before 
loading. Electrophoresis was carried out at 300V for several.hours with the 
gel submerged in 1/2x TBE running buffer. At the end of the run, the gel 
was photographed upon UV illumination and processed similarly to the TAB 
gel. 
2.4.9.3 DNA Molecular Weight Markers: Different DNA molecular 
weight markers were used according to the size range of the fractionated 
DNA (Table 2.2). One set were either Hindill or EcoRI/HindIII digests of 
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Table 2.2 Sizes of DNA fragments in Molecular Weight Markers 
Sizes of DNA fragments in Molecular Weight Markers (bp) 
)cI 7 123bp ladder 1kb ladder 
Hind ifi EcoRI/Hin dIll  
23,130 21,226 4182 12,216 
9,416 5,148 4059 11,198 
6,562 4,973 3936 10,180 
4,368 4,268 3813 9,162 
2,322 3,530 3690 8,144 
2,027 2,027 3567 7,126 
564 1,904 3444 6,108 
125 1,584 3321 5,090 
1,375 3198 4,072 
947 3075 3,054 
831 2952 2,036 
564 2829 1,635 
125 2706 1,018 






















phage AcI 7 DNA. Another consisted of a synthetic 123bp ladder (Bethesda 
Res. Lab.) or 1kb ladder (Bethesda Res. Lab.). 
2.4.9.4 Gel Photography: Agarose gels were photographed under 
short wave UV light and a red filter using Ilford HP5 professional 5" x 411 
film. Exposure times varied from 30 seconds to a few mm. depending on the 
intensity of the bands. The film was developed for 5mm. in Ilford Microphen 
developer, stopped and fixed for 5mm. followed by immediate flushing in cold 
water to remove excess fixer. The film was then dried. 
2.4.10 Purification of DNA Fragments 
2.4.10.1 Electroelution: DNA fragments could be purified from TAE 
gel (Section 2.4.9.2) by electroelution. After the DNA was fractionated by 
electrophoresis, a trough of 2-3mm wide was cut right in front of the DNA 
band to be purified. The far side of the trough was lined with dialysis tubing 
and the trough was filled with lx TAE. Electrophoresis was continued at 
300V until all the DNA had run into the trough and stuck onto the dialysis 
tubing. This was checked by UV illumination. After reversing the current 
at 300V for 30 seconds to detach the DNA from the dialysis tubing, the 
buffer in the trough containing the DNA was collected and extracted 3-6 
times with butanol to remove the ethidium bromide. The DNA was 
recovered by phenol extraction and ethanol precipitation as described in 
Section 2.4.1. 
2.4.10.2 GENECLEAN II Kit (BlO 101 Inc.): DNA fragments could 
be purified from TAE or TBE gel using a GENECLEAN II kit (BlO 101 
Inc.). After the DNA was fractionated by electrophoresis, the appropriate 
DNA band was excised from the gel. A maximum of 0.4g gel was put in an 
eppendorf tube and dissolved by heating in 2.5 volumes of Nal solution at 
55°C for 5mm. For gel slices obtained from TBE gels, 1 volume of TBE 
modifier was added in addition. Sufficient quantity of Glassmilk- a 
suspension of porous silica (5ptl to bind the first 5jtg DNA, then 1ul for each 
additional 0.5 jig of DNA) was added to adsorb the DNA at 4 °C for 5mm. 
The pelleted Glassmilk was washed 3 times in 0.5m1 of NEW WASH with 
centrifugation (microfuge, 5 seconds). The adsorbed DNA was eluted in 5-
10jtl of TE at 55°C/5min. The Glassmilk was spun down (microfuge, 30 
seconds) to obtain the supernatant which contained the eluted DNA. The 
elution procedure was repeated once and the eluted DNA was pooled. 
2.4.11 Southern Blotting 
This technique was used to transfer DNA from agarose gel onto filters 
for the detection of specific sequences among DNA fragments (Southern, 
1975). The method of Smith & Summers (1980) was adopted with 
modifications. 
DNA fractionated on slab gels was denatured twice for 15mm. in 
denaturation solution (0.5M NaOH; 1.5M NaCl), then neutralized twice for 
20mm. in neutralizing solution (1M ammonium acetate; 0.02M NaOH). The 
gel was put on a clean glass plate and overlaid with a Hybond-N membrane 
(Amersham) followed by three sheets of filter paper saturated with 
neutralizing solution, five sheets of dry filter paper and finally a stack of 
paper towels. Another glass plate was put on top which supported a heavy 
weight. Transfer under a heavy weight was completed in 1-2hrs. The 
Hybond-N membrane was recovered, washed for 2mm. in 2xSSC and air 
dried for an hour. After fixing the DNA upon UV illumination for 5mm., the 
membrane was ready for hybridization. 
2.4.12 Dot-blots 
Dot-blot analysis was used to compare the number of copies of a gene 
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in different isolates of parasite, following the method of the Bio-Dot 
Microfiltration Apparatus Instruction Manual (Bio-Rad). The Bio-Dot 
Apparatus was assembled according to the manufacturer's instruction. A 
Hybond-N membrane (Amersham), pre-wetted in 1M ammonium acetate for 
30mm., was aligned into the apparatus. Vacuum was applied to dry the 
membrane. The membrane was washed once with 1M ammonium acetate, 
100.tl/well. Unused wells were closed off with masking tape. DNA diluted 
in TE was denatured with 1/10 volume of 3M NaOH for 5mm. and 
neutralized with an equal volume of 2M ammonium acetate before it was 
applied to the wells. After the solution had passed through the filter and the 
DNA stuck to the membrane, the wells were washed once in 1M ammonium 
acetate. The membrane was removed from the apparatus and air dried for 
an hour. The DNA was fixed by UV illumination (5mm.) after which the 
membrane was ready for hybridization. 
2.4.13 Labelling of DNA 
DNA was labelled with radioactive nucleotides for use as probes in 
hybridization experiments. Several methods are available for labelling DNA. 
End-labelling with polynucleotide kinase has been employed with short 
oligonucleotides, while longer DNA molecules have been labelled by nick 
translation and random priming methods. DNA subcloned into M13 vectors 
can be labelled directly from the single-stranded templates. 
2.4.13.1 Nick Translation: The method follows essentially the same 
as described (Rigby et al., 1977) using a nick translation reagent kit (Bethesda 
Research Lab.). In this reaction 10Ci (1/21) of radioactive labelled 
nucleotide [a- 32P] dCTP or [a- 32P] dATP (Amersham) of specific activity 
3,000 Ci/mM was used to label 1g of DNA in a reaction mix containing 5/21 
of solution A (which contains all nucleotides except the one used in 
radioactive form in a suitable reaction buffer) and water to a total volume of 
451.4. Nick translation was initiated by adding 5 4ul of solution C (DNA 
polymerase I and DNaseI) and proceeded at 15 °C for lhr. Unincorporated 
nucleotides were separated from the labelled DNA by chromatography on a 
column of Sephadex G-50 (see Section 2.4.13.3 below). The activity 
incorporated into the labelled DNA was typically 5x10 7 cpm/g. 
2.4.13.2 Random Priming Method: DNA labelled to high activities 
was obtained using the randomly primed DNA labelling method (Feinberg 
& Vogelstein, 1983). This method enables the labelling of DNA available 
only in minimal amounts. It is based on the hybridization of a mixture of 
hexanucleotides to the DNA to be labelled. Many sequence combinations 
are represented in the hexanucleotide primer mixture, which leads to binding 
of primer to template in a statistical manner. The complementary strand is 
synthesized from the 3'OH termini of the random hexanucleotide primer 
using Kienow enzyme during which radiolabelled dNTP is incorporated into 
the newly synthesized DNA strand. 
A reaction buffer, OLB, containing nucleotides and random primers 
is required for this method. It is made by mixing 50u1 Solution A (1.25M 
Tris-HC1 pH 8.0; 0.125M MgCl 2; 25mM 3-mercaptoethanol; 0.5mM each of 
dGTP, dTTP, dCTP/dATP), 125/4 Solution B (2M HEPES buffer adjusted 
to pH 6.6 with NaOH) and 75jtl Solution C (random hexanucleotides 
OD = 90 in TB). 
The DNA (bOng and water to 7.5 4u1) was denatured by boiling for 
2mm., spun and chilled on ice briefly. After that, 11.4/4 of OLB buffer, 2/4 
of 10mg/mi bovine serum albumin (BSA), 5/4 of [a- 32P] dATP or [a-32P] 
dTP and 1 unit of Klenow (Pharmacia) were added to the denatured DNA 
at room temperature. The incubation was continued at room temperature 
overnight. Unincorporated nucleotides were separated from labelled DNA 
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by chromatography on a Sephadex G-50 column (see Section 2.4.13.3 below). 
2.4.13.3 Separation of Unincorporated Nucleotides from Labelled 
DNA: A Sephadex G-50 (Pharmacia) column was used to remove 
unincorporated [a- 32p]dNTP from labelled DNA fragment (Maniatis et al., 
1982). The column was prepared by packing a imi syringe with Sephadex G-
50 in 10mM Tris pH 7.5, 1mM EDTA,, 100mM NaCl with centrifugation 
(1,500rpm/4min./4 °C) until the packed volume was 0.7m1. The Sephadex was 
washed with 70/A of the same buffer with centrifugation. The labelling mix 
was applied to the column and eluted into an eppendorf tube by 
centrifugation. Incorporated counts were monitored by a mini-monitor. The 
elution was repeated by washing the column with 100 4u1 aliquots of the buffer 
until insignificant counts were detected in the eluted fractions. Those 
fractions with high counts were pooled and boiled for 5mm. to denature the 
DNA before they were used as probes in hybridization. 
2.4.13.4 Priming from M13 Single-stranded DNA Templates: The 
M13 17-base sequencing primer (8ng) was boiled with 1ug of the single- 
stranded template DNA in a mixture containing ljA of lOx polymerase 
reaction buffer (lOx: 100mM Tris-HC1 pH 8.0; 100mM MgC1 2 ; 300mM NaC1) 
and water in a total volume of 12/A. After 5mm., the mixture was cooled at 
room temperature for 30mm. for annealing of primer to the template DNA. 
At the end of the annealing step, 2/A of dNTP mix (0.4mM each of dGTP, 
dTTP, dCTP), 1/A of Kienow (1U/itl) and 1/A of [a- 32P] dATP were added 
and incubation was continued at room temperature for 30mm. The labelled 
DNA was used directly in hybridization without further purification by 
chromatography. Before use, the probe was denatured by boiling for 5mm. 
2.4.13.5 End-labelling of Oligonucleotides: Oligonucleotide (8pmol) 
was end-labelled with 3.5/A [Y_32  P]CIATP in a kinasing reaction containing 2/A 
lOx kinase buffer (lOx: 500mM Tris-HC1 pH 7.6; 100mM MgCl2; 50mM DTT; 
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1mM spermidine; 1mM EDTA), 2l T4 polynucleotide kinase (5U/ul) and 
water in a total volume of 20l. After incubation at 37 °C for lhr, the end-
labelled oligonucleotide was used, without further processing or boiling steps, 
directly in hybridization. 
2.4.14 Hybridization of DNA 
By adjusting the stringency of hybridization, it is possible to distinguish 
between closely- and distantly-related members of a family. In practice, to 
distinguish between the distantly-related members of a family of sequences, 
hybridization should take place under permissive conditions followed by 
washing under progressively more stringent conditions. To identify closely-
related members, a stringent hybridization followed by a stringent wash is 
better. The stringency of hybridization depends on a number of factors, the 
most significant ones are listed below. 
Definitions: 
Tm (melting temperature): the temperature at which the strands of a 
DNA duplex or an RNA.DNA hybrid are half dissociated or denatured. Tm 
is dependent on ionic strength, base composition and denaturing agents. 
Tin = 81.5 + 16.6(logM) + 0.41(%G+C) - 0.72(% formamide) 
where M is the molarity of the monovalent cation and (%G + C) is the 
percentage of guanine and cytosine residues in the DNA. 
For oligonucleotides in aqueous 1M Na, the relationship of the G+ C 
content on duplex stability is given by the parameter Td. 
Td = 4(G+C) + 2(A+T) 
RN 
Ti = incubation temperature 
Temperature: The temperature of reaction affects the rate of 
hybridization which increases to reach a maximum at 20-25 °C below Tm. 
Self-hybridization is favoured at higher temperature. At low temperatures, 
a high rate of cross-hybridization is attained. So, ideally, hybridization should 
be carried out at a Ti that is 20-25 °C below Tin. In practice, for well-
matched hybrids, the hybridization reaction is usually carried out at 68 °C in 
aqueous solution and at 42°C for solutions containing 50% formamide. For 
poorly-matched hybrids, incubation is generally at 35-42°C in formamide 
containing solutions. 
Formamide: Formamide can be used to alter the stringency of the 
reaction conditions. Formamide destabilises double-stranded nucleic acid. 
Thus, the Ti can be decreased whilst maintaining the stringency of the nucleic 
acid interaction. By including 30-50% formamide in the hybridization solution, 
the Ti can be reduced to 30-42°C. 
Ionic strength: 	High salt concentrations stabilize mismatched 
duplexes, so to detect cross-hybridizing species, the salt concentration of 
hybridization and washing solutions must be kept fairly high. 
Dextran sulphate: Addition of an inert polymer such as dextran 
sulphate increases the rate of hybridization. The effect is attributed to the 
exclusion of the DNA from the volume occupied by the polymer, effectively 
increasing the concentration of the DNA. This favours the formation of 
concatenates i.e. extensive networks of reassociated probe which by virtue of 
single-stranded regions, hybridize to filter-bound nucleic acid and so lead to 
an increase in hybridization signal. 
2.4.14.1 Hybridization with Homologous DNA Probes: Hybridization 
with homologous DNA fragments was performed under stringent conditions 
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in 0.5M sodium phosphate (Na2HPO4/NaH2PO4 pH 7.5), 7% SDS at 65°C 
overnight with a lhr pre-hybridization under the same conditions. Non-
specifically bound nucleotides were removed by washing the membrane 
stringently in several changes of 0.2xSSC, 0.1%SDS at 65°C over a period of 
2hrs. Filters were then autoradiographed. 
2.4. 14.2 Hybridization with Oligonucleotide Probes: Hybridization 
with oligonucleotides was performed under a less stringent condition. Pre-
hybridization was carried out in 5x Denhardt's solution (lOOx: 2% BSA-Pentax 
Fraction V; 2% Ficoll; 2% polyvinylpyrollidone), 0.2%SDS, 6xSSC at 37 °C 
from 2hrs to overnight. Hybridization to end-labelled oligonucleotides was 
performed under the same conditions overnight. The membrane was initially 
washed in several changes of 6xSSC at 37°C for lhr before being 
autoradiographed. In case of high background, more stringent wash could be 
carried out in 6xSSC at 57°C or in 0.1xSSC, 0.1%SDS at 37 °C for lhr. 
2.4.14.3 Autoradiography: Autoradiography was performed using 
CRONEX 4 X-ray film in a cassette with lightning plus intensifying screens 
(Du Pont). The cassettes were stored at -70 °C during exposure as this results 
in a sharper signal. 
2.4. 14.4 Removal of Probes and Re-use of Blots: The blots could be 
re-used after dehybridization. This was achieved by boiling in 0. 1xSSC for 
lhr. The blots were autoradiographed to confirm that dehybridization was 
complete. 
2.4.15 Polymerase Chain Reactions (PCR) 
Polymerase chain reactions (PCR) are simple and powerful methods, 
used to amplify specific DNA segments in vitro through a succession of 
incubation steps at different temperatures (Saiki et al., 1985; 1988). Typically, 
the double stranded DNA is heat denatured, the two primers complementary 
to the 5' and 3' boundaries of the target segment are annealed at low 
temperature and then extended at an intermediate temperature. Repetition 
of this cycle can amplify DNA segments by at least 10 5 fold, and potentially 
as high as 109 fold. The process was made possible by the discovery of a 
DNA polymerase from Thermus aquaticus (Taq), which is thermostable. 
Taq polymerase was originally purchased from Cetus. More recently, 
mi and Boehringer enzymes were also used. 
PCR was carried out in 0.5m1 eppendorf tubes with the Techne 
heating block following the thermal profile listed in Table 2.3. Each 100.t1 
reaction contained bOng genomic DNA, 0.1jtM of each 5' and 3' primers, 
200MM of each dNTP and 2 units of Taq polymerase in a reaction buffer of 
0.05M KC1; 0.01M Tris-HC1 pH 8.3; 1.5mM MgCl2). For the Cetus enzyme, 
the buffer contained gelatin at 0.01%. For the IBI and Boehringer enzymes, 
the buffer contained gelatin, Tween 20 and NP-40 each at 0.1%. The 
reactions were overlaid with lOOjil paraffin oil. The eppendorf lids were 
punctured with a needle before subjected to PCR. At the end of the 
reaction, paraffin oil was removed by extracting with chloroform. The PCR 
products were typically checked by agarose gel electrophoresis of 5j.tl samples. 
The PCR product was purified by gene-clean (Section 2.4.10.2) with or 
without prior separation by gel electrophoresis. 
2.4.16 Preparation of Plating Cells 
Plating cells were prepared by diluting an overnight culture of bacteria 
1150 in 5m1 L-broth and incubating for 1.5-2.5hrs at 37 °C until the cells 
reached logarithmic phase of growth. The L-broth was supplemented with 
1% maltose when plating cells were prepared for bacteriophage A. They 





Table 2.3 The thermal profile for polymerase chain reactions (PCR) 
Cycle No. of Loops Temperature 
(°C)  
Time 
1 1 95 5mm. 
2 1 92 5mm. 
45 10 seconds 
70 1mm. 
3 1 92 3mm. 
40 10 seconds 
70 1mm. 
4 1 92 1mm. 
40 10 seconds 
70 1mm. 
5 27 92 10 seconds 
40 10 seconds 
70 1mm. 
6 1 70 5mm. 
7 30 hold 
2.4.17 Lambda Phage Titration 
The phage stock to be titrated was serially diluted in phage buffer. To 
100l of each dilution was added 10041 of plating cells and 3m1 molten BBL 
Top Agar. The whole mixture was poured onto a BBL-agar plate. The 
plates were incubated at 37 °C overnight. 
2.4.18 Preparation of Competent Cells 
An overnight culture of bacteria was diluted 1/50 in L-broth. 
Incubation was continued at 37°C with shaking until the culture had reached 
logarithmic phase of growth, normally 2hrs. The bacterial cells were pelleted 
(1,SOOrpm/l5min./4 °C) and resuspended in ice-cold 0.1M (l to half of 
the original volume. The cells were pelleted once more 
(1,500rpm/15min./4 0C), resuspended in ice-cold 0.1M CaCl, to 1/20 of the 
original volume. The calcium treated cells were put on ice for 30mm. or 
longer before use. 
2.4.19 Ligation of DNA 
Both insert and vector DNA were cut with suitable restriction enzymes 
to create competent clonable sites. Ligation of insert to the vector was 
performed in a ratio of 3 molecules of insert DNA to 1 molecule of vector 
DNA in a 10ul reaction mixture containing 50mM Tris-HC1 pH 7.5; 10mM 
MgC12; 10mM DYF; 10mM ATP and 1 unit of T4 DNA ligase at 15°C 
overnight. The ligated DNA was transformed into E. coli or in vitro packaged 
into A phage. 
2.4.20 Plaque Hybridization 
Plaques were lifted by overlaying a pre-chilled agar plate with Hybond-
N membrane for 2mm. The orientation of the filters in respect to the agar 
plates was marked. The DNA was denatured by putting the membrane, 
plaque-side-up, onto filter papers saturated with denaturation solution (1.5M 
NaCl, 0.5M NaOH) for 5mm. and then neutralized by placing on filters 
saturated with neutralizing solution (1.5M NaCl, 0.5M Tris-HC1 pH8.0) for 
a further 5mm. The filters were finally transferred to filter papers saturated 
with 2xSSC for 5mm. After drying at 37 °C for 5mm., the DNA was fixed 
onto the Hybond-N membrane by UV cross-linking. The membranes were 
now ready for pre-hybridization and hybridization (Section 2.4.14). Positive 
signals were identified and corresponding regions of plates were picked into 
phage buffer. 
2.4.21 Colony Hybridization 
Colonies were streaked onto a master L-amp plate and then duplicated 
onto a Hybond-N membrane overlaid a L-amp plate. The cells were allowed 
to grow for at least óhrs to overnight. The filters were removed and 
processed as for plaque hybridization (Section 2.4.20). Pre-hybridization and 
hybridization were carried Out under stringent conditions (Section 2.4.14). 
Positive signals were identified and corresponding regions of plates were 
picked into L-broth. 
2.4.22 Identification of Recombinants 
To identify recombinants from those putative positive clones, DNA was 
prepared from them by the mini-prep method (Section 2.4.5.2, Section 2.4.6.2 
& Section 2.4.7.2). The DNA was digested with the appropriate enzyme to 
release the subcloned inserts. The sizes of the inserts were checked by 
agarose gel electrophoresis (Section 2.4.9) and the specificity of the inserts 
was checked by hybridization of a Southern blot (Section 2.4.11) with an 
appropriate probe (Section 2.4.14). 
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2.413 Construction of Genomic Library 
A library of EcoRI fragments of HB3 DNA was constructed for the 
screening of recombinants containing the DHFR-TS inserts. Bacteriophage 
)NM1149 (Murray, 1983) was used as the cloning vector. The genetic map 
of ANM1149 is shown in Fig. 2.1. The vector contains both EcoRI and 
Hind ifi cloning sites though only the EcoRI site was used in this study. The 
strategy used to construct such libraries is illustrated in Fig. 2.2. The genomic 
DNA and the vector DNA were cleaved by EcoRI to generate compatible 
cloning sites for ligation to form a concatamenc, recombinant DNA. Ligation 
was performed as in Section 2.4.19 using 0.5 4ug EcoRI cleaved HB3 genomic 
DNA and 1/2g EcoRl cleaved )NM1149 DNA in a total volume of 20l. 
After that, the phage particles were packaged in vitro during which a different 
recombinant DNA molecule was inserted into each bacteriophage particle. 
Phage infected E. coli cell extracts were used to supply the mixture of 
proteins and precursors required for encapsidating ) DNA. A sonicated 
extract from E. coli BHB2690 (SE) served as the prohead donor while a 
freeze-thaw lysate from E. coli BHB2688 (FTL) served as the packaging 
protein donor. Both SE and FTL were kindly provided by N. Somia. In vitro 
packaging was carried out by incubating 6ul of ligation mix with 74 of buffer 
A (20mM Tris-HC1 pH 8.0; 3mM MgCl2 ; 0.05% 3-mercaptoethanol; 1mM 
EDTA), 1ul of Ml buffer (110l water; 6l 500mM Tris-HC1 pH 7.5; 300ul 
50mM spermidine; 100mM putriscine 7.0; 9l 1M MgCl 2; 75ul 100mM ATP; 
1.t1 3-mercaptoethano1), 10.tl of SE and 12l of FTL at room temperature 
for lhr. All the reagents were kept on ice before the packaging reaction 
started. After lhr, the packaging mix was diluted with 2000 of phage buffer. 
For transfection into E. coli, aliquots (14 and 10ul) of the diluted packaging 
mix were incubated with 1001 of NM494 plating cells at 37 °C for 20mm. 
The infected cells were then mixed with 9m1 molten BBL top agar and plated 
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Fig. 2.1 A restriction enzyme map of Lambda N}11149 vector 
DNA illustrating the unique Hindill and EcoRI cloning sites. 
91 
FIG 2.2 The strategy used to construct libraries of random 
fragments of eukaryotic DNA. Left: preparation of the vector 
DNA fragments. Right: preparation of eukaryotic DNA fragments. 
A concatemeric recombinant DNA molecule is produced by the 
action of bacteriophage T4 DNA ligase. This concatemer is the 
substrate for the in vitro packaging reaction during which a 
different recombinant DNA molecule is inserted into each 
bacteriophage lambda particle. Following amplification by growth 
in E. coli, a lysate is obtained, consisting of a library of 
recombinant clones that, in aggregate, contain most of the 
sequences present in the eukaryotic genome. H =HindIII; 
E =EcoRI. The figure represents digestions with EcoRI. 
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out on BBL-agar plate at a density of > 10,000 plaques per 150-mm dish for 
primary screening (see below). Controls included packaging self re-ligated 
vectors and uncut vectors. 
2.4.23.1 Amplification and Storage of Library: The plates containing 
the recombinants were overlaid with 12m1 of phage buffer and stored at 4 °C 
overnight. The bacteriophage suspension was recovered from each plate and 
transferred to a sterile polypropylene tube. The plates were then further 
rinsed with 4m1 of phage buffer. After incubation for 15mm. at room 
temperature with occasional shaking, the cells and agar debris were removed 
by centrifugation (3,500rpm/S min. /4 °C). The supernatant was collected into 
a glass bottle. A few drops of chloroform were added and the library was 
stored at 4°C. 
2.4.24 Screening of Library 
The library was screened by plaque hybridization (Section 2.4.20) with 
a homologous 5.65kb DHFR-TS gene fragment from the Ki isolate which 
had beeen cloned into the EcoRI sites of ANM1 149 (Snewin et al., 1989). To 
isolate the insert DNA for use as a probe, the phage DNA was digested with 
EcoRI and fractionated by agarose gel electrophoresis (Section 2.4.9.2). The 
insert DNA was purified from the gel (Section 2.4.10) and labelled (Section 
2.4.13) for hybridization. However, some of the vector DNA might have co-
purified with the insert DNA. This would give rise to cross-hybridization 
between the vector DNA resulting in a high background. This was prevented 
by pre-hybridizing the filters with 10/.Lg of sheared A DNA at 65 °C for at least 
4hrs before hybridization with the probe. The sheared A DNA bound to the 
A sequence in the library, thus blocking it from hybridizing to the vector 
DNA within the probe. Hybridization was then carried out under stringent 
conditions as described in Section 2.4.14.1. Plaques giving rise to positive 
signals were picked and re-screened until plaque pure. Clones remaining 
positive were further characterized as in Section 2.4.22. 
2.4.24.1 Preparation of Stock Culture of I Recombinant Clones: 
Individual positive clones were picked, diluted and plated out on fresh 90-mm 
BBL-plate at near confluent lysis. Top agar from fresh BBL plate was 
transferred to 2.5m1 phage buffer and left to extract for several hours with 
occasional shaking. The agar and cell debris were spun down by 
centrifugation at 3,500rpm/lOmin. A drop of chloroform was added to the 
supernatant which was stored at 4 °C as stock. 
2.4.25 Subcloning of DNA Fragments into M13 Vectors 
The multiple cloning sites of the M13 vectors are depicted in Fig. 2.3. 
Insert DNA was subcloned into the multiple cloning sites, which have been 
inserted into the 5' end of the lacZ gene in M13. Recombinant phage with 
a lac phenotype due to the insertion of DNA fragment into the 5' end of 
lacZ were selected as white plaques on indicator plates. 
Both insert and vector DNA were cut with suitable restriction enzyme 
to create competent clonable sites. Ligation of insert to the replicative forms 
of M13mp18 and M13mp19 was performed as described in Section 2.4.19. 
The ligated DNA was transfected into competent E. coli cells. This was done 
by mixing aliquots (1j4 and 0.5A) of the ligation mix with 1001 of competent 
TG1 cells (Section 2.4.18). The preparation was left on ice for 30mm., heat-
shocked at 42°C for 2mm. and then left on ice for another 30mm. After that, 
100.t1 of TG  plating cells (Section 2.4.16), 20 4u1 of 2% X-gal, 20g1 of 100mM 
IPTG and 3ml of molten BBL Top Agar were added and the whole mixture 
was plated out on minimal plates. The plates were incubated at 37 °C 
overnight. White plaques were picked onto a master plate which was then 
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FIG. 2.3 Multiple cloning sites of M13 vectors, a) illustrates the position of 
the multiple cloning sites of M13mp18 in respect to the lacZ gene and the 
sequences and locations of the sequencing primers. b) shows the sequences 
of the multiple cloning sites in M13mp18 and M13mp19. 
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obtained from the master plate (Section 2.4.20) were then screened by 
probing with appropriate fragments. Putative positive clones were identified 
as described in Section 2.4.22. 
2.4.26 Subcloning of DNA Fragments into pUBS1 
The multiple cloning sites of pUBS1 are shown in Fig. 2.4. DNA 
fragments were subcloned into the multiple cloning sites of pUBS 1 by 
transformation. Since pUBS 1 does not contain a lacZ gene, no colour 
selection with X-gal was available. Screening for positive clones was 
therefore carried out by colony hybridization (Section 2.4.21). 
After cutting the DNA fragments and the plasmid pUBS 1 with 
appropriate restriction enzymes to generate compatible cloning sites, they 
were ligated as described in Section 2.4.19. Aliquots (1A) of the ligation mix 
were mixed with 1001.L1 of competent JM83 cells (see Section 2.4.18), kept on 
ice for 30mm., heat-shocked at 42 °C for 5mm. To this was added 0.5m1 L-
broth and incubation was continued with rotation at 37 °C for 1-2hrs. 
Different dilutions (100/21/50/21/20/4) of the mixture were spreaded onto L-
amp plates (L-plate supplemented with 50/2g/ml ampicillin) which were then 
incubated at 37°C overnight to allow the bacteria to grow. Positive clones 
were screened (Section 2.4.22.1) and identified (Section 2.4.22.2). 
2.4.27 DNA Sequencing 
DNA sequencing was performed with either M13 templates, plasmid 
DNA, ) DNA or PCR amplified fragments using a protocol according to the 
dideoxynucleotide chain termination principle of Sanger (Sanger et al., 1977). 
Sequencing in M13 vectors requires cloning the DNA fragments into the 
M13mp series of phage vectors (see Section 2.4.25) from which the single-
stranded DNA can be prepared (Messing et al., 1981) which is the template 
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FIG 2.4 pIJBS1 plasmid multiple cloning sites. M13-UP, T7 
Primer, KS Primer, T3 Primer and M13 RP are oligonucleotide 
primers commonly used in sequencing reactions. 
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for DNA sequencing. For the others, the double-stranded DNA is the 
template for sequencing. 
2.4.27.1. Preparation of Single-stranded M13 Templates: A lOptl 
aliquot of phage stock were added to 5rnl L-broth containing 1004 of an 
overnight culture of TG1 cells. After shaking at 37°C for 4-6hrs, the cells 
were pelleted (microfuge, 5mm.). To 1.5m1 of the supernatant was added 
200ul of PN (20% polyethylene glycol 6000, 2.5M NaCl) which precipitated 
the virus. After 15mm. at room temperature, the phage were pelleted by 
spinning in a microfuge for 5min and the PN solution removed. The phage 
pellet was resuspended in 125iA TES (20mM Tris-HC1 pH 7.5; 10mM NaCl; 
0.1mM EDTA). The suspension was extracted once with 50u1 phenol and 
once with phenol: chloroform: isoamyl alcohol (25:24:1). The aqueous phase 
was collected and the DNA was precipitated by adding 10u1 of 3M sodium 
acetate pH4.5 and 275jtl of absolute ethanol. After centrifugation 
(microfuge/20min.) and washing once in lml 95% ethanol, the DNA pellet 
was dried and resuspended in 40j.d TE. The single-stranded DNA template 
preparations were stored at -20°C until required. 
2.4.27.2 Sequencing Reactions Using Single-stranded M13 DNA as 
Templates: Single-stranded M13 clones were sequenced following the dideoxy 
chain termination protocols supplied by the United States Biochemical 
Corporation (USB) with modifications. An annealing mixture containing 2j.d 
5x sequencing buffer (5x: 200mM Tris-HC1 pH 7.5; 100mM MgC12; 250mM 
NaCl), 14 primer (0.5pmol) and 7.tl template DNA was incubated at 55°C 
for 5mm. and then put on ice for another 5mm. to allow annealing of the 
primer to the DNA. Complementary DNA strand was synthesized and 
labelled by adding 141 of 0.1M DTT, 2j.d lx labelling mix (1.5 4uM each of 
dGTP/dCTP/dTTP), 0.51 [a-32S] dATP and 24 2 units of T7 DNA 
polymerase (Sequenase, USB) to the annealed DNA mixture. After 
incubation at room temperature for 5mm., 3.5j0 of labelling reaction were 
transferred to pre-warmed termination tubes containing 2.54 of G/A/T/C 
termination mixes (Table 2.4) respectively. Incubation of the termination 
reaction continued at 37 °C for 5mm. before 4tl of stop solution (95% 
formamide; 20mM EDTA; 0.05% bromophenol blue; 0.05% xylene cyanol 
FF) was added to stop the reaction. The samples were heated to 75 °C for 
2mm. immediately before loading. 
2.4.27.3 Sequencing Reactions Using Double-stranded DNA as 
Templates: Sequencing from double-stranded DNA templates followed 
essentially the same method of single-stranded sequencing except that it was 
performed in the presence of 10% dimethylsulphoxide (DMSO) to keep DNA 
denatured. This method has been successfully employed to sequence from 
plasmid, ) and PCR products in the present study. 
An annealing mixture containing 2/21 5x sequencing buffer (5x: 200mM 
Tris-HC1 pH 7.5; 100mM MgC1 2 ; 250mM NaCl), ljzl (8-10ng) primer, 6/21 
DNA and ljzl DMSO was boiled for 5mm. to denature the DNA and then 
put on ice for 10mm. to allow annealing of the primer to the denatured 
single-stranded templates. To this was added 1/21 0.1M DTT, 1/21 labelling 
mix (0.3751LM each of dGTP/dTTP/dCTP), All (10/2Ci) [a- 32S] dATP and 1ul 
2 units Sequenase (USB). Immediately after that, 3.5/21 were transferred 
to pre-warmed tubes containing 2/21 0/A/TIC termination mixes respectively 
(Table 2.5). Incubation was continued at 37°C for 5mm. before 4u1 of stop 
solution was added. The samples were boiled for 5mm. immediately before 
loading onto a 6% denaturing polyacrylamide gel for separation. 
2.4.27.4 Primers: The primers used in single-stranded and double-
stranded sequencing reactions were either the M13 sequencing primers or 
synthetic oligonucleotide primers synthesized by Oswell DNA Service, 
Department of Chemistry, University of Edinburgh. 
Table 2.4 The composition of the termination mixes used in single-stranded 
sequencing reactions 
Component G A T C 
ddGTP 8M - - - 
MAT? - 	 V 8aM - - 
ddTTP - - 8tM - 
ddCTP - - V 	 - 8M 
dGTP 80uM 80jtM 80jtM 80uM 
dATP 80M 80M 8012M 80/2M 
d1TP 80uM 804uM 80M 80M 
dCTP 80M 80M 80M 80M 
NaC1 50mM 50mM 50mM 50mM 
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Table 2.5 The composition of the termination mixes used in double-stranded 
sequencing reactions 
Component G A T C 
ddGTP 8M - - - 
ddATP - 8uM - - 
dd'TTP - - 8uM - 
ddCTP - - 
- 8uM 
dGTP 80M 80M 801.LM 801UM 
dATP 80M 80AUM 80tM 804uM 
dTP 80uM 804uM 80itM 80M 
dCI? 80M 80M 80M 80M 
NaC1 50mM 50mM 50mM 50mM 
DMSO 10% 10% 10% 10% 
101 
2.4.27.5 Sequencing Gel Electrophoresis: Sequencing reactions were 
separated on a 6% polyacrylamide gel (38cmx 17cmx 0.3mm) which was 
prepared by dissolving 28.8g urea, 3.6g acrylamide, 0.18g bis-acrylamide in 
28m1 distilled water and 6ml lOx TBE. Polymerization was initiated by 
addition of 360/2110% ammonium persulfate and 50121 TEMED (NNN'N-
tetra-methyl-1,2-diamino-ethane) immediately before pouring the gel. The gel 
was allowed to set for 2hrs to overnight. Sequencing reaction samples were 
loaded onto wells formed by a Sharkstooth comb. Electrophoresis was 
carried out in lx TBE at 40W constant power. The gel was fixed in 10% 
acetic acid, 12% methanol for 15mm. and dried under vacuum at 80 °C before 
being exposed for autoradiography. 
2.4.27.6 DNA Sequence Data Compilation and Analysis: •Sequence 
information was read off the autoradiograph and compiled by version 2.0 of 
the programmes of Staden (1984) and analysed by version 4.0 of the 
programmes of the University of Wisconsin Genetic Computer Group 
(Devereux et al., 1984). 
2.4.28 Alkaline Denaturing Gels 
Alkaline denaturing gels are usually used to check the size of the DNA 
strand in nuclease-S1-resistant DNA.RNA hybrids and the size of first and 
second DNA strands synthesized by reverse transcriptase etc. (Maniatis et al., 
1982). This method was employed in this study to check the actual size of 
denatured DNA fragments which presumably had a secondary structure. 
The DNA fragments were dephosphorylated, end-labelled with [-y-"P] 
dATP and fractionated on an alkaline denaturing gel. 
2.4.28.1 Dephosphorylation of DNA Fragment: The terminal 5' 
phosphates were removed from DNA by treatment with 1/21 of calf intestinal 
alkaline phosphatase (CAP) (Boehringer) in a reaction mixture containing 5/21 
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lOx CAP buffer (lOx: 0.5M Tris-HCI pH 9.0; 10mM MgC1 2; 1mM ZnC12 ; 
10mM spermidine) and distilled water in a total volume of 49A. After 
successive incubation at 37°C for 15mm. and 56°C for 15mm., another ljA of 
CAP was added and the incubation cycle was repeated. The reaction was 
terminated by inactivating the enzyme at 68 °C for 15mm. in a solution 
containing 10ul of 1OxSTE (lOx: 100mM Tris-HC1 pH 8.0; 1M NaCl; 10mM 
EDTA) and 2.5l of 20% SDS and distilled water in a total volume of 100ul. 
The dephosphorylated DNA was purified using the gene-clean procedure 
(Section 2.4.10.2) and extracted into 10l of TE. 
2.4.28.2 	End-labelling of Dephosphorylated DNA: 	The 
dephosphorylated DNA was end-labelled as described in Section 2.4.13.5. 
The labelling mix contained 101 of dephosphorylated DNA, 2l of kinase 
buffer, 2.5ul of distilled water, 3.5ptl of [Y_32  P]dATP and 2u1 of kinase 
(5U//.Ll). After incubation at 37 °C for lhr, the labelled DNA was purified 
using the gene-clean procedure (Section 2.4.10.2) and extracted into 20l of 
TE. 
2.4.28.3 Alkaline Denaturing Gel: The gel was prepared as 1.2% 
agarose in a neutral, unbuffered solution (50mM NaCl, 1mM EDTA) and 
then equilibrated in alkaline electrophoresis buffer (30mM NaOH, 1mM 
EDTA) for at least 30mm. Excess buffer was removed to leave sufficient 
buffer to cover the gel to a depth of 1mm. DNA samples were mixed with 
1/10 volume of lOx alkaline loading buffer (lOx: 500mM NaOH, 10mM 
EDTA, 25% Ficoll type 400 (Pharmacia), 0.25% bromocresol purple) before 
being loaded onto the gel. Electrophoresis was carried out at 60V. After the 
dye had migrated out of the loading slot, a glass plate was put on top of the 
gel to prevent diffusion of the dye into the buffer. After 7hrs, the gel was 
recovered and processed by soaking in 7% trichloroacetic acid for 30mm. at 
room temperature. The gel was dried for several hours under stacks of filter 
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papers and paper towels and a heavy weight and was autoradiographed. 
2.5 RNA METHODS 
All solutions for RNA works were prepared in diethylpyrocarbonate 
(DEPC)-treated water. DEPC was added to distilled water at a final 
concentration of 0.1% to remove contaminants which would otherwise 
degrade RNA. After 30mm., the water was autoclaved twice to destroy the 
DEPC. 
2.5.1 Preparation of RNA from P. falciparum 
RNA was prepared according to Chomczynski & Sacchi (1987) from 
40m1 packed red blood cells obtained from 500m1 of an asynchronized 
culture. The parasites were collected by saponin lysing the infected red blood 
cells as described in Section 2.2.4. Aliquots of the parasites (0.7m1) were 
transferred to an eppendorl tube and lysed in 0.5m1 of solution D containing 
4M guanidinium thiocyanate, 25mM sodium citrate, 0.5% Sarcosyl and 0.1M 
13-mercaptoethanol. To this was added 50/21 2M sodium acetate pH4.0, 0.5m1 
water-saturated phenol and 0.1ml chloroform:isoamyl alcohol (49:1) 
sequentially. After vortexing the contents in the eppendorf tube for 10 
seconds, the lysate was left on ice for 15mm. before centrifugation in a 
microfuge (20min./4 °C). The aqueous phase was collected and the nucleic 
acids were precipitated with 0.5m1 isopropanol at -20 °C for at least lhr. The 
pellet obtained (microfuge/2Omin./4 °C) was resuspended in 0.3m1 solution D 
and the RNA was re-precipitated with 0.3mi of isopropanol at -20 °C for lhr 
followed by centrifugation (microfuge/20min./4 °C). The RNA pellet was 
washed once with 70% ethanol, dried and resuspended in 50/21 water. 
2.51 Separation of Poly A 4 RNA from Poly K RNA 
Poly A RNA can be separated from poly K RNA by passing through 
a column of oligo-(dT)-cellulose during which poly A RNA will be adsorbed 
onto the oligo-(dT) substrate. 
A column was rinsed with autoclaved water supplemented with 0.1% 
DEPC and then DEPC-treated water before packing with 0.5mJ oligo-(dT)-
cellulose. The cellulose was washed with 2.5m1 of 0.1M NaOH and 5m1 of 
application buffer (10mM Tris pH7.5, 1mM EDTA, 0.5M NaCl). Total RNA 
was made up to lml with 1xTE. After incubation at 65°C for 5mm., the 
preparation was put on ice and imi of 1M NaCl was added. The mixture 
was then applied to the column at room temperature. The eluate was re-
applied to the column which was then washed with 2.5rnl application buffer. 
The poly K RNA was collected. The bound poly A RNA was eluted into 
100Ø-200jil fractions with 1.5m1 TE. Fractions containing RNA were 
checked by examining a mixture of 2ul from each fraction, 81.J water and 11 
(20.ig/m1) ethidium bromide on Saran-wrap upon UV illumination. This 
purification step was then repeated. The eluate was pooled, incubated at 
65°C for 5mm., and then chilled on ice. To this was added an equal volume 
of 1M NaCl. The whole preparation was recycled through the column once. 
The poly K RNA and the poly A RNA were collected as before. 
2.5.3 Measurement of RNA Concentrations 
The quantity of RNA was measured spectrophotometrically at 
wavelengths of 260nm and 280nm as in Section 2.4.3. An OD 2 = 1 was 
equivalent to about 40kg/mi RNA. A value of 2.0 for OD/OD indicates 
pure preparations of RNA. 
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2.5.4 PCR from RNA 
The demonstration of the ability of Taq polymerase to directly 
transcribe RNA templates in vitro (Tse & Forget, 1990) makes it more 
convenient to amplify the RNA transcripts using the same procedure as DNA 
PCR (Section 2.4.15). Instead of DNA, 4ug of total RNA were used as 
templates. To remove contaminating DNA, the RNA was first treated with 
lb'l of RNase-free DNase (Boehringer) at 37 °C for lhr. The DNase was then 
denatured by boiling for 10mm. before subjected to PCR. 
A control was included in which a portion of the DNase-treated RNA 
sample was further treated with RNase at 37 °C for lhr before subjected to 
PCR. Since all RNA would be destroyed in this procedure, no fragments 
should be amplified from the samples. This would confirm that in previous 
experiments, the signals came from RNA but not contaminating DNA. 
2.5.5 Primer Extension 
This technique was used to map the 5' termini of mRNA. It involves 
hybridization of the test RNA with a synthetic oligonucleotide primer 
radiolabelled at its 5' end by phosphorylation, extension of the primer by 
reverse transcriptase to produce a cDNA which was analysed by denaturing 
polyacrylamide gel electrophoresis. 
The oligonucleotide was labelled at its 5' end in a reaction mixture 
containing 1.tl (20pmol) of oligonucleotide, 20iCi [Y_32  P]dATP, 3ul lOx 
kinase buffer (lOx: 500mM Tris-HCI pH 8.0, 100mM MgCl2), 3j.tl 100mM 
DT!', 2l distilled water and 0.3u1 T4 polynucleotide kinase (Sunits/,ul). The 
labelling reaction proceeded at 37 °C for 15mm. and then terminated at 70 °C 
for 10mm. 
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Total RNA (30/2g) was mixed with 0.5 A41-2/21 of the labelled 
oligonucleotide primer mix (from above) and hybridization mix (50mM Tris-
HC1 pH 7.5, 7.5mM KC1, 3mM MgCl2) in a total volume of 30/4. The 
sample was incubated for 30mm. at 5 °C below the calculated Td (for 
definition see Section 2.4.14) of the oligonucleotide and then put on ice for 
15-30mm. To this was added 1/4 1M Tris-HC1 pH 7.5, 1.5/4 1M KC1, 0.5/21 
0.2M MgCl2, 5/21 0.1M DT!', 2.5/21 dNTP mix (10mM each), 1/21 BSA 
(5mg/mi) and 7.5/21 distilled water. Extension of the primer was initiated by 
adding 1-2/21 (200U//2l) M-MLV (Moloney Murine Leukemia Virus) reverse 
transcriptase (Bethesda Res. Lab.) and proceeded at 37 °C for 60mm. The 
reaction was terminated by boiling in 12.5/21 0.5M NaOH for 3mm. and then 
transferred to ice. After neutralizing with 12.5/21 of 0.5M HC1, 12.5/21 of 1M 
Tris-HCI pH 7.4 were added and the nucleic acids were precipitated with 2 
volumes of ethanol at -20°C for at least 30mm. The pellet obtained after 
centrifugation (microfuge/l5min./4 °C) was washed with 66% ethanol. The 
nucleic acids were re-precipitated and vacuum dried. After"resuspended in 
5/21 of 2x urea loading buffer (2x: 10M urea, 1xTBE, 0.2% bromophenol blue, 
0.2% xylene cyanol) and boiled for 5mm., the sample was subjected to 
denaturing polyacrylamide gel electrophoresis as described in Section 2.4.27.5 
except that a pre-run at 40W for 30mm. was required to heat up the gel. 
2.5.6 Northern Blotting 
mRNA transcripts were analysed by Northern hybridization. Total 
RNA from P. falciparum was fractionated under denaturing conditions using 
an agarose-formaldehyde gel. A 1.2% agarose gel was made up by dissolving 
1.8g of agarose (Sigma) in 117m1 DEPC-treated water and then cooled to 
50°C. To this was added 30m.l of 5x MOPS buffer (5x: 41.8g MOPS, 6.8g 
sodium acetate, lOmi 500mM EDTA; pH to 7 with SM NaOH in 1 litre final 
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volume), 3nil formaldehyde and 7.5j.l ethidium bromide (10mg/mi). The gel 
was allowed to set in a fume cupboard and then in cold room for at least 
15mm. 
Total RNA (30kg) was made up to 10.1u1 with water. To this was 
added 4.51 5x MOPS, 7.9 4u1 37% formaldehyde and 22.51 deionized 
formamide. The sample was denatured at 55°C for 15mm. After a brief chill 
on ice and the addition of 5zl of formamide/EDTA/dye mix (95% 
formamide; 20mM EDTA pH 8.0; 0.05% bromophenol blue; 0.05% xylene 
cyanol), the sample was run at 100V for 2-3hrs in lx MOPS buffer. Markers 
used were E. coli ribosomal RNA subunits 16S (1.7kb) and 23S (3.5kb) and 
P. falciparum ribosomal RNA subunits of sizes 2.1kb and 3.7kb. 
The gel was recovered and photographed under short wave UV light. 
The gel was rinsed 2 times with lOx SSC for 20mm. and transferred to 
Hybond-N filter in lOx SSC overnight as shown in Fig. 2.5. After transfer the 
filter was recovered and rinsed 2 times in 2x SSC, air dried and baked at 
80°C under vacuum for 2hrs. 
Pre-hybridization and hybridization were performed as described in 
Section 2.4.13.1 using labelled DNA as probe. Unbound labelled DNA 
fragments were removed by washing the filters in 0.lx SSC, 0.1% SDS at 
room temperature for 15mm. and then 0.2x SSC, 0.1% SDS at 65 °C for 
30mm. before being autoradiographed. 
For re-use of the filters, the bound probe could be removed by 






Fig. 2.5 Cross section of a Northern transfer apparatus. 
(1) tray filled with lOx SSC, (2) glass plate (supported 
by two sides of the tray), (3) wick of three sheets of 
Whatman 3MM paper, (4) gel, (5) Parafilm round all 
sides of gel, (6) Nylon membrane (Hybond-N), (7) three 
sheets of Whatman 3MM paper, (8) paper towels, 
(9) glass plate, (10) weight. 
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2.6 PROTEIN METHODS 
2.6.1 Protein Preparation 
Total protein was extracted from synchronized cultures of P. falczpaium 
according to Inselburg et aL (1987) with modifications. A 500ml 
asynchronized culture containing 40m1 infected red blood cells was sorbitol 
synchronized as in Section 2.2.7. Parasites were then harvested 72hrs after 
sorbitol synchronization. The number of parasites/ml of red blood cells was 
determined from the parasitaemia and the haematocrit. These data were 
used to calculate the final concentration of parasites to be resuspended in 
buffer. The parasitized red blood cells were washed and resuspended in 40m1 
of phosphate buffered saline (PBS) and lysed with 0.15% saponin at room 
temperature for 10mm. The pellet, obtained after centrifugation at 3,500rpm 
for 15mm. (4°C) in a Chillspin swingout rotor, was washed 3 times in cold 
PBS pH7.4. The parasites were resuspended at a concentration of 1x10 9 
parasites/ml TEK (50mM Tris-HC1 pH7.4, 1mM EDTA, 03M KC1) in the 
presence of protein inhibitors (10mM benzamidine, 20/Ag/mi leupeptin, 
20/Ag/mi pepstatin, 50/Ag/mi aprotinin, 50/Ag/mi soybean trypsin inhibitor). 
Parasite protein was extracted by sonication at full power with five 10 seconds 
bursts with 1mm. cooling in between. After spinning down the debris at 
15,000rpm in a Sorvall SS-34 rotor for 30mm. at 4 °C, the supernatant 
containing parasite protein was collected and stored at -70 °C as source of 
parasite enzyme. 
2.6.2 Estimation of Protein Concentration (Bradford's Method) 
Bradford's reagent was made up by dissolving 100mg Coomassie 
Brilliant Blue G-250 (Bio-Rad) in 50mi 95% ethanol which was stirred until 
dye completely dissolved (Bradford, 1976). Then, lOOmI 85% (w/v) 
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phosphoric acid were added and made up to 1 litre with distilled water. 
The test protein (lOOj.tl) was mixed with 5m1 of Bradford's reagent. 
Protein standards of 12.5g-125ug11OOul bovine albumin were used for 
calibration. The absorbance at wavelength 595nm was read between 2-60mm. 
after mixing against a blank of buffered reagent. A standard curve was 
plotted from the readings of the protein standards. Protein concentrations 
of the parasite preparations were determined from the standard curve. 
2.6.3 Thymidylate Synthetase (TS) Assay 
Expression of the dihydrofolate reductase (DHFR) gene can be 
measured by quantifying the thymidylate synthetase (TS), since DHFR and 
TS are translated into a single polypeptide chain. Thus, measurement of the 
TS will reveal the number of DHFR molecules in the cell. 
The assay depends on the use of a substrate analogue F-dUMP tagged 
with tritium. During the conversion of dUMP to dTMP, an intermediate is 
formed among the substrate, TS and the co-factor methylenetetrahydrofolate. 
Substitution of dUMP with F-dUMP will inhibit ion exchange between dUMP 
and methylenetetrahydrofolate due to the presence of the fluoride ion, thus 
the reaction will be arrested at this stage. By tagging the F-dUMP with 
tritium, the products, after PPO (2,5-diphenyloxazole) impregnation, could be 
detected by fluorography. 
2.6.3.1 Preparation of Methylenetetrahydrofolate (CH 2FAH4): The 
assay was performed according to Sand et al. (1974) and Inselburg et al. 
(1987) with modifications. The co-factor methylenetetrahydrofolate for the 
conversion of dUMP to dTMP was prepared in a imi reaction mixture 
consisting of 300mM Tris-HC1 pH7.2, 20mM DL-tetrahydrofolate (Sigma) and 
40 mM formaldehyde. The methylation reaction was carried out at room 
temperature for 30mm. and protected from light. 
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2.63.2. TS Quantification: The assay was done in a 0.4inl assay 
mixture containing 50mM NMM (N-methylmorpholine) (Sigma), 25mM 
MgC12, 1mM EDTA, 75mM 2-mercaptoethanol, 6.5mM formaldehyde, 
50/2g/ml bovine albumin. 0.17 mM CH2FAH4, 95 nM [6-3H] F-dUMP 
(Moravek Biochemicals, Inc) and 0.3m1 parasite protein extract. Control 
included a reaction mixture without the parasite extracts. Instead, an 
equivalent volume of TEK buffer was used. The reaction was carried out at 
room temperature for lhr, in the dark. After lhr, 50ul of the assay mixture 
were mixed with an equal volume of sample buffer and then heat denatured 
for 5mm. before loaded onto a 10% SDS-PAGE gel for further analysis (see 
below). 
2.6.3.3 SDS-PAGE (Sodium Dodecyl Sulphate-polyacrylamide Gel 
Electrophoresis): Total protein from parasite extracts was fractionated by 
SDS-PAGE according to Laeminli (1970) and Hames (1981). 
The gel mixtures were prepared as listed in Table 2.6. A 10% 
acrylamide was used in the resolving gel and a 3.75% acrylamide was used 
in the stacking gel. Sufficient quantity of 10% acrylamide was poured into 
a 170mm x 150mm x 1.5mm glass-plate, leaving 2-3cm for the stacking gel. 
Small quantity of distilled water was now gently layered onto the gel surface. 
After the completion of polymerization, the overlay was poured off. The 
surface of the separating gel was washed 3 times with stacking buffer. The 
remaining space between the glass plates was filled with stacking gel mixture. 
A comb was inserted into the stacking gel to form sample wells in the 
stacking gel. After the completion of polymerization, the comb was removed 
and the sample wells were rinsed 3 times with reservoir buffer (0.025M Tris, 
0.192M glycine pH 8.3). 
The reaction samples were brought to final concentrations of 0.0625M 
Tris-HC1 (pH 6.8), 2% SDS, 5% 3-mercaptoethanol, 10% glycerol and 
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Table 2.6 Recipe for gel preparation using SDS-discontinuous buffer 
system. 
Concentrations 
Stock solution 	 Final 	acrylamide 
concentrations 
Stacking gel Resolving gel 
3.75% 	10% 
Acrylamide:bisacrylamide 	 2.5m1 	20m1 
(30:0.8) 
Stacking gel buffer stock* 	 5.Oml 	- 
0.5M Tris-HC1 (pH 6.8) 
Resolving gel buffer stock** 	 - 	 7.5rnl 
IOM Tris-HC1 (pH 8.8) 
10% SDS 
	
200 /21 	600/21 
10% ammonium persuiphate 	 100/21 	300/21 




* Final concentration 0.125M Tris-HCI pH 6.8 
* * Final concentration 0.375M Tris-HC1 pH 8.8 
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0.002% of bromophenol blue by mixing with an equal volume of sample 
buffer. Bromophenol blue was included as the tracking dye. 
The protein was denatured by boiling for 5mm. A sample load of 
100l was used. Molecular weight markers (Prestained SDS Molecular 
Weight Markers, Sigma) of u 2-macroglobulin (human plasma) 180 kDa, 3-
galactosidase (E. coli) 116 kDa, fructose-6-phosphate kinase (rabbit muscle) 
84 kDa, pyruvate kinase (chicken muscle) 58 kDa, fumarase (porcine heart) 
48.5 kDa, lactic dehydrogenase (rabbit muscle) 36.5 kDa and triosephosphate 
isomerase (rabbit muscle) 26.6 kDa were used to calibrate the system. 
Electrophoresis in 0.025M Tris, 0.192M glycine pH 8.3, 0.1% SDS was 
carried out at 100V constant voltage until the tracking dye reached the last 
centimeter of gel. 
The gel was stained in 0.25% Coomassie Brilliant Blue R-250 (Bio-
Rad) in water: methanol: glacial acetic acid (5:5:1) at 37°C for 2 hrs. Excess 
stain was removed by destaining in water: methanol: glacial acetic acid 
(4.5:4.5:1) at 37°C until a clear background came up. Photographs were 
taken as records before proceeding to the next step. 
2.6.3.4 Detection of the Reaction Products: The tritium labelled 
reaction products were detected according to Bonner & Laskey (1974). The 
gel was dehydrated by soaking in about 20x its volume of DMSO for 30mm., 
and then immersed in fresh DMSO for another 30mm. These two solutions 
can be re-used in the same sequence for several times. A third immersion 
in unused DMSO is recommended if old DMSO solutions are used in the 
previous two steps. The gel was then immersed in 4 volumes of 22.2% (w/v) 
of the scintillator 2,5-diphenyloxazole (PPO) in DMSO for 3hrs and then 
transferred to 20 volumes of water for lhr. After drying the gel under 
vacuum, the gel was exposed to an X-ray film at -70 °C for fluorography. 
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CHAPTER THREE 




3.1.1 RFLP Associated with the DHFR-TS Gene of Parent Lines 
3.1.2 Segregation of the DHFR-TS Gene with Pyrimethamine Resistance 
Phenotype in Progeny of a Genetic Cross 
3.1.3 No Aberrant Sensitive Alleles were Detected in At Least 100 of the 
Resistant Progeny Clones 
3.1.4 The DHFR-TS Associated RFLP in Other Parasites 
3.2 DISCUSSION 
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Drug chemotherapy has been used extensively to treat malaria patients and 
it remains one of the most effective ways to combat the disease. However, 
the global spread of drug resistant parasites has had a great impact on 
malaria chemotherapy (Spencer, 1985). Resistance to almost all major 
antimalarial compounds has been reported. Despite this, little is understood 
about the mechanisms underlying drug resistance in malaria. For example, 
the precise target for the most widely used drug, chloroquine, is still 
unknown. Pyrimethamine is an analogue of dihydrofolate and its target is 
thought to be the enzyme dihydrofolate reductase (DHFR) (Ferone, 1977; 
Kan & Siddiqui, 1979). It is speculated from sequencing and biochemical 
data that resistance to pyrimethamine is caused by single base changes in the 
DHFR gene, resulting in a structurally altered enzyme with reduced affinity 
for the drug (McCutchan et al., 1984b; Sirawaraporn & Yuthavong, 1984; 
Dieckmann & Jung, 1986a; Walter, 1986; Chen et al., 1987; Cowman et al., 
1988; Peterson et al., 1988; Snewin et al., 1989; Zoig et al., 1989). However, 
the contribution of other possible mechanisms e.g. over-production of the 
protein or reduced drug accumulation to pyrimethamine resistance in malaria 
parasites cannot be excluded. This is open to genetic test. If the sole cause 
of pyrimethamine resistance is a structural change in the enzyme DHFR, then 
we should be able to localize the responsible alteration to the gene encoding 
DHFR. 
The first successful cross performed by Professor David Walliker 
(Walliker et al., 1987) between a pyrimethamine sensitive (pyrS) clone 3D7 
and a pyrimethamine resistant (pyrR) clone 11133 was made available to me 
for the performance of such a genetic test. This, together with the isolation 
of a cloned dihydrofolate reductase-thymidylate synthetase (DHFR-TS) gene 
(Snewin et al., 1989) and the feasibility of using restriction-fragment-length-
polymorphism (RFLP) as a marker to tag corresponding genes (Section 1.1.4) 
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form the basis of the present study. 
In the study of Walliker et al. (1987), the pyrS clone 3D7 was derived 
from isolate NF54 by limiting dilution and the pyrR clone HB3 was derived 
from the Honduras isolate Hi by microscopic selection. The method for 
making crosses has been described in INTRODUCTION Section 1.1.3. 
Briefly, the gametocytes from the two parent clones were mixed and 
transmitted through mosquitoes to allow cross-fertilizations to take place. 
The resulting sporozoites became infective to chimpanzees. Cultures of 
parasites taken from chimpanzees were established in the laboratory. 
Genetically pure clones (denoted as Xi, X2 etc) were obtained by limiting 
dilution or micro-manipulation. 
The absence of intermediate resistance among the progeny has already 
suggested the involvement of a single locus in conferring pyrimethamine 
resistance on the clone HB3 (Walliker et al., 1987). When tested for their 
sensitivity to pyrimethamine, the progeny gave MIC (minimum-inhibitory-
concentration) values characteristic of the two parents of either 10 5M 
(pyrimethamine resistant) or 10 7M (pyrimethamine sensitive). The MIC is 
defined as the lowest concentration of the drug that will kill all or nearly all 
the parasites after exposure to drug containing media for 72hrs (Section 
2.2.8). 
Analysis of the progeny of the genetic cross for the linkage relationship 
between the RFLP-tagged DHFR alleles and the resistance phenotype helped 
us to formulate models about the mechanism underlying resistance to 
pyrimethamine. 
To facilitate the performance of genetic tests on a large number of 
progeny clones, a simple and rapid protocol for the extraction of DNA from 
a small quantity of infected blood is an essential pre-requisite. Previously, 
extraction of DNA from parasites was a time consuming and laborious 
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process involving weeks of large scale culture with daily medium change. At 
least 500m1 of culture at 8-10% parasitaemia was needed. To circumvent this 
I devised a mini-prep method (see MATERIALS & METHODS Section 
2.4.4.2). Briefly, parasites are collected from 100 4ul packed red blood cells 
and subjected to Proteinase K treatment followed by phenol extraction. The 
nucleic acids are then collected by ethanol precipitation. This method 
produces an average of 30J2g DNA per preparation. The DNA is pure 
enough for restriction enzyme analysis. 
3.1 RESULTS 
3.1.1 RFLP Associated with the DHFR-TS Gene of Parent Lines 
The lack of available genetic markers for rapid screening of progeny 
from a genetic cross presents a problem for genetic studies on Plasmodium. 
The emergence of a new class of markers termed restriction-fragment-length-
polymorphisms (RFLP) (see INTRODUCTION Section 1.1.4) offers a new 
approach for linkage analysis. By tagging corresponding genes with a defined 
RFLP, the alleles of a given gene can be distinguished and thereby the 
inheritance pattern of the alleles in the progeny of a genetic cross can be 
analysed. RFLP analysis has been used successfully on several occasions in 
the study of Plasmodium genetics (Wellems et al., 1987; 1990; 1991; Peterson 
et al., 1988). 
The probe used to define RFLP for the DHFR-TS gene was a 5.65kb 
genomic fragment isolated from the Ki strain by Snewin et al. (1989) (see 
Fig. 3.1). Genomic DNA prepared by the standard method from clones of 
3D7 and HB3 was digested with a large number of different restriction 
enzymes. The resulting patterns in the region of the DHFR-TS gene were 
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1 5159 108 	228 	326 	 608 
0.6kb 
4 	 1.8kb 
H- 	 —5.65kb 
ADHFRCLONE 
EcoRI 	 EcoRI 
Fig. 3.1 Organization of the gene encoding DHFR-TS isolated from the Ki isolate. 
A 5.65kb Eco  RI fragment comprising the 5' flanking region of the DHFR-TS gene, 
the DHFR domain, the junction domain and the 5' end of the TS domain was cloned 
in a A vector (Snewin et al., 1989). Amino acid positions are numbered. Codon 51, 
59 and 108 are candidate sites for amino acid changes affecting pyrimethamine 
sensitivity. 
detected by probing Southern blots with the probe described above. The 
results are shown in Fig. 3.2. An easily recognisable RFLP was observed 
upon digestion with AccI. In addition to common bands of 1.65kb, 1.1kb and 
1.0kb, differing fragment sizes of 2.4kb from 3D7 DNA and 2. 15kb from HB3 
DNA were found. The difference in apparent sizes between these two 
fragments from 3D7 and 14B3 DNA defines a RFLP for the DHFR-TS which 
can be used as a marker for the two alleles of the gene. 
As mentioned above, the use of a mini-prep method for preparing 
DNA from P. falczparum would greatly facilitate genetic analysis on 
Plasmodium. However, before this mini-prep method could be employed in 
routine DNA preparation, the quality of DNA prepared by this method must 
be checked. Genomic DNA from 3D7 and HB3 prepared by the mini-prep 
method was digested with AccI, blotted and probed. The results are shown 
in Fig. 3.3. The ethidium bromide stained gel (plate a) revealed complete 
digestion of the genomic DNA prepared by the mini-prep method. Note that 
there is a small amount of contaminating RNA shown at the base of the 
ethidium bromide stained gel. However, this has not affected the quality of 
the digest (plate b). Restriction patterns identical to that obtained from 
DNA prepared by the standard method were observed. The pattern observed 
using 3D7 and HB3 DNA prepared by the conventional large scale method 
is shown in plate c for comparison. These results illustrate that DNA 
prepared by the mini-prep method is pure enough for restriction digestion 
and hence subsequent DNA preparations were obtained by the mini-prep 
method. 
3.1.2 Segregation of the DHFR-TS Gene with Pyrimethamine Resistance 
Phenotype in Progeny of a Genetic Cross 
The genetic determinant for pyrimethamine resistance in HB3 can be 
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Fig. 32 Search for an RFLP associated with the DHFR-TS gene. 
Southern blots of restriction enzyme digested genomic DNA from 
3D7 and HB3, probed with the 5.65kb DHFR-TS gene fragment 
from the Ki isolate. 
Track 1: HB3 
Track 2: 3D7 
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Fig. 3.3 An 4I RFLP associated with the parasite clones 3D7 
and HB3 is detectable using DNA prepared by the mini-prep 
method. Genomic DNA from 3137 and HB3 was digested with 
AccI, fractionated by agarose gel and then blotted for 
hybridization. 
Ethidium bromide stained gel of AccI digested genomic DNA 
of 3D7 and HB3 obtained by mini-prep method (Section 2.4.4.2). 
Southern blot of gel probed with the 5.65kb DHFR-TS gene 
fragment from the Ki isolate showing differing sizes of 2.4kb and 
2.15kb in the upper band between 3D7 and HB3. 
Southern blot of AccI digested genomic DNA of 3D7 and HB3 
obtained by the conventional large scale method (Section 2.4.4.1), 
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precise detected using a genetic cross. The cross between a pyrS 3D7 
parent clone and a pyrR HB3 parent clone of P. falczparum displaying well-
defined characteristics enables genetic analysis to be undertaken on the 
progeny. In many of the progeny the characters of the two parents are 
reassorted in a Mendelian manner (Walliker et al., 1987). Hence, by 
mapping the DHFR marker in the cross, we should be able to correlate the 
inheritance of this DNA marker with the inheritance of resistance to the drug 
in the cloned progeny. 
A total of 29 progeny clones obtained by Walliker et al., (1987) by 
limiting dilution or by micro-manipulation have been tested for 
pyrimethamine sensitivity and were made available to me. The recombinant 
progeny were screened to see if the RFLP segregated with pyrimethamine 
resistance. Genomic DNA prepared from independent progeny clones was 
digested with AccI, fractionated by agarose gel electrophoresis, blotted and 
probed with the 5.65kb DHFR-TS fragment from the Ki isolate. The results 
are shown in Fig. 3.4 and are summarised in Table 3.1. These results show 
that the RFLP associated with the DHFR-TS gene co-segregates with the 
resistance phenotypes. All pyrS progeny had the 2.4kb fragment characteristic 
of the sensitive parent 3D7 while pyrR progeny had the 2.15kb fragment 
characteristic of the resistant parent HB3. This implies that the o&.ar&h on 
conferring drug-resistance on the clone HB3 is linked to the DHFR-TS gene 
and is probably located close to the gene or within it. 
A control test was performed on clones 3D7B and HB3B which were 
obtained after passing the parent clones through mosquitoes independently. 
RFLP patterns similar to the parent 3137 and HB3 were obtained for 3137B 
and HB3B (Fig. 3.4t), showing that the passage through mosquitoes did not 
affect the RFLP patterns. 
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Fig. 3.4 RFLP patterns in progeny of a genetic cross. 
a-e) Southern blots of AccI digested genomic DNA from progeny, 
probed with the 5.65kb DHFR-TS gene fragment from the Ki 
isolate. Note that the progeny clones have only one of the two 
possible RFLP's. Clone X59 represents a mixed population of 
sensitive and resistant parasites. The sensitive parent clone 3D7 
and resistant parent clone HB3 were included as controls. 
f) Southern blot of AccI digested genomic DNA from 3D7B and 
HB3B, probed with the same gene fragment. 
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Table 3.1 Linkage of RFLP with pyrimethamine resistance in the progeny 
of a cross 
RFLP PyrR/5 Progeny Phenotype 
3D7 1 S 
HB3 2 R 
3D7B 1 S 
HB3B 2 R 
X2 2 R rec 
X4 2 R rec 
X6 2 R rec 
X8 1 S par 
X1O 1 S rec 
Xli 2 R rec 
X12 2 R rec 
X30 1 S rec 
X33 2 R rec 
X34 2 R rec 
X35 2 R rec 
X36 1 S par 
X37 1 S par 
X41 2 R rec 
X44 1 S rec 
X45 1 S rec 
X47 1 S rec 
X48 1 S rec 
X50 1 S rec 
X51 1 S rec 
X52 1 S rec 
X58 1 S rec 
X63 1 S rec 
XP1 2 R rec 
XP3 2 R rec 
XPS 2 R rec 
XP7 2 R rec 
XP8 2 R rec 
XP9 2 R rec 
Legend to Table 3.1 
The segregation of RFLP marker and the pyrimethamine resistance phenotype are shown in 
progeny of a cross between 3137 and HB3. The RFLP pattern for 3137 is denoted as 1 which 
is observed as a 2.4kb fragment whereas the RFLP pattern for HB3 is denoted as 2 which is 
observed as a 2.15 kb fragment. The data on pyrimethamine sensitivity is provided by 
Professor David Waffiker. Parasites that are sensitive to 10 -7M pyrimethamine or more are 
denoted as S whereas parasites that are resistant to 10 5M pyrimethamine or less are denoted 
as R. Progeny are designated either parental (par) from selfed zygotes or recombinant (rec) 
from crossed zygotes as judged by their reactivities towards different monoclonal antibodies 
and 2D-PAGE studies (Walliker et al., 1987; D. Walliker, personal communication). 
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3.1.3 No Aberrant Sensitive Alleles were Detected in At Least 100 of the 
Resistant Progeny Clones 
The number of progeny clones which can be tested is limited by the 
tedious process of in vitro cultivation and DNA preparation. Even with the 
development of a rapid method to prepare DNA from small scale cultures 
(see MATERIALS & METHODS Section 2.4.4.2), it is still a time-consuming 
and laborious process to prepare DNA from a large number of parasites for 
genetic analysis. The sample size could be increased conveniently if a large 
number of progeny could be tested without the laborious isolation of 
individual clones by selecting pyrR parasites from the cross. In order to do 
this we used the fact that the uncloned progeny represented a mixture of 
pyrR and pyrS parasites. Treatment with a dosage of pyrimethamine (10M) 
lethal to the sensitive parasites but tolerated by the resistant parasites had 
previously been used to select a population of parasites resistant to 
pyrimethamine (denoted as XP) (Walliker et al., 1987). 
To detect any aberrant sensitive alleles in XP, DNA was prepared 
from the uncloned mixture XP and, as a control, DNA was also prepared 
from the mixture of uncloned unselected progeny (denoted as X). After 
digestion with AccI and fractionation by agarose gel electrophoresis, the DNA 
was blotted and probed with the 5.65kb DHFR-TS gene fragment from the 
Ki isolate. The results are shown in Fig. 3.5. Parasites selected with 
pyrimethamine (XP) showed the pattern associated with the resistant DHFR-
TS allele only, with the characteristic 2.15kb band. Those unselected with 
pyrimethamine (X) showed a pattern characteristic of both the sensitive and 
resistant alleles i.e. 2.4kb and 2.15kb. 
The limits which a 3137 type RFLP could be detected in a HB3 
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Fig. 3.5 RFLP pattern in uncloned progeny selected with 
pyrimethamine (XP). Southern blot of AccI digested genomic 
DNA obtained from progeny selected with pyrimethamine (XP), 
probed with the 5.65kb DHFR-TS gene fragment from the Ki 
isolate. Controls included AccI digested genomic DNA from 3137, 
HB3 and the original uncloned progeny unselected with 
pyrimethamine (X). 
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background was calibrated by mixing known amounts of 3D7 and HB3 DNA 
in the AccI restriction enzyme digest. The ratio of the two types of DNA 
varied from 1:1 to 1:10 7 (Fig. 3.6). The results clearly show that with a ratio 
of 1:10, the 2.4kb band can be detected in the mixture. Over-exposure of this 
blot revealed a faint 2.4kb band even when 3D7 DNA was mixed with HB3 
DNA in a 1:100 ratio (Fig. 3.7). No such band was ever observed upon 
probing XP. This indicates that no aberrant sensitive DHFR-TS alleles were 
detected in at least 100 resistant parasites. 
To make sure that no 2.4kb band was masked by the 2. 15kb band from 
the XP digest, AccI digested genomic DNA from X and XP was fractionated 
and probed with the 5.65kb fragment from the Ki isolate. The blot was 
initially exposed overnight to reveal the restriction patterns. A piece of filter 
from the XP track at the position corresponding to the 2. 15kb band was cut 
out and re-exposed. The piece of cut-out filter was exposed alongside as a 
control. As shown in Fig. 3.8, prolonged exposure of the filter did not reveal 
any 2.4kb band in the XP track. 
3.1.4 The DHFR-TS Associated RFLP in Other Parasites 
Parasites isolated from the wild were screened to see whether the 
occurrence of the AccI RFLP denoted by the 2.15kb/2.4kb fragments was 
restricted to 3D7 and HB3. Variant parasites tested included a series of 
Tak9 isolates and clones, the Ki isolate and the cloned line PR70/CB3 from 
Thailand, a Papua New Guinea strain MAD20 and two in vitro selected pyrR 
mutants derived from T9/94 parent. DNA was prepared from these parasites 
by the mini-prep method and digested with AccI. After fractionation by 
agarose gel electrophoresis, the DNA was blotted and probed with the 5.65kb 
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Fig. 3.6 RFLP analysis on XP (I). Southern blot of AccI digested 
genomic DNA from the parasite mixtures X and XP, probed with 
the 5.65kb DHFR-TS gene fragment from the Ki isolate. The 
sensitivity of the test was calibrated against known amounts of HB3 
and 3D7 DNA mixed in different ratios from 1:1 to 1:10-7 . Tracks 
containing 3137 and 14133 DNA were included as controls. 
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Fig. 3.7 RFLP analysis on XP (II). An over-exposure of the 
Southern blot in Fig. 3.6 to show the faint band (arrow) detected 
when 3D7 and HB3 DNA were mixed in a ratio 1:100 (track 5). 
Track 1 unselected progeny X 
Track 2 selected progeny XP 










calibration U) -_ 
1: 	1: 	1: 	3070N4 ai 1 10 100 HB3DNA 
gas 4- 




12345   
Fig. 3.8 Absence of the 2.4kb band in XP. An over-exposure of 
Southern blot of AccI digested genomic DNA from the parasite 
mixtures X and XP, probed with the 5.65kb DHFR-TS gene 
fragment from the Ki isolate. The filter was initially exposed 
overnight to reveal the restriction patterns. A piece of filter at the 
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DHFR-TS fragment from the Ki strain. The hybridization patterns were 
dimorphic in nature (Fig. 3.9). Either the 2.4kb or the 2.15kb dimorphic AccI 
fragment was present in the parasite strains. 
The dimorphic RFLP patterns in these parasites did not seem to have 
any correlation with their resistance to pyrimethamine, however. For 
example, the Ki isolate, which is resistant to pyrimethamine, showed a 
restriction pattern like that of the sensitive clone, 3D7, displaying the 
characteristic 2.4kb band. From this we conclude that the AccI RFLP 
associated with DHFR-TS is dimorphic in nature but that this dimorphism in 
itself does not bear any correlation with pyrimethamine resistance. 
3.2 DISCUSSION 
Genetic analysis can often provide evidence for the genetic determinants of 
drug resistance. The success achieved in making crosses of the human 
malaria parasite, P. falciparum (Walliker et al., 1987) enables genetic analysis 
to be undertaken on this human malaria parasite. The drawback is that the 
sample size is very often limited. Therefore, in the present study, the number 
of progeny clones screened was as high as possible. The results of screening 
29 progeny show a linkage between the RFLP associated with the DHFR-TS 
gene and the resistance phenotype. It should be noted that for three of the 
progeny X8, X36 and X37, using a variety of assays, it has not yet been 
possible to distinguish them from the sensitive parent 3D7. It may be 
therefore that these are not true recombinants but could have derived by self-
fertilization. Taking this into account, however, the linkage between the 
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Fig. 3.9 RFLP patterns in different parasite strains and in vitro 
selected mutants. Southern blot of AccI digested genomic DNA 
from different parasite strains (K1/MAD20/T9), the cloned lines 
derived from T9 (T9/94/96/98/101/102/106), the clones 3137, 
HB3, PR70/CB3 and the mutants T9/94 (Ml-1), T9/94 (S300.300) 
selected from T9/94. The probe used was derived from the 5.65kb 
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DHFR-TS gene and pyrimethamine resistance is still confirmed with at least 
26 progeny. Moreover, the sample size was raised to 100 when the analysis 
on parasites selected with pyrimethamine (XP) was calibrated against known 
mixtures of DNA from 3D7 and HB3. In other RFLP-related studies on P. 
falciparum, the sample sizes have been smaller and still clear predictions have 
been reached (Wellems et al., 1987; 1990; 1991; Peterson et al., 1988). For 
example, using 16 progeny, Wellems et al., (1990) are able to disprove the 
role of the mdr-like genes in chioroquine resistance as suggested by Foote et 
al. (1990b). Analysis on segregation of a number of RFLP markers in these 
16 progeny has mapped the resistance allele for chioroquine to within 400kb 
in chromosome 7 (Wellems, 1991). 
The present study provides genetic evidence about the target for 
pyrimethamine and the changes causing pyrimethamine resistance. In the 
genetic cross pyrimethamine resistance behaved as a single locus (Walliker 
et al., 1987). As shown in the present study, this locus is linked to the gene 
for DHFR-TS and is probably located close to the gene or within it. 
Although the RFLP is used as a genetic marker, the polymorphism itself is 
not responsible for pyrimethamine resistance i.e. the pyrimethamine resistant 
Ki isolate displays an RFLP characteristic of the sensitive 3D7 clone. 
These results provide genetic confirmation for the conclusion drawn 
from biochemical and sequencing studies (McCutchan et al., 1984b; 
Sirawaraporn & Yuthavong, 1984; Dieckmann & Jung, 1986a; Walter, 1986; 
Chen et al., 1987; Cowman et al., 1988; Peterson et al., 1988; Snewin et al., 
1989; Zoig et al., 1989). Their results have suggested that single base changes 
within the gene for DHFR-TS cause structural changes in the enzyme and 
thereby reduce its affinity for the drug. 
Further proof has come from functional analysis on the products of in 
vitro mutagenized genes expressed in E. coli (Sirawaraporn er al., 1990). 
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Using site-directed in vitro mutagenesis the DHFR-TS gene cloned from a 
resistant parasite was changed to that of a sensitive parasite. The affinity of 
the expressed protein for pyrimethamine is increased to the same magnitude 
as that obtained from the wild isolate. Alternatively, the functional 
importance of the amino acid residues in forming the active site cavity and 
their interaction with substrate/inhibitor can be studied in vitro by X-ray 
crystallography. Ultimately, the effect of these mutations on phenotypes need 
to be studied in vivo to see whether the mutated gene can confer resistance 
to a pyrS parasite. This would depend on the development of a 
transformation system to place altered genes back into the genome of malaria 
parasites. 
The role of single base changes within the DHFR-TS gene in giving 
rise to pyrimethamine resistance is confirmed from biochemical, sequencing 
and the present genetic results. It remains to be seen whether other 
mechanisms also play a part in conferring resistance on malaria parasites. 
Parasites in nature exhibit a wide range of resistance to pyrimethamine. This 
0 
varies fromvery low level of resistance to as much as 10 6-fold more resistant 
than the sensitive organism (Thaithong et al., 1983), suggesting the possibility 
of a variety of mechanisms. Already alterations other than single base 
changes have been identified. Inselburg's laboratory have generated a class 
of mutants which" appears over-produce DHFR-TS due to gene 
amplification (Banyal & Inselburg, 1986; Inselburg et al., 1987; Tanaka et al., 
1990a; b). In one wild type isolate measurements of DHFR specific activity 
from parasite extracts lead Kan & Siddiqui (1979) to conclude that the isolate 
may have increased levels of enzyme. These results lead us to investigate the 
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There are several possible basic mechanisms contributing to pyrimethamine 
resistance in P. falciparum: 
The structure of the target enzyme may be altered so that 
its affinity for pyrimethamine is reduced. 
The enzyme may be over-produced to titrate the toxic effect 
of the drug. 
The accumulation of the drug inside the parasite may be 
reduced. 
The utilization of the metabolic pathway in folate 
metabolism may be altered to bypass the inhibitory effect of 
the drug. 
The role of single base changes in the dihydrofolate reductase-
thymidylate synthetase (DHFR-TS) gene contributing to pyrimethamine 
resistance by inducing structural alteration in the enzyme has been well 
established from biochemical, sequencing and genetic results (McCutchan et 
al., 1984b; Sirawaraporn & Yuthavong, 1984; Walter, 1986; Dieckmann & 
Jung, 1986a; Chen et al., 1987; Cowman et al., 1988; Peterson et al., 1988; 
Snewin et al., 1989; Zoig et al., 1989; Sirawarapron et al., 1990 and the 
present study). 
Over-production of the protein as a result of gene amplification and/or 
increased gene expression has not been documented in naturally occurring P. 
falciparum, however, a mutant isolated in vitro (Banyal & Inselburg, 1986) 
appears to function in this way (Inselburg et al., 1987). Over-production of 
the gene product is a known mechanism of resistance to another antifolate-
methotrexate in L. major (Coderre et al., 1983; Beverley et al., 1986) and of 
cultured mammalian cells (Schimke et al., 1978). 
A reduction in the uptake of the antifolate methotrexate has been 
implicated as one mechanism for drug resistance in the kinetoplastids 
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(Ellenberger & Beverley, 1987) although this has yet to be found in P. 
falczparum. 
The possible use of an alternative pathway in folate metabolism to 
circumvent the toxic effect of the drug is highlighted by the increasing 
recognition of the salvage pathway (Krungkrai et al., 1989a; 1990) and the 
demonstration of a de novo methionine synthesis cycle in P. falciparum 
(Krungkrai et al., 1989b). Resistance to sulfadoxine which inhibits the same 
metabolic pathway as pyrimethamine in P. falciparum is thought to be due to 
shifting from salvage to de novo synthesis of p-aminobenzoate (Dickemann 
& Jung, 1986b). 
In this chapter the investigation of over-production of DHFR-TS as a 
possible mechanism of pyrimethamine resistance is described using (a) the 
cloned line HB3; (b) an in vitro selected mutant and (c) a naturally occurring 
clone PR70/CB3. 
4.1 BASIS OF THE ASSAY FOR MEASURING THE DHFR-TS CONTENT 
OF P. FALCIPARUM 
The amount of DHFR-TS enzyme in P. falciparum parasites is measured 
using a thymidylate synthetase assay (TS assay) which quantifies the amount 
of thymidylate synthetase (TS) in the parasite. Since dihydrofolate reductase 
(DHFR) and TS are translated into a single polypeptide chain (Bzik et al., 
1987; Snewin et al., 1989), expression of the DHFR-TS gene in the two types 
of parasite can be compared by quantifying the thymidylate synthetase. The 
basis of the assay is outlined in Fig. 4.1. It relies on the fact that TS is the 
key enzyme in catalysing the conversion of dUMP to dTMP (Fig. 4.1a). The 
methylation reaction is mediated by 5, 10-methylenetetrahydrofolate as a co- 
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Fig. 4.1 Basis of the TS assay for over-production of DHFR-TS 
The synthesis of dTMP from dUMP. The conversion of dUMP 
to dTMP is catalysed by the enzyme thymidylate synthetase and 
mediated by the co-factor 5, 10-methylenetetrahydrofolate. In this 
reaction, 5, 10-methylenetetrahydrofolate serves as both a one-
carbon donor and a reducing agent which is itself converted into 
dihydrofolate. 
In a normal reaction, the enzyme will form a covalent complex 
with the substrate and co-factor 5, 10-methylenetetrahydrofolate. 
After ion exchange among them, the products dTMP and 
dihydrofolate are formed. 
When the substrate is replaced by an analogue 
fluorodeoxyuridylate (F-dUMP), the reaction is irreversibly 
inhibited at the stage of intermediate formation. The presence of 
the fluoride ion inhibits ion exchange and hence the conversion of 
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factor which serves as both a one-carbon donor and reducing agent. In a 
normal reaction (Fig. 4.1b), the TS enzyme and the co-factor 5,10-
methylenetetrahydrofolate covalently bind to the substrate dUMP to form an 
intermediate. Further reaction to the final products requires ion exchange 
between the co-factor, the enzyme and the hydrogen ion of the substrate 
(shadowed in the figure). When the substrate is replaced with a fluoride 
analogue F-dUMP, the reaction will be irreversibly inhibited at the stage of 
covalent complex formation because the fluoride ion cannot be abstracted by 
the enzyme (Fig. 4.1c). 
By tagging this substrate analogue with tritium, binding of the 
radiolabelled product to thymidylate synthetase can be measured. 
To test for TS, I prepared parasites by sapomn lysis of the red blood 
cells (Section 2.6.1). Total protein was then extracted from the parasites by 
sonication. The lysates were centrifuged and the supernatant which contains 
DHFR-TS was used in the TS assay as described in MATERIALS & 
METHODS Section 2.6.3. Briefly, 0.3m1 of the protein extract reacted with 
[6-3H] F-dUMP in a reaction buffer containing the co-factor 5,10-
methylenetetrahydrofolate for lhr. The reaction products were fractionated 
on SDS-PAGE and the signals detected by fluorography. 
4.2 RESULTS 
4.2.1 Stability of the Enzyme at 37°C 
The instability of the DHFR-TS enzyme from P. falciparum has been 
reported (McCutchan et al., 1984b; Chen & Zoig, 1987). The enzyme lost its 
activity upon storage (McCutchan et al., 1984b). An experiment was 
therefore performed to see whether the enzyme stability was affected by some 
in vitro conditions. 
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The rate of deterioration of the enzyme at 37 °C was measured. The 
total protein was incubated at 37 °C for different lengths of time before being 
subjected to the TS assay. Control reactions without any pre-incubations at 
37°C were included. A graph of the relative amount of TS at T  (as 
quantified by densitometric scanning of the bands) was plotted against 
duration of incubation at 37°C. 
As shown in Fig. 4.2 and Fig. 4.3, the enzyme content dropped off 
after the total protein had been incubated at 37 °C, resulting in only '60% of 
the original enzyme content after 2hrs of incubation. There was a gradual 
deterioration of the enzyme with increasing length of incubation at 37'C, 
indicating that the enzyme is greatly affected by incubation at this 
temperature. Therefore, great care should be taken in handling the enzymes. 
Much of the ensu irv. work depends on comparing DHFR-TS levels between 
different strains. In the light of these results it was decided that proteins 
should be prepared simultaneously from the different parasite strains to be 
compared and that aliquots of parasite extract should be stored under similar 
conditions. 
4.2.2 Synchronization of the Parasites 
Based on studies on mammalian systems it is likely that DHFR-TS is 
cell-cycle regulated and expressed at different rates at different stages of 
development in P. falciparum. Obviously, precise comparison between two 
parasite strains would require protein obtained from parasites at similar 
stages of development. This can be achieved by sorbitol treatment to 
synchronize the parasite growth (see MATERIALS & METHODS Section 
2.2.7). 
The efficiency of this method was first examined by following the 
CtbflcL Une -çq/qij 
growth of the parasite ', after  sorbitol treatment using Giemsa-stained smears 
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Fig. 4.2 Deterioration of the DHFR-TS enzyme at 37 °C. 
Fluorograph of the tritium labelled reaction products (arrow) from 
the TS assay fractionated by 10% SDS-PAGE. Total protein from 
3D7 and HB3 were incubated for different length of time at 37 °C 
before being subjected to the TS assay. 
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Legend to Fig. 4.3 
The bands in Fig. 4.2 were scanned by a densitometer. The readings obtained were 
plotted as percentage of the control band (which was taken as 100) against 
duration of incubation at 37 ° C (hrs). 
(Table 4.1, Fig. 4.4a). The same culture, which was not subjected to sorbitol 
treatment was followed as control (Fig. 4.4b). Immediately after sorbitol 
treatment, the parasitaemia dropped from 6% to 1.8%, due to the toxic effect 
of sorbitol. The mature stages were killed, leaving 87% of the parasites in 
the ring forms. In the next 24hr, the ring forms mature to the trophozoites 
and schizonts. By 48hrs, all parasites were found in the ring stage and the 
parasitaemia had increased several fold to 5%. The synchrony was 
maintained up to 72hrs when more than 95% of the parasites were in the 
trophozoite and schizont stages. After another round of re-invasion and 
replication (t = 120hrs), however, the culture lost its synchrony and a mixed 
population with all three stages of parasites were again obvious. From these 
results the optimal conditions for harvesting were judged to be at t=72hrs. 
At that time the parasites were predominantly in the late trophozoite and 
early schizont stages when the DNA synthesis is exponential (Newbold et al., 
1982; Inselburg & Banyal, 1984; de Rojas & Wesserman, 1985) and the 
parasitaemia was relatively high (5%). 
4.2.3 Calibration of the Conditions Used in TS Assay 
Comparative studies require equal amounts of total protein from each 
of the parasite clones investigated to be used in the TS assay. This was 
ensured in several ways. 
All parasites were harvested 72hrs after sorbitol 
synchronization at similar stages of development (see above). 
Before protein was extracted, the parasites were resuspended 
to the same density as calculated from the parasitaemia and 
haematocrit. 
Total protein content obtained from the parasite extract was 
measured with Bradford's reagent (Bradford, 1976). Similar 
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Sorbitol treated Control without sorbitol 
treatment 
 Percentage(%)  Percentage (% 
R T S Parasi- 
taemia 
R T S Parasi- 
taemia 
0 87 13 0 1.8 64 14 19 2.1 
3 72 26 2 1.5 74 0 26 1.9 
24 10 20 70 1.5 84 16 0 1.9 
48 100 0 0 5.0 42 8 50 3.6 
72 4.3 65 30 5.1 53 18 30 5.7 
96 94 2 4 8.5 33 8 59 8.3 
120 24 31 45 8.7 57 5 38 9.6 
Key: R = rings 
T = trophozoites 
S = schizonts 
* 	rçik. 	cb\ecs 1,VQ- 1/'1 1t 
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Fig. 4.4 Relative percent distribution of P. falciparum*  stages 
during three cycles of synchronized growth in culture. 
culture treated with 5% sorbitol for 5mm. 
control culture without sorbitol treatment. 
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amounts of protein, as adjusted from the measurements, were 
then used in the reaction. 
3. The reaction products were fractionated by 10% SDS-PAGE 
gel which was then stained. The staining pattern of the 
fractionated polypeptides invariably indicated that similar 
amounts of protein had been applied to the gel. 
It is important when quantifying the enzyme, other factors should not 
be limiting. The use of 1ul and 10/21 of the substrate [6- 3H] F-dUMP was 
therefore compared in the quantification of TS in initial experiments (see 
below). As no differences in the intensity of the bands were detected, this 
indicated that 1/21 of the substrate is not limiting and therefore this quantity 
of [6-3H] F-dUMP was used in subsequent experiments. 
4.2.4 The DHFR-TS is Not Over-produced in H113 Compared to 3D7 
At the time of harvest, the parasites of 3D7 and HB3 were at similar 
stages of synchronized development, with about 80% of the parasites in the 
schizont stage (Table 4.2). After resuspending the parasites to a similar 
density and extracting the total protein by sonication, equal amounts of 
protein, as measured by Bradford's reagents, were used for the assay. The 
results of the assay are shown in Fig. 4.5 and the densitometric values are 
listed in Table 4.3. Either 1/21 (tracks 3 & 4) or 1041 (tracks 1 & 2) of [6- 3H] 
F-dUMP were used in the assay. Similar staining patterns of the fractionated 
polypeptides from 3D7 (tracks 2 & 4) and HB3 (tracks 1 & 3) on SDS-PAGE 
gel indicated that similar amounts of protein were loaded onto the gel. The 
[6-3H] F-dUMP labelled proteins of 3D7 and HB3 had a relative molecular 
mass of 70kDa, as resolved on SDS-PAGE gel, confirming that there were no 
gross aberrant structural changes in the proteins which would otherwise affect 
its mobility on polyacrylamide gel. The molecular mass of the DHFR-TS 
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Table 4.2 The percentage distribution of parasites at different stages of 
development from HB3 and 3D7. 
HB3 3D7 
Percentage (%) Percentage (%) 
RTISIGIRITSG 
10 2 83 5 12 2 1 	79 7 
Parasitaemia 6 8.6 
R= rings; T= trophozoites; S= schizonts; G=gametocytes 
150 
Fig. 4.5 Measurement of the quantity of thymidylate synthetase in 
3D7 and HB3. Total protein from 3D7 (tracks 2 & 4) and HB3 
(tracks 1 & 3) was quantified by the TS assay using either 11 
(tracks 3 & 4) or 10u1 (tracks 1 & 2) of [6- 3H] F-dUMP in the 
reaction. The reaction products were fractionated by 10% SDS-
PAGE gel before subjected to processing for fluorography. 
Coomassie stained SDS-PAGE gel of the fractionated 
polypeptides. 
Fluorographs of the gel. The tritium labelled reaction products 
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Table 4.3 Densitometric values of the reaction products of the thymidylate 
synthetase assay from HB3 and 3D7. 
Quantity of [6-3H] 
F-dUMP used in 
the assay 
Densitometric values Ratio 
HB3 
3D7 HB3 3D7 
1Ou1 10578 10277 1.0 
1u1 10317 10172 1.0 
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protein has been estimated by gel chromatography and SDS-PAGE to be 
70kDa (Chen & Zoig, 1987). Similarly, the DHFR-TS gene sequence 
predicts a protein with MW of 72kDa (Bzik et al., 1987; Snewin et al., 1989). 
Densitometric scanning of the 3D7 and HB3 bands gave similar values 
showing that the DHFR-TS was produced at a similar level in the two 
parasites. Similar readings were obtained with 11 or 10u1 of [6- 3H] F-dUMP 
in the assay. Control reactions replacing the parasite extracts with equal 
volume of buffer were performed in parallel. The absence of any bands 
confirmed the parasitic origin of the radiolabelled products in previous 
experiments (data not shown). 
The results shown here were reproducible and I therefore conclude 
that the protein is produced at a similar level in the two parasite clones. 
4.2.5 The DHFR-TS Gene is Not Amplified in HB3 Compared to 3D7 
Since the enzyme is not over-produced in HB3, we would not expect 
to see any amplification of the gene in HB3. This was confirmed using dot-
blot analysis on genomic DNA obtained from the two clones HB3 and 3D7. 
The concentrations of DNA were determined spectrophotometrically 
(see MATERIALS & METHODS Section 2.4.3). Measured amounts of 
DNA from 3D7 and HB3 at serial dilutions (from 125/123ng to 8ng) were 
spotted onto Hybond-N filters which were then probed with the 5.65kb 
DHFR-TS gene fragment from the Ki isolate. To confirm that equal 
amounts of DNA were spotted onto the filters from the two clones, control 
filters containing serial dilutions of DNA (900ng, 450ng, 225ng and 1 l3ng) 
were probed with a rRNA gene fragment whose content is conserved among 
various strains (Langsley et al., 1983). 
The results are shown in Fig. 4.6 and the densitometric values are 
listed in Table 4.4. Hybridization of different dilutions of the two DNA 
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Fig. 4.6 Dot-blot analysis of DNA from parasite clones 3D7 and 
HB3. Dilutions of DNA (as shown) were spotted onto Hybond-N 
filters, denatured and probed with the 5.65kb DHFR-TS gene 
fragment from the Ki isolate or the rRNA gene fragment prib2. 
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3D7 S... 
H  I... 
rRNA gene 
probe 
125 63 31 16 8 	ng total DNA 
307 	s. 0 	 DHFR 
HB3 	• , OA 	 probe 
123 61 31 15 8 	ng total DNA 
900 450 225 113 
	
rig total DNA 
900 450 225 113 
	
ng total DNA 




Densitometric values Ratio 
H133 
3137 HB3 3137 
123/125 26804 29156 0.91 
61/63 15046 15665 0.95 
31 10068 9864 1.04 
15/16 3778 3754 1.00 
8 n.m. n.m. - 
Average 1.00 
n.m. = no measurements 
rRNA gene probe 
DNA 
concentrations (ng) 
Densitometric values Ratio 
HB3 
3D7 HB3 3D7 
900 18575 16663 1.10 
450 12980 11470 1.10 
225 7408 7309 1.00 
113 4584 4042 1.10 
Average 1.08 
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samples with equal intensity to the DHFR-TS gene probe, as determined by 
densitometric scanning of the dots, suggested that the 3137 and HB3 parasites 
have the same number of copies of the gene. The control filters probed with 
the rRNA gene fragment gave similar densitometric values for the two DNA 
samples at the four different dilutions of DNA, confirming that equal 
amounts of DNA were spotted onto the filter. 
We can therefore conclude that the two parasites possess the same 
number of copies of the DHFR-TS gene which is expressed at a similar level 
in the two parasites. The change associated with the DHFR-TS gene which 
affects the level of resistance to pyrimethamine in HB3 is most likely the 
single base change converting a serine to an asparagine at codon 108, 
resulting in a structural altered enzyme with reduced affinity for 
pyrimethamine (Cowman et al., 1988; Peterson et al., 1988). 
4.2.6 The DHFR-TS is Over-produced in an in vitro Selected Mutant 19/94 
(Ml-1) Than in the Parent Clone 19/94 
An array of pyrimethamine resistant (pyrR) mutants has already been 
obtained in the laboratory of Dr Sodsri Thaithong, Chulalongkorn University, 
Thailand. Briefly, 1.7x107 parasites of the parent clone T9/94 synchronized 
to the early schizont stage were treated with 1.0/.Lg/ml of the mutagen N-
methyl-N-nitro-N-nitrosoguanidine (MNNG) in complete RPM! medium when 
the parasites were actively replicating. After 12hrs, a second treatment with 
the same concentration of mutagen was given. Parasites surviving after 12hrs 
of incubation in the mutagen were allowed to go through asexual cycles of 
development without the mutagen for 20 days to express the mutant 
phenotypes. Parasites resistant to pyrimethamine were selected by exposing 
5x107 parasites to 5x10 -8M pyrimethamine for five days. The selection 
procedure was repeated with increasing concentrations of pyrimethamine (10 
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7M and. 3x10 7M) on surviving parasites expressing resistance to 
pyrimethamine. Individual pyrR clones were then isolated. One of them, 
T9/94 (Ml-1), had a MIC of 5x10M and is 100 times more resistant than 
ThS doe 
the parent clone T9/94."was selected for analysis in this study. 
The level of DHFR-TS expressed in the pyrR mutant T9/94 (MM), 
as compared to its sensitive parent T9/94, was first quantified by the TS assay 
to see whether there is any over-production of the enzyme in the mutant. 
Similar measures as described in Secion 4.2.3 were undertaken to ensure that 
equal amounts of protein were put into the reactions. At the time of harvest, 
the parasites of T9/94 and T9/94(M1-1) were at similar stages of 
synchronized development, with more than 86% of the parasites in the young 
schizont stage (Table 4.5). Protein extracts prepared from these synchronized 
cultures were used in equal amounts, as determined by the Bradford's 
method, in comparative studies. The reaction products [6- 3H] F-dUMP 
labelled proteins were electrophoresed on SDS-PAGE gel and visualised by 
PPO impregnation followed by fluorography. 
The results are shown in Fig. 4.7. The Coomassie staining pattern of 
the fractionated polypeptides from T9/94 (tracks 2 & 4) and T9/94 (MM) 
(tracks 1 & 3) revealed that similar amounts of protein were applied to the 
gel. Both the T9/94 and T9/94 (MM) DHFR-TS enzymes had a relative 
molecular mass of 70kDa suggesting that there were no gross structural 
changes in the mutant protein. Densitometric scanning of the bands detected 
a two-fold increase in the level of DHFR-TS in the mutant (Table 4.6). 
Similar readings were obtained with either 11 (tracks 3 & 4) or 10j4 (tracks 
1 & 2) of [6- 3H] F-dUMP in the assay. Control reactions using equivalent 
volume of buffer instead of parasite extracts did not reveal any radiolabelled 
bands (data not shown). 
The assay was repeated several times starting from fresh cultures of 
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Table 4.5 The percentage distribution of parasites at different stages of 
development from T9/94 (Ml-1) and 179/94. 
T9/94 T9/94 (Ml-1) 
Percentage (%) Percentage (%) 
R T S R TI S 
8 6 86 6 7 87 
Parasitaemia 6.9 6.8 
R= rings; T=trophozoites; S= schizonts 
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Fig. 4.7 Measurement of the quantity of thymidylate synthetase in 
/94 and T9/94 (MI-1). Total protein from T9/94 (tracks 2 & 
4) and T9/94 (Ml-1) (tracks 1 & 3) was quantified by the TS assay 
using either 11 (tracks 3 & 4) or 10 1ul (tracks 1 & 2) of [6- 3H] F-
dUMP in the reaction. The reaction products were fractionated by 
10% SDS-PAGE gel before subjected to processing for 
fluorography. 
Coomassie stained SDS-PAGE gel of the fractionated 
polypeptides. 
Fluorographs of the gel. The tritium labelled reaction products 
are indicated (arrow). 
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Table 4.6 Densitometric values of the reaction products of the thymidylate 
synthetase assay from 179/94 (Mi-i) and 179/94. 
Quantity of [6-3H] 






T9/94 T9/94 (MM) 
10u1 2150 4026 1.90 
11 1695 3682 2.20 
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parasite and these results were fully reproducible giving increased protein 
values ranging from 1.80 to 2.20. 
4.2.7 The DHFR-TS Gene is Not Amplified in T9/94 (MM) 
Having established that there is a two-fold increase in the level of the 
protein in the pyrimethamine resistant mutant from T9/94, it is necessary to 
find out the mutation responsible for the change in the enzyme level. 
An obvious cause could be amplification of the gene. Attempts were 
made to detect any variation in the number of copies of the gene in the 
mutant by dot-blot analysis. Equal amounts of the two DNA samples, as 
determined spectrophotometrically (Section 2.4.3), were spotted at serial 
dilutions from 360ng to 2.8ng onto Hybond-N filters. These filters were then 
probed with the 5.65kb DHFR-TS fragment from the Ki isolate to quantify 
the number of copies of the gene. As a control, serial dilutions of 500ng, 
125ng, 50ng and 12.5ng DNA were spotted onto the filters which were then 
probed with the rRNA gene fragment. 
The results are shown in Fig. 4.8 and the densitometric values are 
listed in Table 4.7. Hybridization of different dilutions of the two DNA 
samples with equal intensity to the DHFR-TS gene probe, as determined by 
densitometric scanning of the dots, suggested that the number of copies of the 
gene is unchanged in the mutant. The control filters probed with the rRNA 
gene fragment gave similar densitometric values for the two DNA samples at 
the four different dilutions of DNA, confirming that equal amounts of DNA 
were spotted onto the filters. 
These results suggest that amplification of the DHFR-TS gene had not 
occurred in the mutant T9/94 (Ml-1) to account for the over-production of 
the protein in this mutant. In addition, it is worth noting that the parent 
clone T9/94 and the mutant T9/94 (MM) were included in an RFLP 
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Fig. 4.8 Dot-blot analysis of DNA from parasite clones T9/94 and 
T9/94 (Ml-1). Dilutions of DNA (as shown) were spotted onto 
Hybond-N filters, denatured and probed with the 5.65kb DHFR-TS 
gene fragment from the Ki isolate or a rDNA gene fragment. 
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T9/94 	. . S... 
T9/94 • • . 	 DHFR 
(Ml-1) • • . . probe 
500 125 5012-5 	ng total DNA 
.. 
.. 
T9/94 • . 	 rRNA gene 
(Mi -i) • • probe 




Densitometric values Ratio 
T9194 (MM) 
T9/94 T9/94 T9/94 (MM) 
180 41922 41446 1.0 
90 22793 23595 1.0 
45 13056 11209 0.9 
22.5 4582 3624 0.8 
Average 0.9 
rRNA gene probe 
DNA 
concentrations (ng) 
Densitometric values Ratio 
T9194 (MM) 
T9/94 T9/94 T9/94 (MM) 
500 77907 69300 0.9 
125 13999 11401 0.8 
50 1920 1708 0.9 
Average 0.9 
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analysis in CHAPTER 3 (Fig. 3.9). No difference was observed between the 
two patterns suggesting that there is no gross rearrangement across 5.65kb 
within the immediate vicinity of the gene that may affect gene expression. 
Therefore, an alteration resulting in over-production of the protein at the 
transcriptional level would seem to be likely. 
4.2.8 The Level of DHFR-TS is Elevated in a Parasite Clone PR70/CB3 
Obtained from a Thai Isolate, PR70 Compared to T9/94 
Identification of an in vitro selected mutant over-producing the protein 
suggests this as a possible mechanism for pyrimethamine resistance. It is 
therefore interesting to see whether over-production of the enzyme occurs in 
the wild isolates. A preliminary study was carried out with a cloned line of 
PR70, PR70/CB3. This cloned line is 400 times more resistant to 
pyrimethamine than the pyrS Thai isolate T9/94. 
The level of TS was compared in T9/94 and PR70/CB3 by the TS 
assay using equal amounts of synchronous parasites. Both parasite cultures 
were harvested at the time of synchronized development, with more than 80% 
of the parasites in schizont stage (Table 4.8). Similar amounts of protein, as 
measured by Bradford's reagent, were put into the reactions. The results are 
depicted in Fig. 4.9. The Coomassie staining patterns of the fractionated 
polypeptides confirmed that equal amounts of protein were used in the 
reactions. The fluorographs showed that both enzymes had an identical 
relative molecular mass of 70kDa, suggesting that there were no gross 
aberrant changes in the proteins. The amount of TS, however, was 
quantitatively greater in PR70/CB3. Densitometric scanning of the bands 
showed that the level of the protein was at least 1.3-fold higher in PR70/CB3 
than in T9/94. Control reactions using an equivalent volume of buffer in 
place of parasite extracts did not reveal any radiolabelled bands (data not 
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Table 4.8 The percentage distribution of parasites at different stages of 
development from PR70/CB3 and T9/94. 
PR70/CB3 T9/94 
Percentage (%) Percentage 
RITISIGIRITIST-G II  
51918214 9 1 6 1 85 1 0 
Parasitaemia 5.2 6.9 
R= rings; T= trophozoites; S= schizonts; G=gametocytes 
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Fig. 4.9 Measurement of the quantity of thymidylate synthetase in 
PR70/CB3 and T9/94. Total protein from PR70/CB3 (track 2) 
and T9/94 (track 1) was quantified by the TS assay using 1u1 of [6-
3H] F-dUMP in the reaction. The reaction products were 
fractionated by 10% SDS-PAGE gel before subjected to processing 
for fluorography. 
Coomassie stained SDS-PAGE gel of the fractionated 
polypeptides. 
Fluorographs of the gel. The tritium labelled reaction products 









shown). It would therefore seem possible that PR70/CB3 produces the 
enzyme at a higher level than T9/94. 
4.2.9 The DHFR-TS Gene is Not Amplified in PR70/CB3 
The increased level of the protein in PR70/CB3 as compared to T9/94 
might be due to changes such as gene amplification. However, dot-blot 
analysis excluded this possibility as the same number of copies of gene was 
detected in PR70/CB3 and T9/94. 
The results are shown in Fig. 4.10 and the densitometric values are 
listed in Table 4.9. Serial dilutions of equal amounts of the two DNA 
samples, as determined spectrophotometrically, were spotted onto Hybond-N 
filters. The filters were probed with the 5.65kb DHFR-TS gene fragment 
from the Ki isolate and the rRNA fragment respectively. As revealed from 
the hybridization intensity to the rRNA probe, about 1.7 times more DNA 
from PR70/CB3 was spotted onto the filters. Similarly, hybridization of the 
PR70/CB3 DNA to the DHFR-TS gene probe was about 1.7 times more 
intense than T9/94 DNA. These results suggest that the number of copies 
of the gene in PR70/CB3 is the same as that in T9/94. 
This experiment confirms the importance of the controls. If a control 
was not included, the above results would be wrongly interpreted as the 
presence of an increased number of copies of the gene in PR70/CB3 
compared to that of T9/94. 
In addition, there were no gross changes within the immediate vicinity 
of the gene to account for the increased level of the enzyme in PR70/CB3 
since the AccI restriction patterns of the genomic DNA from both clones 
were identical upon probing with the 5.65kb DHFR-TS fragment from the Ki 
isolate (see CHAPTER 3 Fig. 3.9). 
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Fig. 4.10 Dot-blot analysis of DNA from parasite clones 
PR70/CB3 and 179/94. Dilutions of DNA (as shown) were spotted 
onto Hybond-N filters, denatured and probed with the 5.65kb 
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Densitometric values Ratio 
PR70/CB3 
T9/94 PR70/CB3 T9/94 
180 72370 41921 1.70 
90 36988 22792 1.62 
45 21674 13056 1.70 





Densitometric values Ratio 
PR70/CB3 
T9/94 PR70/CB3 T9/94 
125 27218 16559 1.65 
50 11076 6221 1.78 




Resistance to pyrimethamine can be due to one or more of the following 
mechanisms. Firstly, the structure of the enzyme may be altered due to 
single base changes within the coding region. Operation of this mechanism 
in P. falciparum is well confirmed from many sources. Secondly, the amount 
of the enzyme may be increased. This mechanism is found in in vitro selected 
mutants and may occur in wild isolates. Thirdly, the accumulation of the 
drug inside the parasites may be reduced. Finally, the parasites may utilize 
an alternative folate metabolic pathway to bypass the toxic effect of the drug. 
These last two mechanisms have yet to be found in P. falciparum6 
In the clone HB3, a single base substitution within the coding region 
of the gene is detected as the only change so far identified which can account 
for its resistance to pyrimethamine although Zolg's results (Chen et al., 1987; 
Zoig et al., 1989) have pointed out the possible participation of other 
mechanisms contributing to pyrimethamine resistance in HB3. In their 
studies, they found a disproportionality in the concentration of pyrimethamine 
needed to inhibit the growth of the parasite and the concentration of 
pyrimethamine required to inhibit the activity of the enzyme. The present 
study has excluded over-production of the protein as one of these possible 
changes. 
The existence of other possible mechanisms is illustrated by an in vitro 
selected mutant T9/94 (MM) which over-produces the protein two-fold 
compared to the T9/94 parent from which it is derived. In this mutant, the 
gene has not been amplified. The sensitivity of the tests in detecting over -
production of the enzyme or gene amplification is evident from the 
reproducibility of these results and similar analyses undertaken by Inselburg 
and co-workers (1987). Using the same techniques as in the present study, 
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Inselburg's group was able to detect a mutant which over-produces the 
protein ten-fold and contains about three copies of the DHFR-TS gene. 
Evidently, the present results identify a mutant which over-produces the 
protein but not because of amplification of the gene. The region encoding 
DHFR of the DHFR-TS gene of T9/94 (MM) has been sequenced and 
showed no difference from that of the parent clone T9/94 (G. Beale, 
personal communication). A change at the transcriptional level would seem 
to be likely. 
The fact that this mutant derives from a genetically pure parent clone 
makes more precise analysis of the mutation(s) causing pyrimethamine 
resistance possible. However, during the process of transcription of DNA to 
RNA and translation of RNA to protein, a number of events may have 
occurred resulting in an over-production of the final product. It is therefore 
necessary to carry out further tests to define more precisely the number and 
the type of mutation(s) resulting in an over-production of the enzyme in 
T9/94 (Ml-1). Northern blot analysis and pulsed-field gel electrophoresis 
would be required to detect any changes in the level of mRNA transcribed 
and the structure of the chromosome in the mutant DNA. 
The readiness to select mutants which over-produce the protein in two 
independent selection procedures, namely those of Inselburg and ourselves, 
suggests that these mutations may already exist and constitute a major portion 
of the natural gene pool. Perhaps over-production of the protein may have 
a more common occurrence in nature than has so far been thought. It is 
important that more clones obtained from pyrR field isolates be investigated 
and their DHFR-TS quantified. The results may reveal a high incidence of 
over-production of the protein among those pyrR parasite strains. 
Preliminary data in the present study has already suggested an elevated level 
of the enzyme in the pyrimethamine resistant cloned line PR70/CB3 
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compared to a pyrimethamine sensitive clone T9/94. Previous studies of Kan 
& Siddiqui (1979) also suggested an elevated level of the protein, as 
measured by the specific activity of the enzyme, in the Uganda isolate Palo-
alto. 
The T9/94 (MM) represents a putative expression mutant which 
derived from a genetically pure clone. This mutant offers a well-defined 
model for comparative studies to map the changes giving rise to increased 
production of the protein. To further identify the changes causing variation 
in gene expression, we need to look at transcriptional control. An initial step 
will be to map the transcriptional start sites. However, previous results in 
CHAPTER 3 show that a RFLP dimorphism exists in the region which could 
contain the transcriptional start sites. Therefore, we must first investigate 
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The mutations giving rise to restriction-fragment-length-polymorphisms 
(RFLPs) of human genes are most often point mutation(s) resulting in 
creation or destruction of restriction enzyme sites such as occurs in the case 
of the 3-g1obin gene (Kan et al., 1980; Orkin et al., 1982). It is also possible, 
however, that large insertion/deletion of DNA sequences is involved as in the 
case of a-globin genes (Higgs et al., 1981). RFLP markers have proved to be 
useful and effective in prenatal diagnosis of human genetic diseases such as 
sickle cell anaemia and 13-thalassaemia (Kan & Dozy, 1978a; b; Philips III et 
al., 1980; Harper et al., 1984; Oberle et al., 1985). 
RFLPs have been found associated with the dihydrofolate reductase-
thymidylate synthetase (DHFR-TS) gene of P. falciparum (Peterson et al., 
1988 and see CHAPTER 3) and also the pfmdrl gene (Foote et al., 1990b; 
Wellems et al., 1990; 1991), the histidine-rich-protein-II (HRP-II) and HRP-
III genes (Wellems et al., 1987). Despite the utilization of RFLP markers in 
genetic studies of P. falcipamm, the nature of a given RFLP has yet to be 
defined in this organism. 
In this chapter I will describe results on the DHFR-TS gene which 
exclude the possibility of a simple creation/destruction of a restriction enzyme 
site. They predict the possible involvement of an insertion or deletion as 
large as 250bp within 1.35-1.6kb 5' of the initiating methionine codon. To 
further characterize the RFLP the non-coding regions of both the 3137 and 
HB3 DHFR-TS genes were cloned and sequenced. Furthermore, sequencing 
the 5' untranslated regions upstream of the DHFR-TS gene was a pre-
requisite for attempts to characterize the transcriptional unit of this gene (see 
CHAPTER 6) in the two dimorphic alleles described by the AccI RFLP. 
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5.1 RESULTS 
5.1.1 A Deletion Appears Responsible for the RFLP 
A composite restriction map for the P. falciparum DHFR-TS genomic 
clone (Fig. 5.1) was constructed based on information obtained from 
restriction mapping of parasite strains K1 and Honduras-1 (Bzik et al., 1987; 
Snewin et al., 1989) and sequence data from a number of parasite strains 
(Cowman et al., 1988; Peterson et al., 1988). On the map, an AccI site was 
located immediately 3' to the gene while another unique AccI site was found 
within the coding region of the gene. These two sites delimited a fragment 
of 1.1kb in length which was common to 3D7 and HB3. The AccI site within 
the coding region of the gene is conserved in both 3D7 and HB3 (Cowman 
et al., 1988; Peterson et al., 1988). 
Since the AccI restriction pattern gave four bands, two further AccI 
sites were likely to be positioned upstream of the gene. The RFLP pattern 
is consistent with deletions. Sequence data on these genes did not reveal a 
large deletion of sequence within the coding region (Cowman et al., 1988; 
Peterson et al., 1988; Snewin et al., 1989), theAdeletion  covered by the probe 
is therefore likely to occur in the 5' flanking region. If so, cleavage with XbaI 
and EcoRI should also give dimorphic patterns. To do this, genomic DNA 
from 3D7 and HB3 was digested with either EcoRI or XbaI. After 
fractionation by agarose gel electrophoresis, the gel was blotted and the 
restriction patterns revealed by hybridization with the 5.65kb DHFR-TS 
fragment from the Ki isolate. The results are illustrated in Fig. 5.2. The 
dimorphic pattern was not unique to AccI digestion, instead, consistent RFLP 
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Fig. 5.1 The restriction map of the P. falclparum DHFR-TS gene. The map 
Is composed from restriction mapping data of parasite strains Ki and 
Honduras-I and sequencing data from a number of parasite strains. 
(Bzik et al.,1987; Cowman et al., 1988; Peterson et al., 1988; 
Snewin et al., 1989). The dotted line representsthe upstream region 
of the gene which contains 2 Acc I sites and aeietn in the 1-1133 clone. 
The 5.4/5.65kb Eco RI Insert used as a probe for these studies Is Indicated. 
Fig. 5.2 Dimorphic restriction patterns of 3D7 and HB3 genomic 
DNA. Autoradiographs of enzyme restricted genoniic DNA from 
3D7 and HB3 DNA, probed with the 5.65kb DHFR-TS gene 




















Cleavage, with XbaI generated two fragments from each DNA. Size 
dimorphism was detected in the upper band around 5.5kb. Cleavage with 
EcoRI released one band from each DNA. A difference in size between the 
two fragments was again obvious. 
These results suggest that the RFLP as observed in the 3D7 and HB3 
genomic DNA is associated with a deletion of 250bp in HB3 DNA sequence 
and this deletion occurs 5' to the gene. 
5.1.2 Mapping of the RFLP 
From these results, we A . that there is a deletion 5' to the gene and 
the- 
that two AccI sites are located 5' to the gene inregion covered by the probe. 
tKe- 
To definiosition of the first AccI site 5' to the coding region, the BglII site 
at 5' end of the coding region (see Fig. 5.1) can be utilized since the AccI 
fragment immediately 5' to the gene will be cut by BglII. Genomic DNA 
from 3D7 and HB3 was cleaved with restriction enzymes AccI and BglII, 
fractionated by agarose gel electrophoresis, blotted on to a Nylon membrane 
and then probed with the 5.65kb DHFR-TS gene fragment from the Ki 
isolate. The results are shown in Fig. 5.3. The dimorphic AccI fragments 
(2.15/2.4kb) were cut by BglII into smaller fragments. Therefore, the 1  Oki v& 
deletion must occur within this fragment and map to within 1.35kb/1.6kb 
upstream from the methionine initiation codon. The relative position of the 	6R2. 
deletion to the gene is shown in the revised figure of the restriction map (Fig. 
5.4). 
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Fig. 5.3 Identification of the first Accl fragment 5' to the gene. 
Autoradiographs of AccI or AccI/BglII restricted genomic DNA 
from 3D7 and HB3 DNA, probed with the 5.65kb DHFR-TS gene 
fragment from the Ki isolate. 
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Fig. 5.4 A revised restriction map of the P. falciparum DHFR-TS gene. An 
additional Acc I site was located 1.35 kb/1.6kb upstream of the gene. 
This region also contains a deletion in the 1-1133 clone (see bracket). The 
arrows and question marks indicate the possible positions for another Acc 
site. A 0.6 kb Acc  I - Eco R I fragment used as a probe in many of these 
studies is indicated. 	( 	) 
- 5.1.3. Deletion Occurs in a Gene Fragment from the Ki Isolate during A 
Replication in E. coil 
Further evidence from studying the Ki genomic EcoRI fragment used 
as a probe for most of this study also suggests that deletion may occur in the 
non-coding region. 
Preparations of the Ki cloned insert invariably produced a doublet 
despite efforts to purify the bacteriophage by selecting isolated plaques. This 
is illustrated in Fig. 5.5 (plate a). Further digestion of the purified EcoRI 
insert with AccI yielded a pattern identical to that of 3D7 and H133 (plate b). 
The AccI fragment also occurred as a doublet of 2.15kb/2.4kb. By analogy 
to the dimorphic AccI fragments in 3D7 and HB3, the 2.15kb/2.4kb doublet 
was also cleaved by BglII into three smaller fragments of 2.05kb, 1.8kb and 
0.35kb. 
It is thought that the 2.15kb/2.4kb doublet is derived from the same 
region of DNA. This was shown to be true as cross-hybridization was 
observed between these two fragments. Purified EcoRI insert was digested 
with AccI, fractionated by agarose gel electrophoresis, blotted and probed 
with either the 2.4kb or 2.15kb fragment purified independently from the 
doublet. The results (Fig. 5.6) reveal that both fragments were lit up by 
either probe. No cross-hybridization with other AccI fragments were 
observed. 
It appears that a deletion within the cloned Ki fragment has occurred 
during A replication in E. coli. This is analogous to the dimorphic AccI 
fragments which apparently arose from deletion of 250bp of sequence from 
the 5' flanking region of HB3 DNA. Subsequent sections in this chapter 
attempt to identify this dimorphism by cloning and sequencing the 5' non- 
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Fig. 5.5 Studies on the DHFR-TS insert from the isolate Ki 
cloned into I. 
a) Ethidium bromide stained gel of DNA cut with EcoRI to 
release two ).. arms and the insert which occurred as a doublet 
(arrow). 
b Ethidium bromide stained gel of the EcoRI inserts cut with 
















Fig. 5.6 Homology between the 2.4kb and 2.15kb fragments of the 
doublet. Autoradiographs of gels containing AccI subfragments of 
the EcoRI insert from the Ki isolate, probed with the purified 
2.4kb (track 1) or 2.15kb (track 2) fragments. 
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coding region of the DHFR-TS gene from both the 3D7 and HB3 clones. 
5.1.4 Cloning of DHFR-TS Gene from HB3 
The DHFR-TS gene has been successfully cloned from the Ki strain 
as an EcoRI fragment in the bacteriophage vector ANM1149 (Snewin et al., 
1989). Therefore, conventional cloning procedures were employed to clone 
the gene from HB3 into the same vector. 
The cloned insert of Ki gave rise to a doublet and 3137, which 
generated the same sized EcoRI fragment as Ki, may also generate a doublet 
once cloned into a ). vector, yielding fragments of uncertain origin. On the 
other hand, H133, which yielded a smaller EcoRI fragment, was expected to 
be able to maintain the insert in a stable form in I. Therefore, an initial 
attempt was to clone the gene from HB3. To achieve this, I constructed a 
library of EcoRI fragments from the genomic DNA of H133 in the ) vector 
NM1149 (Section 2.4.23). The library was screened for clones containing the 
DHFR-TS gene with a homologous 0.6kb AccI-EcoRI gene fragment isolated 
from the I Ki clone (see Fig. 5.4). Plaques giving positive signals were 
picked, enriched and purified (Section 2.4.24). The purification of one of 
these clones is illustrated in Fig. 5.7. Positive plaques were detected at a rate 
of 1 in 3,200 recombinant phages. 
5.1.4.1. Characterization of the DHFR-TS Genomic Clones: To 
further characterize the inserts from a number of putative positive clones, 
bacteriophage ).. DNA was prepared from 11 of them by the mini-prep 
method (Section 2.4.5.2). To check the sizes of the inserts, the phage DNA 
was digested with EcoRI to release the inserts from the A arms. The sizes 
of the restricted DNA were then determined by agarose gel electrophoresis. 
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Fig. 5.7 Screening of HB3 F&QRI genomic library for recombinant 
clones containing DHFR-TS gene fragment. 
Primary screening: Autoradiograph of plaque lift from the HB3 
EcoRI genomic library, probed with the 0.6kb AccI-EcoRI gene 
fragment from the Ki isolate. Agar containing positive plaque 
(arrow) was removed, diluted and the phages re-plated at an 
appropriate dilution to give well isolated plaques for re-screening. 
Secondary screening: Autoradiograph of plaque lift after re-
plating, probed with the same probe. During the secondary 
screening, positive plaques were segregated from negative plaques. 
One of them (arrow) was picked and re-plated at an appropriate 
dilution for tertiary screening. 
Tertiary screening: Autoradiograph of plaque lift from second 
re-plating, probed with the same probe. Results showed that at 
this stage the phage were effectively plaque pure. 
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The results are depicted in Fig. 5.8 (plate a). In contrast to the cloned Ki 
insert which occurred as a 5.4kb/5.65kb doublet, only one insert of 5.4kb was 
released from each of these clones. This demonstrates the stability of the 
insert in A. 
To confirm that the DHFR-TS gene has been cloned, the gel was 
blotted and probed with the 0.6kb AccI-EcoRI gene fragment from the Ki 
isolate. The results (Fig. 5.8, plate b) show that all of these 5.4kb inserts 
hybridized with the probe, which illustrates a high positive rate in clones 
screened from the library. 
Two clones 423 and 92a3 were selected for further analysis. A large 
amount of DNA from these clones was prepared by the maxi-prep method 
(Section 2.4.5.1) and the EcoRI insert purified by electroelution from agarose 
gels (see MATERIALS & METHODS Section 2.4.10.1). These inserts were 
then analysed by restriction enzyme mapping to confirm the nature of the 
cloned insert by comparing with that of the cloned insert from the Ki isolate. 
The results are illustrated in Fig. 5.9. Upon digestion with EcoRI, a 
5.4kb insert was released from the HB3 clones. Further digestion of the 
purified EcoRI insert by either AccI alone or AccI and BglII yielded a pattern 
similar to that of Ki. The DNA was then blotted and probed with the 0.6kb 
AccI-EcoRI fragment from the Ki isolate. These results confirmed the 
isolation of the DHFR-TS gene of HB3 and allowed a restriction enzyme 
map of the gene to be produced (Fig. 5.10). The clone 423 was selected for 
all further work. 
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Fig. 5.8 Characterization of the DHFR-TS genomic clones. 
Ethidium bromide stained gel of EcoRI digested DNA from 11 
positive recombinant clones (tracks 1-11) of HB3. 
Southern blot of gel probed with the 0.6kb AccI-EcoRI 
fragment from the Ki isolate. 
Tracks 1-11: recombinant clones from the EcoRI genomic 
library of HB3 
Track 1: 92b2 
Track 2: 92b1 
Track 3: 92a2 
Track 4: 92a1 
Track 5: 911 
Track 6: 712 
Track 7: 711 
Track 8: 422 
Track 9: 421 
Track 10: 112 
Track 11: 111 
Track 12: recombinant clone of the Ki isolate 











b IIàWWWWft 	—23 
—9.4 
—656 
Fig. 5.9 Characterization of the DHFR-TS genomic clones 423 and 
92a3. 
Ethidium bromide stained gel of enzyme digested DNA from 
the 14133 clones 423, 92a3 and the A Ki clone. 
Southern blot of gel probed with the 0.6kb AccI-EcoRI 
fragment from the Ki isolate. 
Tracks 1-3: Purified EcoRI fragment from the recombinant 
clones 
Track 1: 92a3 
Track 2: Ki 
Track 3: 423 
Tracks 4-5: Insert DNA from clone 92a3 digested with AccI 
and BglII (track 4) or AccI (track 5) 
Tracks 6-7: Insert DNA from A Ki clone digested with AccI 
and BglII (track 6) or AccI (track 7) 
Tracks 8-9: Insert DNA from clone 423 digested with AccI 
and BglII (track 8) or AccI (track 9) 
Tracks 10-12: DNA from recombinant clones digested with 
EcoRI 
Track 10: 92a3 
Track 11: Ki 
Track 12: 423 
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Fig. 5.10 The restriction enzyme map of the P. falciparum 
H133 DHFR-TS genomic clone 
5.1.5 Sequencing Studies on 5' Non-coding Region of DHFR-TS Gene from 
HB3 
Having obtained the cloned DHFR-TS insert from HB3, I was able to 
initiate sequencing studies. The first aim was to sequence the 2.15kb AccI 
fragment which is thought to contain the putative deletion of 250bp. To do 
this, it was necessary to subclone the fragment into a suitable sequencing 
vector. Attempts were made to subclone the entire AccI fragment into M13 
but the insert was unstable. Therefore, another cloning strategy was tried 
which required initial mapping of cloning sites within the fragment. 
Preliminary analysis suggested that the cloned insert possessed many target 
sites for restriction enzyme AluI. Those within and neighbouring the 2.15kb 
dimorphic AccI fragment were mapped and are diagrammatically represented 
in Fig. 5.11. These sites were utilized in the subsequent cloning strategy. 
The cloning and sequencing strategies are illustrated in Fig. 5.12. 
Basically, anAluI-AluI orAluI-BglII fragment was subcloned into M13 vectors 
(Section 2.4.25). Positive plaques were identified by plaque hybridization with 
the appropriate probe (Section 2.4.20). An example of this is shown in Fig. 
5.13. Plaques were isolated and grown to generate single-stranded sequencing 
templates (Section 2.4.27.1). Sequencing was performed by the standard 
methods of dideoxy sequencing (Section 2.4.27.2), using both M13 universal 
17bp and internal oligonucleotide primers. Sequence to 1453bp upstream of 
the gene was obtained. However, a region in the 817bp AluI-AM fragment 
which was bounded on both sides by a stretch of T cannot be sequenced by 
the M13 method. This might be due to formation of secondary structure 
within this region or instability of the cloned insert. Other workers have 
encountered similar problems in sequencing P. falciparum DNA in M13 (A. 
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Fig. 5.11 Location of the Alu I site within or neighbouring the 2.15 kb Acc I 
dimorphic fragment of the 1-1133 DHFR-TS genomic clone. 
• 'I , 	 II 	 I 	 ,.sI 	 • + 1000 
	M. 





























Fig. 5.12 Subclonlng and sequencing strategies of 5' non-coding region of DHFR-TS 
gene from P. falclparum 	clone H133. Sequence data were obtained from M13 
subciones and pUBSI subclones of insert subfragment; pUBSI subclones of PCR 
fragments; purified A DNA and directly from PCR fragments. 
Fig. 5.13 Isolation of M13 subclones containing 0.6kb AiiiI-.giII 
subfragment of the DHFR-TS insert. Autoradiographs of plaque 
lifts from a) M13mp18 and b) M13mp19 recombinant clones 
probed with the 985bp AccI-AluI gene fragment from the cloned 








Khan; V.A. Snewin, personal communications). 
The apparent stability of cloned inserts in the plasmid vector pUBS 1 
(Goman et al., 1991) prompted an attempt to obtain the rest of the sequence 
by subclomng the 817bp AluI-AluI fragment into the Smal site of this vector 
(see MATERIALS & METHODS Section 2.4.26) for double-stranded 
sequencing. The insert could be removed by utilizing the flanking XbaI and 
Hindu! sites as illustrated in Fig. 5.14. The remaining sequence was obtained 
from these clones by the modified methods of dideoxy sequencing (Section 
2.4.27.3), using both the M13 17bp universal primer and internal 
oligonucleotide primers. The complete sequence of 1453bp 5' non-coding 
region of the DHFR-TS gene is compiled in Fig. 5.15. Part of the sequence 
was also confirmed by three other double-stranded sequencing methods. 
These included direct sequencing from the A clone 423, direct sequencing of 
polymerase chain reaction (PCR) products and sequencing of pUBS 1 
subclones of PCR fragments. 
5.1.5.1 Features of the 5' Flanking Sequence of the HB3 DHFR-TS 
Gene: No extensive sequencing of P. falciparum non-coding regions has been 
done probably because of the difficulties in sequencing through AT-rich 
regions. As a result of this work the P. falciparum DHFR-TS gene is one of 
the few genes which has its non-coding 5' region sequenced as far as 1453bp 
from the translation start site. 
The 1453bp 5' flanking sequence showed an elevated frequency of A 
and T. An average of 82% AT was found in this region compared with 75% 
AT in the coding region. The occurrence of AT had gone up to 94% in the 
immediate vicinity of the gene and was as high as 87.5% up to 1kb from the 
ATG codon. While the coding region showed an asymmetry with the purines 
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Fig. 5.14 Characterization of pUBS! subclones containing the 
817bp 4jjI-jjI subfragment of the DHFR-TS insert. 
Ethidium bromide stained gel of XbaI-HindIII digested DNA 
from pUBS 1 subclones. 
Southern blot of gel probed with a synthetic oligonucleotide 
B2. 
Tracks 1 & 10: (Control) pUBS 1 vector DNA cut with XbaI 
and Hindlil 
Tracks 2-5 & 8-9: Plasmid DNA from pUBS 1 subclones cut 
with XbaI and Hin dill 
Track 6: DNA markers 123bp ladder 
Track 7: (Control) Purified 2.15kb AccI fragment cut with 
AluI 
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Fig. 5.15 The nucleotide sequence of the 5' non-coding region of 
the DHFR-TS gene from HB3. Part of the sequence for the coding 
region is also shown. In places where AT tracts and A or T tracts 
occurred, slight variation in the number of AT, As or Ts was 
obtained by different sequencing methods. 
Key: underlined= poly (dT) or poly (dA) ock CAT 
double underlined= poly (AT) 
boxed= AlT I or TAAA repeats 
wavy underlined = potential Z-DNA forming 
sequences 
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-1453 CTTGTCCATATGACTGCGAGAATTAACCGTGGTGAGGCGA -1414 
-1413 TCCCTGAACCAGTAAAACAACTTCCTGTCATGGGCGGTAG -1374 
-1373 ACATAAAATGAkAACAAGAAAAATATATATACAAAGTATA -1334 
-1333 TATACATATACTTATTATTATTTTTATTATTTTAATTTTT -1294 
-1293 TTATTGATGTTCCTTTTCAAATAATTCCAAAGTAATATAC -1254 
-1253 ACAACGTTACAGTTGTTGAATAAATATAGGACCAAATAGA -1214 
-1213 TATATGCCATATAATTTATAAAACCATCACATGTTTAAAG -1174 
-1173 TAAATTTTTCTTCATTTCAAATATTCATGTTGTTCTCTTT -1134 
-1133 CCTATTTCTTTATAAGTTACTCTTATATATGTCTTTTTAT -1094 
-1093 TTTCTATTTTAATTTTCTTTTTTTTATAAGTGAGTAAATA -1054 
-1053 TGAATGTGCATGCTTAATGGAA.AAAAAGAGAGAAAAAAAA -1014 
-1013 GAAAAGCCTTTATATTGAAACTAGCTCAACAAAAATTAAA -974 
-973 TAAATAAATATATATATATTATATATATGTATAATTCTTT -934 
-933 CAGTGCACATATATATATATATATATATATATATATATAT -894 
-893 ATATATATATATAATATTCTCCGTTTTATTTTATTTTATT -854 
-853 TTTTTTTTTTTTAAATATTATATTTTAAAGATATCAATCT -814 
-813 TTTATACAATCATATATATGTCTATGGGAATCTTATAATA -774 
-773 TGTAAAAATAAGAAACAAAAGGATATATAAATAATAATAT -734 
-733 ACCTTAAAAAAATTATTATAGAGAAGGATAAATTTATTTT -694 
-693 TATTATAAGTTCTATTCACATATCCATATGATATAGGTAT -654 
-653 AAAAAAAThkTTATTArTTATTTATTTATTTATTTATTTA -614 
-613 TTTATTTTATTTT*TTATATGCACTTTCCTTGTAAATGT -574 
-573 CATTCTTTATATTAAGAAGAACATATTATACATATATAAA -534 
-533 AATATTATATCTCATATAATTTTTGTACAGTTTTTTATTG -494 
-493 GTTTCTTAATTGTTTTTTTTTTTTTTTTTTTTTCTCATTC -454 
-453 CATTTATATAAGTATGATTAGATTTGTTTAAGAAAAAA.AA -414 
-413 AAAAAAAAAAATTATCATCATAAGAAATATTTTACACATT -374 
-373 TTGAAATATAATTAAGATATTTATTTTATATATATTTAAA -334 
-333 TGAATAGATACATTTATTTATGAATCTGTTTAAAAGTTAT -294 
-293 	ATTAAGGGGATTATAATAAAAATATAATATITAAATAAAT -254 
-253 	AAATATAAATAAITATATATATATATAGTTTTTTTTTTTT -214 
-213 	TTTTTTTTTTTTTTACTAGCCATTTTTGTATTCCCAAATA -174 
-173 	GCTAGTTCATTTTAACTTACACAATATATATTTTTCTTTA -134 
-133 	AATTTATAAAAATATATTCCAACATTTTCAAGATTGATAC -94 
-93 	ATAAAGATAATATATATATATATATATATATATATATATA -54 
-14 
-13 	TTTTCTCCTTTTTATGATGGAACAAGTCTGCGACGTTTTC 27 
MM E 	V C D V F 
28 	 GATATTTATGCCATATGTGCATGTTGTAAGGTTGAAAGCA 67 
DI Y A IC A CC K V ES 
68 	 AAAATGAGGGGAAAAAAAATGAGGTTTTTAATAACTACAC 107 
K NE G K K NE V F N NY T 
108 	ATTTAGAGGT 	 117 
FR G 
in excess by 14% in the coding strand, the non-coding region did not reveal 
any significant bias. Only a 5% pyrimidine excess of the total bases was 
found in the non-coding region. This is in accord with the results obtained 
by Hyde & Sims (1987) who observed a marked excess of purines over 
pyrimidines in the mRNA-synonymous strand of coding regions. The purine 
excess ranges from 14-32% of the total bases. By contrast, there is no 
consistent bias seen in the non-coding region of 25 genes analysed. 
Two long oligo (dT) stretches of 26 and 21 bases and one long oligo 
(dA) stretch of 19 bases were found around -210, -470 and -410bp 
respectively. These sequences were preceded by a G base and followed by 
CAT. A shorter oligo (dT) stretch of 14 bases was located around -850bp. 
A particularly long tract of AT repeats occurred twice in the sequence, 
one between -39 and -84bp and the other between -882 and -925bp. The 
numbers of the repeated AT bases were 22 for the distal tract and 23 for the 
proximal tract. 
Another characteristic of the sequence was the common occurrence of 
the AlT!' repeats. Most of the AlT! repeats were found together with 
other AT domains. The sequence AlT! repeated seven times was found 
from -611 to -638bp preceded by (ATT) 2 and followed by AT4 and then AT.. 
It is also found repeated five times at -17 to -40. Five inverted repeats 
TAAA alternating with other TA domains occurred around -241 to -261bp. 
Putative Z-DNA forming sequences were found along the 5' non- 
coding region of P. falczparum DHFR-TS gene. They consist of short 
stretches of alternating purine-pyrimidine base pairs which are reported to 
have the potential to form Z-DNA when no more than one base pair is out 
of purine-pyrimidine alternations (Nordheim & Rich, 1983a; b). 
Alternatively, a Z-DNA forming sequence is favoured in nucleotide sequences 
such as poly d(GC), poly d(CA), poly d(GT), d(CGCG), d(CGCGCG), 
ow 
d(CA/TG) which has not been found in the non-coding region of P. 
falciparum DHFR-TS gene. 
5.1.6 Cloning of 5' Non-coding Region of DHFR-TS Gene from 3D7 
After the sequence of HB3 DNA was completed, oligonucleotide 
primers were used to amplify corresponding segments from 3137 DNA by 
PCR. The sequences and the relative positions of the synthetic 
oligonucleotides in the gene map are illustrated in Fig. 5.16. The amplified 
fragments were then subcloned into a plasmid vector for sequencing. The 
oligonucleotides, namely A2 and B2 corresponded to nucleotides -93 to -116 
and -677 to -654 of the HB3 sequence given in Fig. 5.15. Using these 
oligonucleotides, a PCR fragment of 585bp was expected from HB3 DNA and 
a fragment of 835bp was expected from 3137 DNA. 
As shown in Fig. 5.17, fragments amplified from 3D7 and HB3 DNA 
using oligonucleotide primers A2 and B2 gave the expected sizes (plate a). 
This implied that the source of the dimorphism was present in this region i.e. 
the putative deletion was contained within this fragment. The identity of the 
fragments was confirmed by probing a Southern blot of this gel with an 
oligonucleotide A3 occurring in between A2 and B2 at position -285 to -308 
(plate b). 
After purification from an agarose gel, these two fragments were 
subcloned into pUBS 1 plasmid (Section 2.4.26). Positive clones were 
identified by screening with the internal oligonucleotide A3 (Section 2.4.21). 
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Al (60 to 37) 5'-AAC C TT ACA ACA TGC ACA TAT GGC-3' 
A2 (-93 to -116) 5'-TGT ATC AAT CTF GAA AAT GTF GGA-3' 
A3 (-285 to -308) 5'-CCC CVF AAT ATA ACT iT! AAA CAG-3' 
Bi (-1008 to -984) 5'-GCC 'IT! ATA TFG AAA CTA GCT CAA C-3' 
B2 (-677 to -654) 5'-CAC ATA TCC ATA TGA TAT AGG TAT-3' 
B3 (-509 to -486) 5'-GTA CAG 'IT!' m ATF GGT TTC TFA-3' 
B4 (-398 to -375) 5'-CAT CAT AAG AAA TAT iT!' ACA AT-3' 
Fig. 5.16 The sequences of the primers used in polymerase chain reactions 
(PCR) and the relative positions of the synthetic oligonucleotides in the gene 
map. The positions of the oligonucleotides (in brackets) are numbered 
according to the HB3 sequence in Fig. 5.15. 
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Fig. 5.17 Dimorphic fragments amplified from 3D7 and HB3 DNA 
using primers A2 and B2 in PCR. 
Ethidium bromide stained gel of PCR amplified fragments 
from 3D7 and HB3 DNA. 
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electrophoresis to confirm that no apparent deletion had occurred during the 
cloning process. The results are shown in Fig. 5.18. Fragments of the correct 
sizes 580bp and 830bp respectively were maintained in HB3 and 3137 
subclones (plate a). The specificity of these fragments was proved by their 
cross-hybridization with internal oligonucleotide A3 (plate b). 
5.1.7 Sequencing Studies on 5' Non-coding Region of DHFR-TS Gene from 
3D7 
The sequencing strategy is shown in Fig. 5.19. The complete sequence 
of the subcloned fragment was obtained by the modified methods of dideoxy 
sequencing (Section 2.4.27.3), using the M13 17bp universal primer, the M13 
16bp reverse primer and internal oligonucleotide primers. Part of the 
sequence within this region was confirmed by direct sequencing from PCR 
products. Sequences on the 5' and 3' sides of the fragment were obtained by 
direct sequencing from another PCR product obtained using the 
oligonucleotides Al and Bi corresponding to positions -137 to -160 and -1008 
to -984 respectively of the HB3 sequence (Fig. 5.15). 
5.1.7.1 Sequence Comparison of the 5' Flanking Regions of 3D7 and 
HB3 DHFR-TS Genes: The sequence of the 5' non-coding region of the 
DHFR-TS gene for 3D7 and its comparison with the sequence for the HB3 
cloned line is shown in Fig. 5.20. There was no 250bp insertion of sequence 
in 3D7 DNA as predicted from the apparent size of 3D7 DNA in agarose gel. 
Instead, only minor variations in the two sequences were detected. The 
presence of an insertion might be mimicked by the presence of 3D7 sequence 
which favoured the formation of secondary structures e.g. bent DNA and 
retarded the passage of the fragment through the agarose but before this 
could be evaluated the difference in the two sequences are illustrated by 
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Fig. 5.18 Characterization of pUBS1 subclones of PCR fragments. 
Ethidium bromide stained gel of XbaI-HindIII digested DNA 
from pUBS 1 subclones containing PCR fragments from either 3D7 
or HB3 DNA. 
Southern blot of gel probed wtih a synthetic oligonucleotide 
A3. 
Tracks 1-3: DNA from pUBS1 subclones containing PCR 
fragment from 3D7 cut with XbaI and Hindlil 
Track 1: D9 
Track 2: D8 
Track 3: D3a 
Track 4: (Control) PCR fragment from 3D7 
Track 5: DNA markers 1kb ladder 
Track 6: (Control) PCR fragment from HB3 
Tracks 7-8: DNA from pUBS1 .subclones containing PCR 
fragment from HB3 cut with XbaI and Hindu! 
Track 7: H4 
Track 8: H5 
Track 9: (Control) vector DNA cut with XbaI and Hindu! 
Track 10: (Control) vector DNA 
Note that the slightly increase in size of the released inserts is due 
to cleavage with enzymes flanking the Smal cloning site, which are 
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Fig. 5.19 	PCR and sequencing strategies of the 5' non-coding region of 
the DHFR-TS gene from P. falciparum 	clone 3137. Sequence data were 
obtained from either pUBS1 subciones of PCR fragments or PCR fragments 
as indicated. 
Fig. 5.20 Alignment of 3D7 and HB3 sequences from the 5' non-
coding regions of the DHFR-TS gene. The sequence of 3137 is 
shown on top. The differences in the HB3 sequence are shown as 
either insertion of sequences or deletion of sequences (dotted line) 
in the bottom line. 
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3D7 TTAAATAAATAA.ATATATATATATTTTATATATATATGTA -901 
HB3 .... -943 
3D7 TAATTCTTTCAGTGCAC .............. ATATATATA -875 
HB3 ATATATATATATAT -903 
3D7 TATATATATATATATATATATAATATTCTCCGTTTTATTT -835 
HB3 -863 
3D7 TATTTTATTTTTTTTTTTTTTAAATATTATATTTTAAAGA -795 
HB3 -823 
3D7 TATCAATCTTTTATACAATCATATATATGTCTATGGGAAT -755 
HB3 -783 
3D7 CTTATAATATGTAAAAATAAGAAACAAAAGGATATATAAA -715 
HB3 -743 
3D7 TAATAATATACCTTAAAAAAATTATTATAGAGAAGGATAA -675 
HB3 -703 
3D7 ATTTATTTTTATTATAAGTTCTATTCACATATCCATATGA -635 
HB3 -663 
3D7 TATAGGTATAAAAAAATAATTATT ............ ATTT -607 
HB3 ATTTATTTATTT -623 
3D7 ATTTATTTATTTATTTTATTTTTCTTATATGCACTTTCCT -567 
HB3 -583 
3D7 TGTAAATGTCATTCTTTATATTAAGAAGAACATATTATAC -527 
HB3 -543 
3D7 ATATATAAAAATATTATATC TCATATAATTTTTGTACAGT -487 
HB3 -503 
3D7 TTTTTATTGGTTTCTTAATTGTTTTTTTTTTTTTTTTTTT -447 
HB3 -463 
3D7 TTCTCATTCCATTTATATAAGTATGATTAGATTTGTTTAA -407 
HB3 -423 
3D7 GAAAAAAAAAAAAAAAAAAATTATCATCATAAGAAATATT -367 
HB3 -383 
3D7 TTACACATTTTGAAATATAATTAAGATATTTATTTTATAT -327 
H33 -343 
3D7 ATATTTAAATGAATAGATACATTTATTTATGAATCTGTTT -287 
HB3 -303 
3D7 AAAAGTTATATTAAGGGGATTATAATAAATATAATATA -247 
HB3 -263 
3D7 TAAATAAATAAATATAAATAAATATATATATATATATATA -207 
HB3 . 	 . 	 . 	
. -227 
3D7 GTTTTTTTTTTTTTTTTTTTTTTTTTTACTAGCCATTTTT -167 
HB3 -187 
3D7 GTATTCCCAAATAGCTAGTTCATTTTAACTTACACTAT -127 
HB3 -147 
3D7 ATATTTTTCTTTAAATTTATAAAAATATATTCCAACATTT -87 
HB3 -107 
3D7 TCAAGATTGATACATAAAGATAATATATATATATATATAT -47 
HB3 -67 
3D7 ATATATATATA .................... TTTATTTAT -27 
HB3 TATATATATATATATATTTA -27 
3D7 TTATATATTTATATTTTCTCCTTTTTATGATGGPACGT 14 
HB3 14 
the sequencing gels shown in Fig. 5.21. Nucleotide positions given refer to 
those of 3D7 sequence shown in Fig. 5.20. There are six differences involving 
either insertion or deletion of A and T bases. 
Two distinctive differences involving the number of AT repeats in two 
AT tracts at positions -36 to -63 and -854 to -883 are shown in plate a and 
b. The 3D7 sequence had eight less TA in the proximal AT tract (positions - 
36 to -63) (plate a) and seven less AT in the distal AT tract (position -854 
to -883) (plate b). Plate a also shows another difference in the number of 
Ti1'A repeats (position -24 to -35) which occurred immediately preceding the 
proximal AT tract. A deletion of 'I'l'I'A in 3D7 sequence (arrow) reduced 
the number of 1TIA repeats from four to three. Plate b also shows an 
insertion of TTAT (positions -912 to -915) in the 3D7 sequence which added 
one AT to a (AT) 4 repeats. 
Plate c shows a difference in the number of A'!'!'! repeats (positions - 
595 to -610). There are four ATE!' repeats in 3D7 sequence whereas seven 
AT!'!7 repeats are present in HB3 sequence. Plate d shows another 
difference in the number of TA repeats (positions -207 to -214) in the two 
sequences. Nine TA repeats were found in 3D7 sequence while only seven 
were present in HB3 sequence. 
5.1.7.2 Comments on Various Methods Used in Sequencing: In the 
course of sequencing the 5' non-coding region of the DHFR-TS gene, 
difficulties were encountered mainly in sequencing through AT ladders and 
poly (dA) and poly (dT) tracts. Many of the methods used in sequencing the 
5' non-coding region of the P. falcipa,um DHFR-TS gene could not read 
through sequences after stretches of A or T. This was a particular problem 
in the case of M13 single-stranded sequencing and direct sequencing from 
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Fig. 5.21 Differences in the two sequences of the 5' non-coding 
regions from 3D7 and HB3. 
Autoradiographs of sequencing gels showing a difference in the 
number of AT repeats in an AT ladder positioned -36 to -63 of 
3D7 sequence. It also shows a deletion of 1TI'A (arrow) from a 
repeat (-24 to -35) of 3D7 sequence. 
Autoradiographs of sequencing gels showing a difference in the 
number of AT repeats in an AT ladder positioned -854 to -883 of 
3D7 sequence. It also shows an addition of ITAT (-912 to -915) 
in the 3D7 sequence. 
Autoradiographs of sequencing gels showing a difference in the 
number of AlT!' repeats positioned -595 to -610 of 3D7 sequence. 
Autoradiographs of sequencing gels showing a difference in the 
number of TA repeats positioned -207 to -214 of 3D7 sequence. 
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A or PCR products. The reason for this is unknown but is presumably due 
to formation of secondary structures or instability of inserts. The plasmid 
vector pUBS 1 proved to be a suitable sequencing vector for Plasmodium genes 
since there were no difficulties in sequencing through these stretches after the 
DNA fragments were subcloned into pUBS1. It gave a long continuous, clear 
and unambiguous sequence. This was found when sequencing both the 3137 
and HB3 DHFR-TS non-coding regions. 
5.1.8 Evaluation of the Secondary Structure as the Cause of the RFLP 
The failure to detect a 250bp difference in the DNA sequence to 
account for the RFLP implies that there must be differences in the DNA 
sequences affecting the mobility of the DNA fragments on agarose gel which 
are not deletions. Since only minor differences in sequence were detected, 
it is tempting to speculate that the anomalous mobility of the DNA fragments 
is due to formation of secondary DNA structure induced by unusual DNA 
sequence e.g. bent DNA. This was tested as described in the following 
experiments. 
5.1.8.1 Dissociation of RFLP by PCR: The occurrence of sequence 
variation in different parts along the 5' non-coding regions leads to the 
speculation that some kind of sequence interaction is involved in giving rise 
to the secondary structure. An experiment was designed to test this 
possibility. 
PCR was used to amplify fragments from different 5' and 3' sites of 
the gene fragment encompassing the RFLP region. The PCR strategy is 
illustrated in Fig. 5.22 and the results summarised in Fig. 5.22 and Table 5.1. 
KIQ 
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jg 	2 PCR strategy to amplify fragments from the 5' non-coding region of DHFR-TS gene from r-. a ciparum 
clones 307 and H133 using different combinations of 5' and 3' primers. The regions 
marked with asterisks are believed to contain sequences involved in interaction to generate 
secondary structure in 3D7 DNA. 
Table 5.1 A list of the expected and apparent sizes of the PCR fragments 
amplified from different primers 

















A2/B2 585 580 577 830 
A1/B3 569 580 553 830 
A2/B3 417 430 421 700 
A1/B4 458 410 442 370 
A3/B2 393 380 381 375 
620 *  
A2/B4 306 310 310 310 
565 *  
A3/B3 225 220 225 220 
450* 
A3/B4 114 125 114 125 
320* 
* detected as faint bands 
@ derived from non-specific amplification products 
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Dimorphic fragments were amplified from primers Al/Bi, A1/132, A2/132, 
A2/B3 and Al/B3. The ethidium bromide stained gels of the PCR products 
are shown in Fig. 5.23 (plate a). The specificity of these fragments were 
confirmed by probing with oligonucleotides B4 (plate b) or A3 (plate c). 
These results show that the source of dimorphism was contained within the 
region encompassed by oligonucleotide sequences A2 and B3. 
However, similar sized fragments were obtained from 3D7 and HB3 
DNA when amplified from primers B3/A3 or A2/134. The primers A3 and 
B4 were positioned in between B3 and A2. The ethidium bromide stained 
gels of the PCR products are shown in Fig. 5.24 (plate a). The specificity of 
these fragments was confirmed by probing with oligonucleotides B4 (plate b) 
or A3 (plate c). These results illustrate that the dimorphism is dissociated 
when either A2 or B3 was used with an internal primer, suggesting that 
deletion of sequence was not a cause for the RFLP. The results also suggest 
that some sequences located between B3/B4 and A2/A3 were involved in 
interaction to generate secondary structure which causes the anomalous 
mobility of the 3D7 DNA in agarose gels. 
If this is the case, similar sized PCR products are expected from 3D7 
and HB3 DNA using primers A3/134, A1/B4 or B2/A3 which encompassed 
only one or none of these two regions. As illustrated in Fig. 5.22 and shown 
in Fig. 5.24, fragments of similar sizes were amplified, confirming the idea 
that the regions between B3/B4 and A2/A3 contained sequences important 
in producing the secondary structure. 
However, the dissociation was not complete. Note that in Fig. 5.24, 
faint bands of bigger sizes were also detected in the PCR products of 3D7 
DNA when amplified from primers A3/B2, A2/134, A3/B3 and A3/134. 
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Fig. 5.23 Dimorphism in PCR fragments from 3D7 and HB3 
DNA. 
Ethidium bromide stained gel of PCR fragments. 
Southern blot of gel probed with internal oligonucleotide B4. 
Southern blot of gel probed with internal oligonucleotide A3. 
Track 1: HB3 DNA 
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Fig. 5.24 Dissociation of dimorphism by PCR. 
Ethidium bromide stained gel of PCR fragments. 
Southern blot of gel probed with internal oligonucleotide B4. 
Southern blot of gel probed with internal oligonucleotide A3. 
Track 1: HB3 DNA 
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These bands also cross-hybridized with the oligonucleotide probes suggesting 
that they were specific PCR products. 
5.1.8.2 Alkaline Denaturing Gel: We cannot therefore exclude the 
possibility of the presence of a 250bp sequence in 3137 DNA which was not 
0- 
sequenced due to the formation of 'cruciform. To check whether there is such 
a loop in 3137 DNA, the natural sizes of the DNA fragments were checked 
under denaturing conditions. 
The PCR amplified fragments from 3137 and HB3 DNA using 
oligonucleotide primers A2 and B2 were purified from agarose gel, 
dephosphorylated, end-labelled with 
[Y_32  P]dATP and then run on an 
alkaline denaturing gel at 60V for 7hrs (Section 2.4.28). The trichioroacetic 
acid fixed gel was dried and autoradiographed. The results are shown in Fig. 
5.25. Dimorphic bands of 580bp and 830bp were still discernable for HB3 
and 3137 DNA segments respectively, suggesting that the natural sizes of the 
two DNA segments are 580bp and 830bp respectively. 
It is therefore possible that a loop of 250bp was formed in 3137 DNA 
which was bypassed by the sequencing enzyme at low temperature (37 °C) 
although it is very unlikely that after bypassing a region of 250bp, the 
sequence obtained can still be as unambiguous as that obtained in this work. 
Furthermore, the conditions used for sequencing included 10% 
dimethylsulphoxide (DMSO) which should be sufficient to keep the DNA 
denatured during sequencing. 
Although the results from these two experiments are conflicting, both 
suggest the formation of some unusual secondary structure in the 5' non-
coding region of 3D7 DNA. 
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Fig. 5.25 Alkaline denaturing gel. Autoradiographs of end-
labelled PCR fragments from 3D7 and HB3 DNA separated by 
alkaline denaturing gels. 
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51 DISCUSSION 
The prevalence of poly (dA), poly (dT), poly (AT) and A-T repeats in the 5' 
non-coding region of the DHFR-TS gene already makes it probable that this 
DNA region will form secondary structures. Comparison between gene 
sequence and gel mobility differences of DNA from the 5' non-coding region 
of the HB3 and 3D7 DHFR-TS genes suggests that secondary structures may 
exist in this region of the 3D7 genome. It could be postulated that a 250bp 
hairpin loop could exist in 3D7 DNA resulting in this region being bypassed 
by the sequencing enzyme such that it was not sequenced. However, if this 
is not the case, the apparent size difference must be caused by other 
secondary structure of 3D7 DNA resulting in its retardation during agarose 
gel electrophoresis. Here we consider bent DNA as a possible cause. 
There is no reason to suppose that P. falciparum would be any 
difference from any other organisms in its possession of bent DNA. The 
ubiquitous occurrence of bent DNA from cellular to viral genomes implies 
its possible occurrence in parasitic protozoa (Marini et al., 1982; Zahn & 
Blattner, 1985; Griffith et al., 1986; Kawamoto et al., 1989; Hagerman, 1990). 
Moreover, a highly repeated element of the P. berghei genome has been 
reported to exhibit bending character (Dore et al., 1988). 
The putative sequences generating the RFLP are limited to two 
regions. Within one region, an A stretch and a T stretch are found. 
Periodically repeated poly (dA) tract are often identified to be the locus of 
bending centre (Koo et al., 1986; Wu & Crothers, 1984; Dore et al., 1988). 
Poly d(A).poly d(T) sequence has been demonstrated to adopt an altered 
DNA configuration in physiological conditions by X-ray crystallography 
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(Arnott et al., .1983; Alexeev et al., 1987). Hence, it is possible to produce 
a bend at the junction of the B-form DNA and this altered DNA form as has 
been demonstrated for the junction between the B-form DNA and another 
DNA configuration, the A-form DNA (Selsing et al., 1979). 
Within the other region, a variation in the two sequences is detected. 
An insertion of four bases is present in the 3D7 sequence. Most noticeably, 
this insertion separates the above mentioned poly (dA) and poly (dT) from 
another poly (dT) stretch. The requirment of periodically repeated sequence 
in phase with the helix repeat to produce inphase bending (Trifonov, 1980; 
Trifonov & Sussman, 1980) implies that the insertion or deletion of short 
DNA sequences may disrupt the phasing of the bends and hence abolish 
DNA bending. In 3D7 DNA, the insertion of four bases may alter the 
phasing of the bends and hence significantly increase the magnitude of the 
bending in this DNA fragment to produce a macroscopic effect which can be 
visualized by gel electrophoresis. 
Variation in other sequences e.g. poly (AT) and AT repeats may also 
play a part in contributing to DNA bending especially since poly (AT) has 
been shown to adopt an alternating B-conformation (Suggs & Wagner, 1986) 
which also has the potential to generate a bend at the junction with the 
conventional B-form DNA. However, their functional importance cannot be 
predicted from the present study. 
These models are open to further testing (Wu & Crothers, 1984; Koo 
et al., 1986). The cloned Ki DNA provides a very good system to study the 
nature of this RFLP since the cloned insert generates a doublet having the 
same size as the 3D7 and HB3 dimorphic DNA fragments and there is 
evidence to suggest that the smaller fragment derives from the upper one. 
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The two bands can be purified and individually sequenced. Any differences 
in the two sequences will pinpoint the variations causing the RFLP. 
Furthermore, sequencing reactions should be ideally performed at high 
temperature (72 °C) using Taq polymerase. Under this condition, any 
cruciform structures should be removed. 
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CHAPTER 6 
CHARACTERIZATION OF THE 
TRANSCRIPTIONAL UNIT OF 
THE DHFR-TS GENE OF 
PLASMODIUM FAL CIPAR UM 
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6.1 RESULTS 
6.1.1 Approximate Mapping of the Transcriptional Start Sites of DHFR-TS 
Genes from 3D7 and HB3 by PCR 
6.1.2 Accurate Mapping of the Transcriptional Start Sites of DHFR-TS 
Genes from 3D7 and HB3 by Primer Extension 
6.13 Analysis of the Upstream Promoter Region 
6.1.4 Determination of the Size of DHFR-TS Transcript 
6.2 DISCUSSION 
NI1 
Because of our ignorance of transcriptional units of Plasmodium genes and 
as no functional test for putative promoter sequences of Plasmodium genes 
exists at present, prediction of putative promoter motifs of Plasmodium genes 
must initially rely on consensus analysis. Thus far, only the transcriptional 
unit of the P. knowlesi circumsporozoite (CS) gene is well characterized (Ruiz 
I Altaba et al., 1987) though the 5' termini of the mRNA of the precursor of 
the major merozoite surface antigen (PMMSA) genes from P. yoelll (Lewis, 
1990) and P. falciparum (Myler, 1990), the aldolase gene (Knapp et al., 1990) 
and the calmodulin gene from P. falciparum (Robson & Jennings, 1991) have 
also been mapped. Dihydrofolate reductase (DHFR) is a functional gene. 
Mapping of its transcriptional unit could form the basis of consensus analysis 
of putative promoter elements of functional genes in Plasmodium. 
Furthermore, there is an additional relevance in mapping the 
transcriptional unit of the DHFR-TS gene as it is possible that a 
pyrimethamine resistant mutant T9/94 (Ml-1) possesses a mutation affecting 
transcription (see CHAPTER 4). 
In this chapter, I describe the mapping of the transcriptional start sites 
of DHFR-TS genes from the cloned lines 3D7 and HB3. The start sites were 




6.1.1 Approximate Mapping of the Transcriptional Start Sites of DHFR-TS 
Genes from 3D7 and HB3 by PCR 
Preliminary studies were carried out using PCR to locate the regions 
where transcription starts. The rationale is illustrated in Fig. 6.1. As DNA 
is transcribed into mRNA which is then translated into protein, specific 
synthesis of certain cDNA can be initiated from an RNA preparation 
containing a population of mRNA by adding a downstream antisense 
oligonucleotide primer 'Pa' which is complementary to a short region of the 
mRNA. The reverse transcriptase activity of the Taq polymerase can then 
start synthesizing a complementary cDNA. Then, by adding an upstream 
primer 'Pb' or 'Pc' from the sense strand to the reaction mixture, the 
secondary DNA strand will be synthesized. If one of the upstream 
oligonucleotide primers 'Pd' is located to a region outside the transcriptional 
unit, there would not be any synthesis of the secondary DNA strand from the 
cDNA strand and hence no template for PCR. The start site of transcription 
can thus be located to within the two oligonucleotide sequences 'Pc' and 'Pd' 
where such a cut-off is observed. 
Controls are very important in this experiment since amplification from 
contaminating DNA could give false positive results. Therefore, the RNA 
preparations were initially treated with DNase to destroy all DNA. The 
efficiency of the DNase was first tested by treating DNA preparations with 
beivc- 
DNase in parallel before Asu6jected  to PCR. The absence of any amplified 
products from the DNA samples confirms that the DNase was active enough 
to destroy the DNA (data not shown). 
I 





3' < 	 - -i-  -- 5' cDNA 
'Pa' 
Fig. 6.1 The rationale of PCR from RNA to map the approximate location of 
the transcription start site. Specific synthesis of cDNA can be initiated by 
Taq polymerase from an RNA preparation by adding a downstream antisense 
oligonucleotide primer 'Pa' which is complementary to a 	regionof the 	 cockovi 
gene. Then, by adding upstream primer 'Pb' or 'Pc' from the sense strand to 
the reaction mixture, the secondary DNA strand will be synthesized. If one 
of the upstream primers 'Pd' is located to a region outside the transcriptional 
unit, there would not be any synthesis of the secondary DNA strand from the 
cDNA strand and hence no template would be generated for PCR. The start 
site of transcription can thus be located within the two oligonucleotide 
sequences 'Pc' and 'Pd' where such a cut-off is observed. 
The DNase-treated RNA preparations were then subjected to PCR 
using the antisense oligonucleotide Al and the sense strand oligonucleotides 
Bi, B2, B3 and B4 (see Fig. 5.16). The sizes and the specificity of the PCR 
fragments were checked on agarose gels. For each experiment a control 
reaction was carried out using RNA which had been treated with both DNase 
and RNase. 
The results are shown in Fig. 6.2. No bands of the expected sizes were 
observed in the control reactions. However, in the experimental reactions, 
the patterns in the agarose gels reveal that specific fragments of the expected 
sizes were amplified from both 3D7 and HB3 RNA preparations using pairs 
of primers A1/B4 and A1/B3. With 3D7 RNA, fragments of 440bp and 
800bp were obtained. With HB3 RNA, fragments of 440bp and 550bp were 
obtained. No amplified fragments were detected from either RNA samples 
using pairs of primers A1/B2 and Al/Bi. This cut-off of PCR signal suggests 
the location of a transcriptional start site between oligonucleotide sequences 
B2 and B3. 
When the sensitivity of the test was increased by Southern blot analysis 
of this gel, probing with the internal oligonucleotide A2, faint bands were also 
detected in tracks loaded with samples amplified from primers A1/B2 (Fig. 
6.3). Signals from samples with primers A1/B4 or A1/B3 showed up readily 
after short exposure (overnight). Upon prolonged exposure (4 days), faint 
bands of 920bp and 730bp were also observed from 3D7 and HB3 RNA 
samples amplified from the primers Al/B2. Since the same amounts of RNA 
were put into each reaction, the difference in PCR efficiency might be 
explained by the existence of major and minor transcriptional start sites 
although it is also possible that this difference might be affected by the 
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Fig. 6.2 Ethidium bromide stained gels of PCR products from 
RNA samples using different combinations of primers. 
3137 RNA 
HB3 RNA 
The oligonucleotides used in these reactions are given above their 
respective samples. For each set of oligonucleotides two 
experiments were carried out. Lane 1 shows the results with RNA 
treated with DNase only. Lane 2 shows the results with RNA 
which had been treated with both RNase and DNase. 
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Fig. 6.3 Southern blot of gels in Fig. 6.2, probed with an internal 
oligonucleotide A2. The bands from A1/133 and A1/134 were 
detected readily after short exposure (overnight). The bands from 
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priming efficiency of various primers used. It should be noted that no signals 
were observed in lane 2 of the samples confirming the products were derived 
from RNA. 
The measurements of the fragment size are tabulated in Table 6.1 and 
a diagrammatic representation of the results is illustrated in Fig. 6.4. In the 
figure, the locations of the major and minor transcriptional start sites are 
marked. As can be seen in the table, the PCR products from RNA still 
display size dimorphism when amplified from the primers A1/133 and A1/132 
respectively but not from the primers A1/B4. This resembles the size 
dimorphism of the DNA fragments amplified from PCR as discussed in 
CHAPTER 5. Furthermore, the hybridization signal of the amplification 
products from 3D7 RNA using the primers A1/133 is much weaker than that 
of HB3 RNA (Fig. 6.3). The less efficient amplification from 3137 RNA 
using this pair of primers may imply the presence of secondary structure in 
this region, as has been discussed in CHAPTER 5. 
With the approximate mapping of the transcriptional start sites 
achieved, I was able to proceed to mapping the sites more accurately using 
primer extension. 
6.1.2 Accurate Mapping of the Transcriptional Start Sites of DHFR-TS 
Genes from 3D7 and HB3 by Primer Extension 
To precisely locate the 5' termini of the DHFR-TS transcripts from 
HB3 and 3D7, end-labelled oligonucleotide primers were used to produce a 
cDNA complementary to the RNA templates (MATERIALS & METHODS 
Section 2.5.5). Analysis of the primer extended products by denaturing 
polyacrylamide gel electrophoresis provided information on the transcriptional 
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Table 6.1. The apparent sizes of the specific PCR fragments amplified from 
RNA preparations of 3D7 and HB3 using different combinations of primers 
Primers Apparent sizes (bp) 
3D7 RNA HB3 RNA 
A1/B4 440 440 
A1/B3 800 550 
A1/B2 920 730 
A1/B1 - - 
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Fig., 6.4 A diagrammatic representation of the strategy used to amplify specific 
fragments from RNA preparations of 3D7 and H133 using the primer Al in 
combination with primers 1311,132,133 or 134. The PCR products were detected by 
agarose gel electrophoresis and Southern blotting, probed with an internal 
oligonucleotide A2 . The presence or absence of specific amplified fragments is 
denoted as + or -. The cut-off of PCR signals suggests a major transcription 
initiation site between oligonucleotide sequence 132 and B3 and a minor site 
between oligonucleotide sequence B1 and B2. 
start sites. 
Since the major start site was located to a region between 
oligonucleotide sequences B2 and B3, the most proximal oligonucleotide A3 
was chosen as the antisense primer in the extension reaction. Note that the 
nucleotide sequences for both HB3 and 3D7 genomic DNA are identical 
upstream of this region (see Fig. 5.20). 
The results are illustrated in Fig. 6.5. Analysis of HB3 mRNA, 
produced a major fragment which mapped to position -552 corresponding to 
a C nucleotide and two minor fragments which were mapped to positions - 
557 and -543 corresponding to A and C bases respectively. The 5' termini 
were mapped to the same bases in 3D7. However, because of the slight 
variation of the 3D7 and HB3 sequences in the 5' non-coding region (see 
CHAPTER 5), the major fragment of the 5' termini is at position -536 in 3D7 
and the minor fragments at positions -541 and -527. These results are in 
agreement with the position indicated for a transcriptional start site by PCR. 
In order to see if a sub-population of mRNAs existed with an earlier 
transcriptional start site as also suggested by PCR, the samples were 
subjected to an extended run and the subsequent gel subjected to a prolonged 
exposure to reveal any bands occurring upstream. Fig. 6.6 illustrates a 
prolonged exposure from such an experiment which shows the occurrence of 
some faint bands in the upstream region. These may represent minor 
transcripts initiating from minor start sites 5' to the major start sites present 
at the bottom of the gel. It is difficult to map these minor start sites 
accurately from this experiment but a rough estimation has located these sites 
to 180, 230 and 265 bases from the major start sites which once again fall 
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Fig. 6.5 Autoradiographs of primer extension products using 
oligonucleotide A3 as primer. RNA preparations from the cloned 
lines 3D7 and HB3 were examined. Sequencing reactions from 
pUBS 1 containing subcloned PCR fragments using the same 
primer were run alongside the primer extension products as 
markers. The arrows indicate a cluster of three start sites. The 
solid arrow represents the major signal whereas the two dotted 













Fig. 6.6 Prolonged exposure of autoradiographs of primer 
extension products using oligonucleotide A3 as primer. Primer 
extended products from RNA samples of the cloned lines 3137 and 
HB3 were subjected to an extended run and the subsequent gel 
subjected to a prolonged exposure. Sequencing reactions from 
pUBS 1 containing subcloned PCR fragments using the same 
primer were run alongside the primer extension products as 
markers. The solid and broken arrows indicate a cluster of the 
major start sites (see also Fig. 6.5). The arrowheads indicate the 
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within the region defined by oligonucleotides Bi and B2 as predicted by 
PCR. 
The results from primer extension therefore fit in with the previous 
PCR results which also predicted major and minor start sites. This is 
represented diagrammatically in Fig. 6.7. The major start sites mapped by 
primer extension are contained within a region also mapped to contain the 
major start sites by PCR. Both experiments also detected a possible 
upstream minor start site. The 5' non-coding sequences of DHFR-TS genes 
and its predicted transcriptional start sites are depicted in Fig. 6.8. 
6.1.3 Analysis of the Upstream Promoter Region 
Thus far, there is no functional test for Plasmodium promoter 
elements. Prediction of putative promoter sequences from the few genes 
analysed (Ruiz I Altaba et al., 1987; Lewis, 1990; Myler, 1990; Robson & 
Jennings, 1991) relies completely on consensus analysis with known promoter 
motifs from other species. 
When the 5' non-coding region of the P. falciparum DHFR gene is 
compared to mouse, human, Chinese hamster or C. fasciculata DHFR genes, 
no significant sequence homologies are found. Therefore, despite the 
similarity in the promoter sequences among the mammalian DHFR systems, 
it is not known which motifs are important in the protozoan system. The two 
kinetoplastids, L. major (Kapler et al., 1987) and C. fasciculata (Hughes et al., 
1989) share striking homologies in the coding regions of the DHFR-TS genes, 
however, the non-coding regions vary significantly. Although closely related 
phylogenetically, they appear to have evolved different transcriptional 
regulation sequences. We cannot predict, therefore, the putative promoter 
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Fig. 6.7 A summary of the results obtained from PCR and primer extension. 
The major start sites (solid arrow) were mapped to about 550bp by primer 
extension, in a region mapped to contain the major start site by PCR. Both 
methods detected a putative minor start site in the 5' upstream region 
(dotted arrow and dotted line). 
Fig. 6.8 The transcriptional unit of the DHFR-TS gene from 3D7 
and HB3. The sequence of the 5' non-coding region of the gene 
from 3137 is shown on top. The sequence begins behind the 
broken lines. The differences in the HB3 sequence are shown as 
either insertion of sequences or deletion of sequences (dotted line) 
in the bottom line. 
Key: 
arrows: major transcriptional start sites as mapped by 
primer extension; solid arrow represents the major 
signal whereas the two dotted arrows represent two 
minor signals (see also Fig. 6.5) 
arrowheads: approximate locations of minor transcriptional 
start sites as mapped by primer extension (see also 
Fig. 6.6) 
boxed: 'TATA' boxes 
boxed and overlined: 'CAAT' boxes 
overlined: oligonucleotide primers, arrows indicate their 
orientations 
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3D7 	 _J_ 
HB 3 AAAAAGAAAAGCCTTTATATTGAAACTAGCTCACAAA 	-979 
3D7 TTAAATAAATAA.ATATATATATATTTTATATATATATGTA 	-901 
HB3 	 . . . . 	 -943 
3D7 TAATTCTTTCAGTGCAC .............. ATATATATA 	-875 
HB3 	 ATATATATATATAT 	 -903 
3D7 TATATATATATATATATATATAATATTCTCCGTTTTATTT 	-835 
HB3 	 -863 
3D7 TATTTTATTTTTTTTTTTTTTAAATATTATATTTTAAAGA 	-795 
HB3 	 -823 
V 	 __ 	 V 
3D7 TAT 	 TTTTATAATATATATGTCTATGGGAAT 	-755 
HB3 	 -783 




3D7 TAATAATATACCTTAAAAAAATTATTATAGAGAAGGAT 	-675 
HB3 	 -703 
B2 
3D7 ATTTATTTTTATTATAAGTTCTATTCACATATCCATATGA 	-635 
HB3 	 -663 
3D7 	 ............ ATTT 	-607 
HB3 ATTTATTTATTT 	 -623 
3D7 ATTTATTTATTTATTTTATTTTTCTTATATGCACTTTCCT 	-567 
HB3 	 u 	 -583 
$ 	$ 
3D7 TGTATGTCATTCTTTATATTAGAAGAACATATTATAC 	-527 
HB3 	 -543 
3D7 ATATATAAAAATATTATATCTCATATAATTTTTGTACAGT 	-487 
HB3 	 -503 
B3 
3D7 TTTTTATTGGTTTCTATTGTTTTTTTTTTTTTTTTTTT 	-447 
HB3 	 -463 
3D7 TTCTCATTCCATTTATATAAGTATGATTAGATTTGTTT 	-407 
HB3 	 -423 
B4 
3D7 GAAAAAAAAAAAAAAAAATTATCATCATAAGAAATATT 	-367 
HB3 	 -383 
3D7 TTACACATTTGAAATATAATTkAGATATTTATTTTATAT 	-327 
H33 	 -343 
3D7 ATATTTAAATGAATAGATACATTTATTTATGAATGTTT -287 
HB3 -303 
'43 
3D7 AAAAGTTATATTAAGGGGATTATAATAAAAATATAATATA -247 
HB3 -263 
3D7 TAAATAAATAAATATAAATAAATATATATATATATATATA -207 
HB3 . 	 . 	 .. -227 
3D7 GTTTTTTTTTTTTTTTTTTTTTTTTTTACTAGCCATTTTT -167 
HB3 -187 
3D7 GTATTCCCAAATAGCTAGTTCATTTTAACTTACACAATAT -127 
HB3 -147 
3D7 ATATTTTTCTTTAAATTTATAA.AATATATCCCATTT -87 
HB3 -107 
'42 
3D7 TCAAGATTGATACATAAAGATAATATATATATATATATAT -47 
HB3 -67 
3D7 ATATATATATA .................... TTTATTTAT -27 
HB3 TATATATATATATATATTTA -27 
3D7 TTATATATTTATATTTTCTCCTTTTTATGATGGAACAAGT 14 
HB3 14 
/11 
3D7 CTGCGACGTTTTCGATATTTATCATATGTGCATGTTGT 54 
HB3 54 
3D7 AAGGTTGAAAGCAAAAATGA 74 
HB3 74 
motifs in. the more remote P. falciparum DHFR-TS gene by comparing with 
other protozoa especially when the AT content of its genome is so different. 
We therefore look for sequences that appear to have frequent 
occurrence namely 'TATA' boxes (Breathnach & Chambon, 1981) and 
'CAAT boxes (Efstratiadis et al., 1980; Grosveld et al., 1982; McKnight et al., 
1985). A 'TATA' box is identified 90-100bp from the major start sites in the 
DHFR-TS genes presented here. Similar 'TATA' sequences are located more 
than 40bp away from the mRNA start sites in P. knowlesi Cs gene (Ruiz I 
Altaba et al., 1987) and P. yoelii PMMSA gene (Lewis, 1990). The location 
of the TATA sequence at this position resembles that of yeast in which the 
'TATA' boxes are located at variable distances up to lOObp from the 
transcriptional start sites (Guarente, 1985). In yeast, the 'TATA' boxes are 
used to determine the level of transcription but not the precise position of 
transcription initiation (Guarente, 1985). The occurrence of heterogeneous 
start sites in Plasmodium genes may also imply a functional similarity of the 
'TATA' boxes between the two species. 
No 'CAAT boxes are found close to the major transcriptional start 
sites of the P. falciparum DHFR-TS gene. However, two 'CAAT' sequences 
are located -816 to -819 and -804 to -807, which are '70-80 bases from one 
of the minor start sites. 'CAAT boxes are normally situated 40-110bp from 
the transcriptional start site in other species (Efstratiadis et al., 1980; 
Grosveld et al., 1982; McKnight et al., 1985). In Plasmodium, 'CAAT boxes 
also occur in some of the genes analysed e.g. the P. knowlesi CS gene (Ruiz 
I Altaba et al., 1987), the PMMSA (gp195) gene (Myler, 1990) and the 
calmodulin genes of P. falciparurn (Robson & Jennings, 1991), in positions 45-
170 bases from the transcriptional start sites. 
A number of potential Z-DNA forming sequences are located in the 
non-coding region of DHFR-TS gene (see Fig. 5.15). Formation of Z-DNA 
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has been evident to associate with transcriptional activities in eukaryotic, viral 
and protozoan systems (Nordheim & Rich, 1983b; Pardue et al., 1983). Poly 
(CA) stretches, capable of adopting a Z-DNA configuration are located in the 
upstream region of L. major DHFR-TS gene (Kapler et al., 1987). Short 
stretches of alternating purine and pyrimidine are also found in P. knowlesi 
CS gene (Ruiz I Altaba et al., 1987) and P. yoelii PMMSA gene (Lewis, 
1990). 
The exceptionally high AT content in the Plasmodium genome may 
imply the possible utilization of a completely different regulatory sequence 
motif from the standard eukaryotic system. Sequences such as poly (AT) and 
oligo (dA), oligo (dT) tracts are commonly found in the Plasmodium non-
coding regions. These sequences have the potential to induce conformational 
changes (Arnott et al., 1983; Suggs & Wagner, 1986; Alexeev et al., 1987), 
thus affecting the binding of regulatory proteins, resulting in activation or 
inactivation of the gene. Proteins such as histone Hi, lac repressor, and 
proteins of unknown function from Drosophila and Dictyostelium have been 
shown to bind to AT rich DNA (Renz & Day, 1976; Klug et al., 1979; 
Levinger & Varshavsky, 1982; Garreau & Williams, 1983). 
6.1.4 Determination of the Size of DHFR-TS Transcript 
Northern blot analysis was used to measure the size of the mRNA 
transcript. Total and poly K RNA was fractionated on formaldehyde 
denaturing gels and blotted before hybridizing with a probe derived from the 
DHFR-TS gene of the Ki isolate (Snewin et al., 1989) 
The results are shown in Fig. 6.9. A single transcript of 3.5kb from 
3D7 total RNA was observed. A control track containing poly K RNA did 
not reveal any band. This message probably derived from the major 
237 
Fig. 6.9 Northern blot of total and poly(A) RNA from 3D7, 
probed with a giII-RI probe from the Ki isolate. The arrow 












transcripts. The absence of other bands derived from the minor transcripts 
may be explained by the small quantity of these transcripts which cannot be 
detected by Northern blotting. 
Considering the size of the gene which is 1.8kb and the major 5' 
termini of the transcript mapped to about 550 bases from the AUG codon, 
this would imply a 3' terminusas long as 1.15kb. 
6.2 DISCUSSION 
Mapping of the transcriptional start sites to the same bases in the two cloned 
lines 3D7 and HB3 indicates conserved start sites in different parasite strains 
which are unaltered by their sensitivity to pyrimethamine. 
Apart from the identified major start sites, putative minor upstream 
start sites are also predicted. The presence of two start sites may imply a 
functional significance as they can be used differentially at different stages 
during the cell cycle. It is believed that the enzyme DHFR is cell cycle 
regulated, following the same temporal relationship of DNA synthesis 
(Newbold et al., 1982; Inselburg & Banyal, 1984; de Rojas & Wasserman, 
1985). Although at present there is no evidence to suggest regulation of 
DHFR synthesis at the level of transcription, preliminary results on assaying 
the quantity of the enzyme suggest the stage-specific expression of the enzyme 
(not shown). The rate of enzyme synthesis is greatest at the early schizont 
stage. Similarly, it is suggested that differential expression of the P. 
falciparum -tubu1in gene in different developmental stages involves 
differences in the 5' or 3' sequences (Delves C.J. et al., 1990). Examples are 
also known in eukaryotes. Young et a! (1981) have shown that a single 
mouse a -amylase gene encodes two tissue specific mRNAs that differ only in 
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5' non-coding. sequences. In the non-mammalian eukaryote, Drosophila 
melanogaster, the alcohol dehydrogenase gene contains two 'TATA' boxes 
which are used differentially in the larval and adult stages (Benjayati et al., 
1983; Posakony et al., 1985). 
In contrast to other eukaryotic genes whose 5' leader sequences are 
relatively short, the 5' non-coding sequence of the major mRNA of the P. 
falciparum DHFR-TS is 550 bases in length. This is in a range similar to that 
of other Plasmodium genes i.e. the P. knowlesi CS gene ('270 bases) (Ruiz 
I Altaba et al., 1987); the P. falciarum histidine-rich-protein (HRP) gene 
(700 bases) (Ravetch et al., 1984); the P. yoelii PMMSA gene (400 bases) 
(Lewis, 1990); the P. falciparum gp195 gene (°520 bases) (Myler, 1990) and 
the P. falciparum aldolase gene ('322 bases) (Knapp et al., 1990). The 
functional significance of a long untranslated region in Plasmodium is 
unknown but information important for gene control may be contained in this 
region. It is known that elements modulating translation are contained in 
sequences within the 5' untranslated regions of the Drosophila heat-shock 
gene hsp22 (Hultmark et al., 1986), the human ferritin m.RNA (Aziz & 
Munro, 1987; Hentze et al., 1987a; b) and the yeast regulatory protein GCN4 
(Fink, 1986; Mueller & Hinnebusch, 1986). 
Similar to the 5' untranslated region, the long 3' untranslated region 
may reflect a functional significance in regulating gene expression e.g. 
sequences influencing translation, stability and the levels of the mRNA may 
be contained in this region (Casey et al., 1988; Ross, 1988). 
Prediction of promoter elements relies on consensus sequence analysis 
with other known eukaryotic promoter motifs. However, the exceptionally 
high AT content of the Plasmodium genome may imply the possible 
utilization of completely different regulatory sequence motifs from the 
standard eukaryotic system. Ideally, consensus analysis should be performed 
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among functional genes of the same species. The present study provides 
sequencing data and information about the transcriptional start sites of 
DHFR-TS gene from two cloned lines of P. falciparum, which will form the 
basis for consensus analysis when information about the transcriptional units 
of other P. falciparum functional genes are available. Another functional 
gene encoding the enzyme hypoxanthine-guanine phosphoribosyltransferase 
(HGPRT) important in the purine synthesis in P. falciparum has already been 
cloned in our laboratory and it would be interesting to map the 
transcriptional start site for this gene. 
The development of a functional test would prove invaluable in 
prediction of promoter motifs although this is as yet unavailable for the 
Plasmodium system as it requires the development of a transformation system. 
It may be that analysis of expression mutants selected in vitro from a 
genetically pure parent (see CHAPTER 4) offers another means to dissect 
the control of transcription in P. falciparum. Mutants that have an altered 
rate of gene expression may possess a mutated promoter which could be 





The present study provides genetic confirmation that the target for the 
antimalarial drug, pyrimethamine is the enzyme dihydrofolate reductase-
thymidylate synthetase (DHFR-TS). It also opens up the possibility of over-
production of this enzyme as a means of resistance. 
From previous sequencing and biochemical studies (McCutchan et al., 
1984b; Sirawaraporn & Yuthayong, 1984; Dieckmann & Jung, 1986a; Walter, 
1986; Chen et al., 1987; Cowman et al., 1988; Peterson et al., 1988; Snewin et 
al., 1989; Zoig et al., 1989; Sirawaraporn et al., 1990), the changes responsible 
for resistance to pyrimethamine in a number of naturally occurring parasites 
have been pinpointed to specific base changes in the coding region of the 
gene encoding dihydrofolate reductase (DHFR), resulting in a structural 
alteration of the enzyme with reduced affinity for pyrimethamine. The 
present study provides genetic confirmation that the target for pyrimethamine 
is DHFR. The DHFR-TS allele from the pyrimethamine resistant clone 
HB3, tagged by a restriction-fragment-length-polymorphism (RFLP) marker, 
is shown to co-segregate with the pyrimethamine resistance phenotype in the 
progeny of a genetic cross with the pyrimethamine sensitive clone 3D7. No 
other changes i.e. over-production of the enzyme, amplification of the DHFR-
TS gene were detected in HB3. It therefore seems that the single base 
difference previously noted between these two clones is the only event 
responsible for resistance to pyrimethamine in HB3. Evidence that a single 
base change is causing pyrimethamine resistance in HB3 is also demonstrated 
by the absence of intermediate levels of resistance in the progeny of the 
genetic cross (Walliker et al., 1987). 
However, the existence in nature of a wide range of resistance to 
pyrimethamine, with MIC values varying by up to a factor of 106  from 10 10M 
to 104M (Thaithong et al., 1983), suggests the operation of additional or 
alternative mechanism(s). In this study an in vitro selected pyrimethamine 
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resistant mutant, derived from a sensitive parent, is shown to contain twice 
the amount of enzyme as the parent clone. It is argued that this may play a 
role in the drug resistance observed. As there is no evidence of gene 
amplification and the sequence of the DHFR gene remains unaltered, it is 
possible that the mutation(s) giving rise to over-production of the protein may 
be at the transcriptional level. 
The ease with which mutants are selected in vitro which over-produce 
the enzyme implies that they may occur in the field isolates more frequently 
than was thought. Preliminary results have already suggested over-production 
of the protein in a naturally occurring pyrimethamine resistant cloned line, 
PR70/CB3. A thorough and comparative quantification of the protein levels 
in naturally occurring parasite strains will be needed to verify this point. 
A lot of interesting questions remain. For example, is over-production 
of the enzyme caused by an increase in the rate of transcription? Is the 
molecular mechanism causing such a change the same in naturally occurring 
parasite strains and in vitro selected mutants? How common is this 
mechanism in nature? The results of the present study form the basis for 
further investigation of these questions. 
Identification of a putative expression mutant prompted a further study 
on the regulatory unit of the DHFR-TS gene. As a first step towards 
understanding the role played by transcriptional control, the 5' flanking region 
of the gene from two parasite cloned lines with different sensitivity to 
pyrimethamine were sequenced and the transcriptional start sites mapped. 
It seems that the transcriptional start sites are conserved in spite of the minor 
variations in the upstream sequences and the difference in sensitivity to 
pyrimethamine. 
Further studies will be focused on comparative analysis of the in vitro 
mutant T9/94 (MM) with the parent T9/94 since this provides a well- 
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defined system. for pinpointing the mutation(s) giving rise to pyrimethamine 
resistance and for studying transcriptional regulation in this organism. 
However, further tests need to be performed to characterize the nature of the 
mutation giving rise to T9/94 (Ml-1) to see whether this mutation represents 
an alteration of the parasites transcriptional machinery. As a start the level 
of the mRNA should be quantified by Northern blotting. The upstream 
region of the pyrimethamine resistant mutant T9/94 (Ml-1) should be 
sequenced and compared to that of the pyrimethamine sensitive parent clone 
T9/94. 
Mutants that have an increased transcription rate may involve an 
altered promoter or possibly other changes such as mutation(s) in 
transcription factors. Mapping of the transcriptional start sites and 
comparative sequence analysis of the upstream regions from mutants and 
parent parasites would not only pinpoint any changes contributing to 
pyrimethamine resistance but could also help to predict elements which are 
significant in gene transcription. This in turn would offer a means to dissect 
the promoter machinery of P. falciparum. At present, however, there is no 
functional test for the Plasmodium transcription system and only few 
Plasmodium genes with known transcriptional units are available for 
consensus analysis. The development of a functional test ultimately relies on 
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11. Aspects of pyrimethamine resistance in Plasmodiumfakipanun 
S. -W. C/ian', D. Waliiker 2, V. Snewin 3, J. E. Hyde3, 
G. Beale 7 andJ.G. Scaife" 
'Department of Molecular Biolo, 
University of Edinburgh, 
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U.K 
The control of malaria remains a major priority in the health programmes of many tropical 
countries. Despite recent efforts to develop a subunit vaccine against the disease, we still 
rely on drugs to combat malarial infections. 
Chemotherapy has one major drawback. Extensive use of popular anti-malarial 
drugs has selected resistant parasites. In certain parts of the world some drugs can no 
longer be used against Plasmodium falciparuin. For example, in S.E. Asia the majority of 
parasites are resistant to chioroquine (chi') and pyrimethamine (pyrR),  so many patients 
must now be treated with drugs which are more expensive or have significant side effects. 
Despite this, little is understood about the mechanisms underlying drug resistance 
in malaria. For example, the precise target for chioroquine is still unknown. In fact this 
drug may have multiple targets in Plasmodium, since in at least one case, a chl' parasite has 
been found to have more than one mutation (Padua, 1981).. Other studies suggest that the 
chlR phenotype may also arise by a different mechanism. Tumour cell lines can become 
drug resistant by activation of a verapamil-sensitive, Ca '-dependent pump which removes 
the drug from the cell (Rogan etal., 1984; Fojo etal., 1985; Chen etal., 1986). A similar 
system may operate for some chi' mutants of P. falciparum (Martin etal., 1987). 
In the present study cur interest focuses on pyrimethamine. Resistance to this drug 
has a different perspective. it is an analogue of dihydrofolate and its target is thought to be 
the enzyme, dihydrofolate reductase (DHFR). The product of the enzyme, tetrahydrofo-
late, and derivatives of this compound participate in several vital steps of parasite metabo-
lism. Perhaps the most important of these is catalysed by the enzyme thymidylate synthase 
(TS) which uses N5, N'° methylene tetrahydrofolate to convert dUMP to dTMP for use in 
DNA synthesis. Remarkably, in P. falciparwn, as in certain other protozoa, a single protein 
molecule carries both DHFR and TS functions (Ferone, 1970; Garrett et al., 1984; Bzik et 
al., 1987). 
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The gene for DHFR-TS has been cloned from P. falciparuin and sequenced. The 
amino-acid sequence encoded by the gene shows a N-terminal segment (amino-acids I to 
228) homologous to DHFR sequences in other organisms. At the C-terminus (amino-acids 
323 to 608) the sequence shows homolo' with TS. Between the two (amino-acids 229 to 
322) is a peptide which presumably functions as a linker (Bzik et al.. 1987; Peterson et al.. 
1988; Snewin et al., 1989). 
This extensive molecular information helps us formulate models about the mecha-
nism underlying resistance to pyrimethamine. They lead to clear predictions, some of 
which will be tested in this paper. 
We can envisage at least three basic mechanisms which could contribute to pyrime-
thamine resistance in malaria parasites. The target enzyme could be changed in structure 
to reduce binding of the drug. Mutations of this type have been documented in other 
organisms which have acquired resistance to antifolates such as methotrexate (Pan et al., 
1983). Equivalent changes have been reported for P. falciparunz (Inselburg et al., 1987). 
The mutant could make an excess of the enzyme so that the drug cannot completely block 
the synthesis of tetra hydrofolate. A mutant of P. falciparum selected in vitro appears to 
function in this way (Inselburg et al., 1987). However, there may be mutants which are 
resistant to the drug, not because the enzyme is changed but, because uptake or subsequent 
processing of the drug in the parasite is changed. To date, pyrR  mutations of this kind have 
yet to be found in P. falciparum. 
In this paper we shall present genetic and molecular biological studies on two 
clones of P. falciparum. One of them is naturally resistant to pyrimethamine. Our data 
throw light on the nature of the pyrR  mutation in this clone. 
DHFR AND PYRIMETHAMINE IN MALARIA PARASITES 
Biochemical studies on both P. falciparum and P. berghei provide direct evidence that 
pyrimethamine blocks DHFR in vivo (Sirawaraporn and Yuthavong, 1984; Walter, 1986). 
When partially purified enzyre prepared from a pyrS  parasite (3D7) is compared with that 
extracted from a pyrR  parasite (HB3), the enzyme from the latter is significantly less inhib-
ited by the drug in vitro (Chen et al., 1987). This result suggests- that drug sensitivity of the 
parasite may be attributed to inhibition of DHFR. However, this conclusion should be 
confirmed in vivo. For example, one of the other factors listed above could contribute to 
the resistance of HB3. 
This possibility is open to genetic test. If the sole cause of drug resistance in HB3 is 
a change in the structure of its DHFR we should be able to localise the responsible muta-
tion in the gene for DHFR. 
Mapping determinant for pyrk  in cross between clones 
One way to find the genetic determinant for pyrimethamine resistance in HB3 is to use a 
genetic cross. We can mate a pyrS  clone of the parasite with the pyrR mutant, and screen 
the progeny to discover whether the allele of the DHFR gene from the pyrR  parent is 
always found in those progeny which have inherited resistance to the drug. In our experi-
ments we tagged this allele by defining a restriction target in the adjacent parasite DNA. 
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The inheritance of this DNA marker was then correlated with inheritance of resistance to 
the drug in cloned progeny parasites. 
Cross between different clones 
In the study presented here we exploit the progeny from an experimental cross already 
performed between two genetically pure clones of the parasite which had been maintained 
in culture in vitro (Walliker et al., 1987). Two parasite lines were chosen which differed in a 
range of characters including antigens, repetitive DNA and drug resistance (Table 1). The 
haploid blood stages were cultured separately in vitro, mixed and fed to mosquitoes (Fig. 
1). In the mosquito gut the sexual stages of the parasite form diploid zygotes. Haploid 
Gametoc ytes HB3 307 
\ 
in culture 
Gametes I? 	c? ? 	°'1 
Ferti 1 'sat ion 
Zygotes Selfed 	 Crossed Crossed 	 Selfed 
l , osisI 
Parental 	 Parental Parental 	 Parental in nestoto 
progeny and and Progeny 








Blood stages 1 o 
In culture 
Cloned In vltr, J 
Fig. 1. Cross between two clones of P. fakiparwn, HB3 and 3D7. The diagram shows the steps leading to selfed 
and crossed zygotes and how these are manipulated to obtain pure progeny clones for testing. Note that genetic 
makers of HB3 and 3D7 appear in Table 1. 
progeny develop and appear in the salivary glands as sporozoites. During this process, 
recombination occurs, both by reassoriment of whole chromosomes and by crossovers 
between them. As a result, in many of the progeny the characters of the two parents are 
reassorted. In the experimental cross the progeny were scored as follows. Firstly, the 
sporozoites were introduced into a chimpanzee and allowed to develop in the liver. These 
ultimately gave rise to asexual stages in the blood which were subsequently cloned in vitro 
and tested for the markers of interest. 
Restriction fragment length polymorphism in vicinity of gene for DHFR 
Like other organisms, P. falciparum shows minor variations in the DNA surrounding a 
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particular gene. These can be used as markers which distinguish the alleles of a given gene 
in a cross. We found a restriction enzyme, AccI (Fig. 2), which cuts the DNA in the neigh-
bourhood of the DHFR gene in the two parents of the cross. The pyrS  parent (3D7) gives a 
DHFR fragment 2.4 kb long, whilst the same enzyme yields a DHFR fragment of 2.15 kb in 
the DNA of the resistant parent (1-1133). The difference can be seen in Fig. 3, where the 
DHFR-containing fragment of HB3 migrates to a lower position on the gel than that of 
3137. These and neighbouring fragments have been visualised in the following way. DNA 
containing the DHFR-TS gene of P. falciparum had previously been inserted into bacterio-
phage lambda in order to sequence the gene (Snewin et al., 1989). The structure of the 
gene and the fragments inserted in the phage vector are shown in Fig. 2. Insert DNA from 
the recombinant phage i contains all the DHFR domain of the gene together with the 
sequence just upstream from the coding sequence (Fig. 2). This insert, labelled with P, 
was used to visualise the fragment in Southern blots of parasite DNA. 





Acci 	 Acci 
2kb 	 4, 
	
I 5159108 	228 	326 	 608 
F" 	 DHFR 	AINCTION 	 TS 	 --- Chromosome i 
I 	 14- 06kb 104 
: 	 1.8kb: 
II— ----------- 54kb 
ADHFR clone 
coRl 	 EcoRl 
Fig. 2. Organisation of the gene for DHFR-TS. Targets and sequence recognised by the restriction enzyme 
AccI in DNA are shown. Important amino acid positions are numbered on the gene (see text). Positions 51, 59 
and 108 are candidate sites for amino acid changes affecting pyrimethamine sensitivity (Peterson et al., 1989; 
Snewin etal., 1988). The origin of the EcoRi A DHFR clone is described by Snewin ci al. (1988). The position of a 
putative deletion responsible for theAccl RFLP is indicated: ]. 
The difference between the fragments detected in the DNA from HB3 and 3D7 by 
the probe thus defines a restriction fragment length polymorphism (RFLP) for the DHFR 
of these two parasite lines which can act as marker for the two alleles of the gene. 
Segregation of DHFR gene in progeny of cross 
Blood from the chimpanzee infected with parasites from the cross described above was 
used as an inoculum for parasite culture in vitro. The parasites established in culture were 
then cloned by the end-point dilution method and by micromanipulation. A total of 29 
independent clones was obtained in this way. These were then screened for the markers in 
the cross (Table 1). Note that three of the clones had a combination of markers identical 
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Table 1. Linkage of RFLP with pyrR  in the progeny of a cross 
RFLP PyrRSb MAb7.3c MAb9.2c MAbI2.3d Progeny 
Phenotypee 
3D7 1 S - + + 
HB3 2 R + - - 
X2 2 R + - + rec 
X4 2 R + - rec * 
X6 2 R - + - rec 
X8 1 S - + + par 
.X1O 1 S + - - rec 
Xli 2 R + - - rec* 
X12 2 R + - rec* 
X30 1 S + - + rec 
X33 2 R + - + rec 
X34. 2 R - + - rec 
X35 2 R - + - rec 
X36 1 5 - + + par 
X37 1 5 - + + par 
X41 2 R • + - rec 
X44 1 S + - + rec 
X45 1 S - + - rec 
X47 1 S + - - rec 
X48 1 S - + - rec 
X50 1 S - + - rec 
X51 1 S + - - rec 
X52 1 S + - - rec 
X58 1 S + - - rec 
X63 1 S - + - rec 
XP1 2 R + - - rec * 
XP3 2 R + - - rec * 
XP5 2 R + - - rec * 
XP7 2 R + - - rec * 
XP8 2 R + - - rec * 
XP9 2 R + - - rec* 
a The 2.4 kb frapnent of 3D7 =1; the 2.15 kb fragment of HB3 = 2. b  Sensitive to 10-7 M pyrimethamine or more; 
resistant to 10 M pyrimetharnine or less. C  Monoclonal antibodies against a 195 kDa schizont surface antigen. 
d Monoclonal antibody against a 40 kDa schizont surface antigen. e  Progeny are designated either parental (par) 
from selled zygotes or recombinant (rec) from crossed zygotes. • These progeny are recombinants as judged by 
other criteria (segregation of proteins on 2D gels). 
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with that of the 3D7 parent. We had to exclude these from the subsequent analysis be-
cause they could have derived from selfed zygotes in which the markers would not be able 
to recombine (see Fig. 1). The remainder, which must have developed from cross-fertilised 
zygotes, were screened for recombination between p yrR and the RFLP marker in the DNA 
in the following way. 
The confirmed recombinant progeny were tested for their sensitivity to pyrimetha-
mine. Note that the results are simple (Table 1). In the drug test, all of the progeny 
behave like one or other of the parents - either resistant (able to survive up to 10 M) or 
sensitive (killed at 10 -'M or more). No progeny of intermediate resistance were found. 
At the same time their DNA was extracted, cut with AccI and checked with the 
DHFR probe. A clear difference is seen between the digests of the sensitive and resistant 
progeny. The results are illustrated in Fig. 3 and summarised in Table 1. All of the proge-
ny with the sensitive phenotype have the 2.4 kb DNA fragment characteristic of the sensi-
tive parent. The remainder have that of the resistant parent (2.15 kb). Thus, in our exper-
iment, pyrimethamine-resistance is always linked to the gene for DHFR tagged by the 
RFLP marker. Our results suggest that the mutation conferring drug-resistance on the 
strain HB3 is linked to the DHFR gene. 
Parent 	 Progeny 	 Parent 
<1 1< 
rr 	(VS •. 	c,-, c—i - 	_ 
— - - 	 - 0 ' 	 - 






Fig. 3. RFLP marker revealed when the DHFR-TS DNA of the parasite is cut withAccl. Note the difference in 
the upper band between the pynrnechamine sensitive (3D7) and resistant (HB3) parents. The lower bands are 
adjacent fragments which hybridise to the probe (see Fig. 2). Note that the progeny clones have only one of the 
two possible RFLP's. Bands were visualised by blotting to a Hybond nylon filter, denatured and probed with 32p - 
labelled DHFR DNA (see Fig. 2). 
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The simple interpretation of our results is that the mutation is in the DHFR itself. 
This conclusion would be strengthened if we could test a larger number of progeny without 
the laborious isolation of individual clones used above. To this end we devised the follow-
ing experiment. Uncloned progeny parasites were cultured in the presence of pyrimetha-
mine long enough to select the resistant parasites from the cross. DNA was then extracted 
from the resulting population, which were a mixture of parasites all resistant to the drug. 
Firstly, this was compared with the DNA of a parallel mixture of parasites, not selected for 
pyrimethamine resistance. In addition, we calibrated the sensitivity of our test by mixing 
known amounts of 3137 and HB3 DNA. The DNA samples cut with AccI and probed for 









U 	cu Calibration 






Fig. 4. Detection of the RFLP for DHFR in uncloncd progeny DNA. Each track contains 3 hg of total DNA 
cut with AccL We show DNA from (track 1) unselected progeny and (track 2) progeny selected for growth in 10 
M pyrimethamine. Tracks 3,4 and 5 contain artificial mixtures of DNA from sensitive (3D7) and resistant (HB3) 
parasites to assess the minimum amount of the 3137 RFLP detected. 
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by the drug, yield DHFR fragments characteristic of both the sensitive and resistant alleles 
in approximately equal proportions (track 1). By contrast, those grown up in the presence 
of pyrimethamine had only one DHFR allele - that characteristic of the resistant parent 
(track 2). In this test, the sensitivity is significantly higher. The mixtures show that if for a 
hundred resistant parasites there were only one 'aberrant' sensitive DHFR allele we would 
have detected it (tracks 3, 4 and 5; see arrow). Thus, our evidence indicates that the muta-
tion to pyrimethamine resistance in the strain HB3 is located in, or at least close to, the 
DI{FR gene. 
DHFR gene not amplified in HB3 
The mutation affecting the DHFR gene in HB3 could change the coding sequence and thus 
reduce the impact of pyrimethamine on the function of the enzyme. Alternatively, or in 
addition, the gene could be amplified, causing overproduction of the enzyme in the para-
site. To test this possibility we have used dot blots (Fig. 5). Measured amounts of the 
DNA from both the resistant and sensitive clones were spotted on to nitrocellulose and 
probed with the DI{FR fragment. Control spots probed with another gene (for ribosomal 
RNA) confirm that equal amounts of total DNA from each parasite was loaded in this 
experiment. If the gene in the resistant clone, HB3, had been amplified, we would have 
expected to see more DHFR copies in its DNA than in the DNA of the sensitive clone, 
3137. In fact, the two DNA samples hybridise with equal intensity to the probe, implying 
that the resistant strain has the same number of copies of this gene as the sensitive one. 
125 63 31 16 8 	ng total DNA 
3D7 	 DHFR 
HB3 	• S 	 probe 
123 61 31 15 8 	ng total DNA 
900 450 225 113 	ng total DNA 
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900 450225113 	ng total DNA 
Fig 5. Dot blot analysis of DNA from pyrimethamine sensitive (3137) and resistant (HB3) clones of F. falcipa.. 
rum. Dilutions of DNA from each parasite were spotted directly to two Hybond nylon filters and denatured. 
Estimated quantities of DNA are shown. Bonded DNA was probed with 32P-labelled DHFR probe (see Fig. 2) 
and a fragment of the rRNA genes (prib2; Langsley ci al., 1983). 
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CONCLUSION AND DISCUSSION 
In a cross between two P. falciparum strains pyrR  behaved as a single mutation. The muta-
tion was linked to the gene for DHFR and is probably located close to the gene or within it. 
No evidence for gene amplification was found. 
Our results provide genetic confirmation for the conclusion recently drawn from 
localised sequencing studies reported by Peterson et al. (1988), which showed that HB3 has 
a base change in the DHFR gene, changing a serine at position 108 in the polypeptide 
chain to an asparagine. Comparisons have been made between the primary amino acid se-
quences of the enzyme DHFR from several different organisms. The crystal structures of 
the enzymes from Escherichia coli and Lactobacillus casei combined with these sequence 
comparisons allow us to pinpoint to the likely places in the polypeptide chain of the P. 
falciparuin enzyme where pyrimethamine could bind. The serine at position 108 is in such 
a place (Peterson et al., 1988; Snewin et al., 1989). 
The present studies leave a number of interesting questions unanswered. Parasites 
isolated from nature have a wide range of resistance to pyrimetha mine. Some parasites 
can tolerate as much as 1,000 times more of the drug than the sensitive organism (see 
Walter, 1986; Thaithong, S., pers.comm.). By contrast those isolated following selection in 
culture in the laboratory show relatively low levels of resistance to the drug (Banyal and 
Inselburg, 1986). This suggests that there may be several other mechanisms which contrib-
ute to resistance. These may include the changes in drug uptake and targetting discussed 
above in addition to changes in the regulation of DHFR gene expression which could give 
more enzyme without amplification of the gene itself. 
SUMMARY 
Current therapy and prophylaxis of malaria are limited by the spread of parasites resistant 
to the commonly used drugs. An understanding of the genetic basis of resistance could 
help in the design of new drugs and the prediction of its mode of spread through a parasite 
population. We are studying resistance to pyrimethamine, whose target is the enzyme 
dihydrofolate reductase. Mutants (pyrR)  resistant to pyrimethamine can have an altered 
dihydrofolate reductase (dhf). However, other factors may participate in resistance to this 
drug e.g. mutation affecting uptake could contribute to resistance. 
Analysis of pyrR  inheritance in a cross between sensitive and resistant clones of 
Plasmodiurn falcipanun could throw light on this question. The dhf gene cloned in phage 
lambda has been used to identify a restriction fragment length polymorphism (RFLP) in 
the DNA of the resistant parent of the cross (HB3). This specifically distinguishes it from 
the DNA of the sensitive parent (3D7). The RFLP is being used as a marker for inheri-
tance of the dhf gene from the resistant parent. If this is the sole determinant of resistance 
to the drug, we should find that all of the pyrR  progeny have this RFLP. 
In parallel studies we are using the cloned gene to seek dhf sequence changes asso-
ciated with resistance. 
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